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ABSTRACT
Alden C. Adrion: Improving PAH Biodegradation in Contaminated Soil by Adding Surfactant 
After Conventional Biological Treatment 
(Under the direction of Michael D. Aitken) 
 
Polycyclic aromatic hydrocarbons (PAHs) are a class of compounds which occur 
frequently at polluted sites and are known or suspected to be toxic and genotoxic. 
Bioremediation is one option for the treatment of PAH-contaminated soil, but PAHs are often 
strongly bound to soil and may be unavailable to degrading microorganisms. Limited PAH 
desorption can be particularly problematic for weathered soils or soils which have undergone 
treatment but fail to meet cleanup goals. Additionally, bioremediation does not always lead to a 
reduction in soil (geno)toxicity. This dissertation addresses these limitations by screening 
nonionic surfactants enhanced desorption and biodegradation of residual PAHs remaining in soil 
after conventional slurry-phase bioreactor-treatment. Surfactant doses were chosen to be below 
the critical micelle concentration in the soil-slurry system. The effect of surfactant-amended 
treatment on soil (geno)toxicity was also evaluated. The best performing surfactant was selected 
for use in a second-stage bioreactor to evaluate the reproducibility of surfactant-amended 
treatment and to investigate the effect of varying residence time. 
In screening experiments, further treatment of the soil with all surfactants resulted in 
modest increases in PAH desorption. Four out of 5 surfactants increased PAH biodegradation 
relative to further treatment without surfactant. The most effective surfactants significantly 
enhanced the biodegradation of 5 of the 7 PAHs considered probable human carcinogens by the 
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Environmental Protection Agency (individual PAH removals up to 80%). Further treatment 
without surfactant significantly reduced the genotoxicity of the soil, while treatment with 
surfactant had varying effects. Increased PAH removal, however, did not always coincide with a 
reduction in soil toxicity and genotoxicity.  
For the two-stage bioreactor system using polyoxyethylene sorbitol hexaoleate surfactant, 
substantial amounts of the PAHs and oxygenated-PAHs remaining after conventional bioreactor-
treatment were removed in the second stage, including more than 80% of residual 4-ring PAHs. 
The most substantial PAH removal in the second stage occurred within the first week of 
treatment. Surfactant-amended treatment consistently made the soil less cytotoxic, but in most 
trials increased the genotoxicity of the soil. With further optimization of the treatment system, 
surfactant-enhanced treatment may increase the applicability of bioremediation as a means of 
meeting soil remediation goals.
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CHAPTER 1: INTRODUCTION 
Polycyclic aromatic hydrocarbons (PAHs) are a class of compounds  of environmental 
and public health concern because of their known or suspected toxicity and genotoxicity and 
frequent occurrence at contaminated sites (ATSDR 1995). The Agency for Toxic Substances and 
Disease Registry (ATSDR) and the United States Environmental Protection Agency (US EPA) 
have consistently ranked PAHs among the top ten contaminants of concern at sites on the 
National Priorities List (NPL). This ranking takes into account not only toxicity, but also 
frequency and potential for human exposure at NPL sites (ATSDR 2011). Over 600 current NPL 
sites are contaminated with PAHs, of which over 400 contain PAH-contaminated soil (EPA 
2015). PAH-contaminated soil poses a human health risk because of the potential for direct 
human exposure to the soil, leaching of PAHs into surface- or groundwater, volatilization of 
PAH, and the transport of PAH-contaminated particles through the air (ATSDR 1995).  
Bioremediation is a “process whereby organic wastes are biologically degraded under 
controlled conditions to an innocuous state, or to levels below concentration limits established by 
regulatory authorities” (Mueller 1996). A 2007 EPA report on treatment technologies states that 
as of 2005, out of 145 remediation projects treating PAH contaminated source material, 37 
utilized bioremediation (EPA 2007). Bioremediation of contaminated soil can be conducted in-
situ by stimulating biological degradation in the intact soil, or ex-situ by stimulating 
biodegradation in excavated soil. One advantage of ex-situ bioremediation is an increased ability 
to control conditions such as temperature, pH, moisture, and nutrient content as well as provide 
mechanical mixing and chemical amendments in an engineered system such as a bioreactor. 
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Between 2009 and 2011 at least three additional NPL sites having PAH-contaminated soil 
selected ex-situ bioremediation as a cleanup method (EPA 2013).  
Although ex-situ bioremediation can be utilized as a cleanup strategy, it is not without 
limitations. Two fundamental limitations of bioremediation include incomplete removal of the 
target PAH (Aitken and Long 2004) and the potential to increase soil (geno)toxicity (Hughes et 
al. 1998; Gillespie et al. 2007; Lemieux et al. 2009; Hu et al. 2012). One factor limiting removal 
can be the slow desorption of PAHs from soil compartments, reducing the availability of PAH to 
degrading microorganisms. The addition of surfactants during bioremediation can enhance the 
bioavailability of PAHs to degrading microorganisms, as reviewed in Makkar and Rockne 
(2003), Li and Chen (2009), Elliot et al. (2011) and in Section 2.3 of this dissertation. The 
purpose of the research described in this dissertation was to investigate the effect of low-dose 
surfactant addition on the ex-situ bioremediation of PAH-contaminated soil from a former 
manufactured-gas plant (MGP) site which had already undergone conventional bioreactor 
treatment. The effects of second-stage surfactant-amended treatment on PAH removal and soil 
(geno)toxicity were evaluated. 
1.1 Specific aims and rationale 
Aim 1: Evaluate the effect of conventional bioreactor treatment on the removal and 
bioavailability of oxy-PAHs in contaminated soil.  
Oxygenated-PAHs (oxy-PAHs) are of concern because some are known to exhibit toxic 
or genotoxic effects (Bolton et al. 2000; Zielinska-Park et al. 2004; Luo et al. 2011), and may 
also inhibit the biodegradation of parent PAHs (Kazunga and Aitken 2000; Kazunga et al. 2001). 
The goal of Aim 1 was to develop a liquid chromatography-mass spectrometry (LC-MS) method 
to measure the concentrations of four oxy-PAHs in solvent-extracts of soil and solid-phase-
extraction resins provided by the former student, Jing Hu. This method was used to determine 
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the removal and desorbable fractions of oxy-PAHs during bioreactor treatment. The LC-MS 
method was also used to evaluate the effect of surfactant-amended treatment on the removal of 
oxy-PAHs in Aim 3. The desorbable fraction of oxy-PAHs remaining after conventional 
bioreactor treatment measured in Aim 1 was compared with the fraction of oxy-PAHs removed 
during second-stage treatment in Aim 3.  
Aim 2: Screen nonionic surfactants for enhanced biodegradation of PAHs remaining in soil after 
conventional bioreactor treatment. 
The efficacy of bioremediation for soil contaminated with PAHs may be limited by the 
fractions of soil-bound PAHs that are less accessible to PAH-degrading microorganisms. 
Although surfactant addition to contaminated soil has been suggested as a means of enhancing 
the biodegradation of hydrophobic contaminants such as PAHs, most studies do not articulate 
that the concept is most relevant to the fraction of a given compound that is relatively non-
desorbable or non-bioaccessible. This would be the case for the PAHs remaining after 
conventional bioreactor treatment has removed the most bioaccessible fraction. Aim 2 was to 
screen nonionic surfactants at the test-tube scale for their ability to enhance desorption and 
biodegradation of PAHs remaining after conventional slurry-phase bioreactor treatment. Five 
surfactants of similar hydrophobicity but with different chemical structures were selected for 
screening. Surfactant doses (mg surfactant/g dry soil) were selected to correspond to 
concentrations less than the critical micelle concentration in the soil-slurry system (sub-CMC 
doses). Sub-CMC doses were evaluated based on evidence of their effectiveness (Zhu and Aitken 
2010) and the reduced field-scale cost of lower doses. Since bioremediation does not always lead 
to a reduction in soil (geno)toxicity, the effect of surfactant-amended treatment on soil  
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(geno)toxicity was also evaluated using the DT40 DNA damage response assay (reviewed in 
Section 2.5.1). 
Aim 3: Implement second-stage treatment of PAH-contaminated soil in a surfactant-amended 
bioreactor and evaluate its performance. 
As a step towards demonstrating the feasibility of surfactant-amended ex-situ 
bioremediation in the field, based on the results of Aim 2, one surfactant was selected for use 
during second-stage treatment of soil in a bench-scale bioreactor. Second-stage reactors were 
operated for a total of six cycles to evaluate the reproducibility of surfactant-amended treatment 
and the effects of residence time on PAH and oxy-PAH removal and on soil (geno)toxicity. 
1.2 Dissertation organization  
There are six chapters in this dissertation. Chapter 1 provides an introduction and briefly 
explains the aims of the dissertation. Chapter 2 is a literature review which provides background 
helpful to understanding the work. Chapters 3, 4, and 5, provide additional introductory material 
on and describe the methods and results of Aims 1, 2, and 3, respectively. Chapter 3 documents 
my contribution to the published work, Hu et al. (2014). Chapters 4 and 5 are manuscripts 
intended for publication. Chapter 5 makes reference to the work in Chapter 4 by citing Adrion et 
al. (in prep.).
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CHAPTER 2: BACKGROUND 
2.1 PAH-contaminated sites 
PAHs are a class of compounds made up of two or more fused benzene rings and/or 
pentacyclic moieties in linear, angular and cluster arrangements (Mueller 1996). This structure 
affords thermodynamic stability due to electron delocalization (resonance). PAHs are 
hydrophobic, characterized by low aqueous solubilities, and typically associated with particles or 
surfaces in the environment. These properties can make PAHs resistant to natural attenuation 
processes such as volatilization, photolysis and biodegradation (Mueller 1996). Although there 
are natural sources of PAH, as well as diffuse deposition of atmospheric anthropogenic PAHs, 
Mueller et al. (1996) point out that contamination of soil, sediment, and groundwater are 
primarily the result of four point source materials: coal tar, creosote, petroleum, and industrial 
effluents. The primary anthropogenic source of coal tar is the gasification of coal, which has 
historically occurred at manufactured-gas plants. Creosote is distilled from coal tar and used as a 
wood preservative at wood-preserving sites. These contaminated sites are often also 
contaminated with benzene, toluene, ethylbenzene and xylene (BTEX), heavy metals and 
aliphatic hydrocarbons (Bamforth and Singleton 2005), heterocyclic aromatic compounds 
(HAC), alkylated-PAH, and oxy-PAH (Lundstedt et al. 2003). The US EPA regulates 16 PAHs 
as priority pollutants, and site cleanup goals are typically based on the concentration of these 
priority PAHs (Aitken and Long 2004). Additionally, the US EPA Ecological Monitoring and 
Assessment Program (EMAP) recommends quantifying 34 PAHs in sediments (Burgess 2009). 
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2.1.1 Distribution of hydrophobic organic contaminants in geosorbents 
Hydrophobic organic contaminants (HOC) such as PAHs are capable of interacting with 
environmental materials such as soil and sediment. Luthy et al. (1997) refer to such materials as 
geosorbents, which comprise discrete domains. Domains are defined based on their more specific 
and homogeneous properties. HOC interaction with geosorbents can include partitioning of 
HOCs into the bulk geosorbent or its pores, or onto the external surface of a geosorbent. 
Thermodynamic and kinetic properties can be assigned to each interaction between an HOC and 
a given geosorbent. Thermodynamic properties describe the extent to which these interactions 
occur at equilibrium, while kinetic properties describe the rate at which the interactions occur 
under non-equilibrium conditions. 
The simplest model derived from thermodynamic considerations is linear partitioning, 
expressed as a partition constant (K′HOC12) as defined in equation 1. The ideal partition constant 
describes the equilibrium distribution of an HOC between any two thermodynamically uniform 
phases (typically the aqueous phase and geosorbent).  
 = 	
 =    
 ∆   (1) 
Where xHOC1 and xHOC2 are the mole fractions of HOC in phase 1 and in phase 2 respectively. 
∆GHOC12 is the free energy of transfer of HOC from phase 1 to phase 2, R is the universal gas 
constant, and T is the absolute temperature in Kelvin. The major assumption underlying equation 
1 is the existence of a single ∆GHOC12 of constant value which applies to the system. Very often 
the geosorbent of interest does not comprise a single thermodynamically uniform phase with 
which the HOC maintains a single type of interaction over all mole fractions. The distribution of 
interest is actually the equilibrium distribution between the aqueous phase and the multiple 
thermodynamically distinct phases of the geosorbent, characterized by various types of 
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interactions, each having its own free energy of transfer. Under these non-ideal conditions, 
K’HOC12 is instead referred to as a partition coefficient (Schwarzenbach et al. 2005). 
 Replacing mole fractions with more environmentally relevant units, equation 1 can be 
represented as a linear sorption isotherm. 
 =  (2) 
Where Cs is the concentration of HOC associated with the geosorbent (typically in mass 
HOC/mass geosorbent), Cw is the aqueous phase HOC concentration, and Kp is a geosorbent-
water partition coefficient (whose units depend on the units used for the other variables). 
Assuming constant Kp, equation 2 describes a linear relationship between the concentration of 
HOC partitioned into and onto the soil and the concentration in the aqueous phase. Very often 
the relationship is non-linear because the geosorbent comprises numerous phases and the system 
is not well characterized by a constant free energy of transfer.  
In order to account for this non-linearity, a model incorporating multiple geosorbent 
domains is employed. The total equilibrium concentration of HOC in the geosorbent can be 
represented by equation 3. 
 =  ∑    (3) 
Where ms is the total mass of geosorbent and mj is the mass of domain j. Individual mjCj can be 
modeled using linear and non-linear equations, but mj, which usually cannot be determined 
experimentally, is factored into a system-specific coefficient. Empirical formulas used to model 
non-linear geosorbent/HOC partitioning include the Freundlich and Langmuir isotherms, and 
numerous composite models. These formulas make use of adjustable parameters which are 
determined by fitting experimental data (Mechlińska et al. 2009).  
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The Freundlich isotherm, equation 4, accounts for the theory that the free energy of 
transfer from aqueous phase to geosorbent can be a function of equilibrium aqueous phase HOC 
concentration (Schwarzenbach et al. 2005). 
 =    (4) 
The Freundlich constant, Kf, and the Freundlich exponent, n, are determined by fitting 
experimental data. 
The Langmuir isotherm, equation 5, accounts for the theory that there can be a limited 
number of geosorbent surface sites onto which an HOC can sorb (Schwarzenbach et al. 2005). 
 = !"#$%#$  (5) 
S0 represents the total number of surface sites per mass geosorbent and b is a Langmuir constant. 
Both S0 and b are determined by fitting experimental data. 
The dual-mode sorption model, equation 6, states that the equilibrium geosorbent 
concentration is the sum of HOC in a domain modeled by a linear isotherm and a domain 
modeled by a Langmuir isotherm (Xing et al. 1996). 
 =  + !"#$%#$  (6) 
This model reflects the theory discussed later that the sorptive behavior of soil and sediment is 
dominated by two hypothetical domains.  
From the standpoint of evaluating HOC levels in a contaminated geosorbent over time 
(for example PAH-contaminated soil in an aqueous bioreactor slurry), it makes sense to frame 
the kinetic model in a form that describes the fraction of HOC remaining in the geosorbent after 
a given time, t. A mass balance for a batch system describing the rate of desorption, rdes, can be 
written for the mass HOC present in the geosorbent with equation 7. 
  
  
9 
'() = ((* = ∑ (+(*   (7) 
Where mHOC is the total mass HOC in the geosorbent, mHOCj is the mass of HOC in the jth 
domain of the geosorbent, and n is the number of domains to be included in the model. 
Researchers have proposed or applied models limited to two geosorbent domains and 
water (Schrap et al. 1994). The HOC desorbs quickly from one domain and slowly from the 
other domain as depicted in Figure 2.1 and equation 8. 
 
Figure 2.1 Two-domain kinetic model of HOC desorption. 
(
(* =
(,--./0 1
(* +
(2-3-./0 4
(* = ((* +
(3
(*  (8) 
Where CHOC is the concentration of HOC in the geosorbent, mHOCs is the mass of HOC in the 
slow domain, mHOCf is the mass of HOC in the fast domain, and mgeo is the total mass of 
geosorbent. If one assumes that desorption is characterized by first order rate constants and that 
transfer between the two domains is negligible, then equation 8 can be expressed as equation 9. 
(
(* = −67	
 + 68 − 6979	
 + 689  (9) 
Where Fs and Ff are the fractions of total geosorbent-bound HOC in the slow and fast domains, 
respectively and ks, k-s, kf, and k-f are the rate constants for adsorption and desorption as 
described in Figure 2.1. Furthermore, assuming that desorption is irreversible or that Cw is kept 
at or near zero and assuming Fs and Ff are constant and equal to their initial values, after 
Water 
Fast Domain 
Slow 
kf 
k-f 
ks 
k-s 
kf,s ks,f 
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separating variables and integrating, equation 10 describes the fraction of HOC remaining in the 
geosorbent after a certain amount of time (Cornelissen et al. 1997).  
:" = 78;* + 798;3*  (10) 
Where CHOC0 is the initial concentration of HOC in the geosorbent. 
2.1.2 Specific geosorbent domains relevant to PAH-contaminated soil 
The domains comprising a geosorbent can be divided into two general categories, organic 
and inorganic. Organic material is derived from living matter typically containing high amounts 
of carbon, while inorganic material comprises metals, minerals and rocks, typically containing 
much less carbon. Organic material can be further divided into soil organic matter and organic 
material of anthropogenic origin. The relative importance of these materials with respect to PAH 
distribution and desorption rates will depend on factors such as the source of PAH 
contamination, geographic location, and “age” of contaminated soil (duration of contamination). 
Partitioning of hydrophobic compounds such as PAH onto water-wet mineral surfaces will be 
characterized by fast sorption/desorption kinetics and low mineral/water partition coefficients; 
therefore, sorption of hydrophobic compounds in soil is dominated by organic domains (Luthy et 
al. 1997).  
Luthy et al. (1997) describe the three major components in PAH-contaminated soil as soil 
organic matter (SOM), combustion residue, and non-aqueous-phase liquids (NAPL). Soil organic 
matter is material derived from biomolecules. Through diagenesis the biomolecules are degraded 
and cross-linked to form humic material. Humic material is further transformed through 
metamorphism into kerogen, coal, and graphite. The effect of soil organic matter on PAH 
sorption depends on properties of the material, which in turn depend on biomolecule origin and 
the extent of diagenesis/metamorphism. Partition coefficients for sorption of PAH to SOM have 
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been shown to increase with increasing SOM aromaticity and decreasing polarity (Liu et al. 
2002). A series of papers by Weber et al. (1992) and work by Xia and Pignatello (2001) suggest 
that SOM can be described as having two domains, soft (or “rubbery”) and hard (or “glassy”), 
with which HOC interact. As an approximation, the soft domain is primarily represented by the 
linear portion of the dual-mode sorption model, while the hard domain is represented by the 
Langmuir portion (Luthy et al. 1997; Mechlińska et al. 2009). Similarly, desorption of PAH 
from the soft domain is represented by the fast-desorbing fraction, while desorption of PAH from 
the hard domain is represented by the slow-desorbing fraction (Luthy et al. 1997). 
Besides SOM, the organic fraction of PAH-contaminated soil, especially soil directly 
impacted with source materials (e.g., MGP sites, petroleum spills, wood-preserving plants), often 
contains combustion residue and NAPL with which PAH are associated (Aitken and Long 2004). 
Combustion residue is solid material remaining after the incomplete combustion of organic 
material. One type of combustion residue is soot or black carbon, resulting from the combustion 
of hydrocarbons. There is evidence that models including a separate black carbon domain more 
accurately predict PAH geosorbent/water partition coefficients than do models only including a 
total organic carbon domain (Accardi-Dey and Gschwend 2003; Cornelissen et al. 2005). 
Hawthorne et al. (2007), however, evaluating 114 historically contaminated sediments, found 
that sediment/water partition coefficients were not better predicted by black carbon content than 
by total organic carbon alone. Although an effort was made to account for the presence of NAPL 
in sediment samples (visual inspection of samples), material other than black carbon (such as 
NAPL) was implicated in PAH partitioning.  
Common NAPL found at PAH-contaminated sites include coal tar and creosote, and 
petroleum products such as oil or diesel fuel (Mueller 1996). Birak and Miller (2009) describe tar 
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as a mixture of a large number of mostly (>90% by mass) organic aromatic compounds, some 
containing as many as 210 rings. Haeseler et al. (1999) profiled the total organic matter of soil 
from former MPG sites and compared it to that of coal tar. They concluded that the 
contamination at MGP sites originated from coal tar, with nearly all PAH mass associated with a 
heavy fraction of the organic matter which could not be dissolved in organic solvent. PAH-
containing NAPL has also been observed coating the surfaces of soil particles from aged 
creosote- and petroleum-contaminated sites (Karimi-Lotfabad and Gray 2000). 
Luthy et al. (1997) liken the differences between the sorptive behavior of soft and hard 
SOM to the differences between the sorptive behavior of NAPL and combustion residue. As an 
approximation, the NAPL is primarily represented by the linear portion of the dual-mode 
sorption model, while the combustion residue is represented by the Langmuir portion (Luthy et 
al. 1997; Mechlińska et al. 2009). Similarly, desorption of PAH from the NAPL domain is 
represented by the fast-desorbing fraction, while desorption of PAH from the combustion residue 
is represented by the slow-desorbing fraction (Luthy et al. 1997). 
2.2 Bioavailability and bioaccessibility 
Bioavailability and bioaccessibility are terms defining the extent to which a chemical is 
in a state permitting interaction with living organisms. For the purpose of this review, 
bioavailable and bioaccessible are defined as described by Semple et al. (2004),with specific 
focus on bioavailability/accessibility of PAH in a soil/water system to PAH-degrading bacteria. 
Based on the definitions proposed by Semple et al. (2004), the bioavailable fraction of PAH is 
the fraction of PAH mass in a system which is freely available to cross the cellular membrane of 
an organism from the medium the organism inhabits at a given time. The bioaccessible fraction 
of PAH, however, is the fraction of PAH mass which has the potential to become bioavailable 
during a time span of interest given the physical and chemical conditions of the system. Bacteria 
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in a soil/water system are either attached to soil particles or suspended in the aqueous phase. 
Experiments designed to measure bioaccessibility assume that bacteria are only capable of 
degrading HOC which desorb from the soil into the aqueous phase which, as described in 
Section 2.2.2, might not be a reasonable assumption. Under this scenario the bioavailable 
fraction of PAH is the fraction of PAH mass in a soil-water system which is in the aqueous 
phase, while bioaccessible fraction of PAH mass in a soil-water system is the mass which has the 
potential to enter the aqueous phase under given a set of conditions. 
2.2.1 Measurements of bioavailability and bioaccessibility 
The bioavailable fraction of a PAH can be determined by measuring the instantaneous 
aqueous-phase PAH concentration. This concentration, however, may be exceedingly small and 
methods such as passive sampling have been developed to determine the time-averaged 
bioavailable concentration (Cachada et al. 2014). The bioaccessible fraction, sometimes 
considered to be the desorbable or fast-desorbing fraction, can be determined using solid phase 
extraction (SPE) from soil water (Cachada et al. 2014). An SPE resin such as Tenax® or XAD® 
added to the system is capable of rapidly and quantitatively adsorbing all PAHs that desorb from 
the soil to the aqueous phase (serving as an “infinite sink” for desorbed compounds), keeping 
aqueous-phase PAH concentration near zero. The mass of PAH sorbed to the resin after a certain 
time is the bioaccessible mass for that time period under the experimental conditions 
(particularly aqueous-phase PAH concentration near zero). The fast-desorbing fraction, Ff, can 
be determined by non-linear regression of equation 10 (Zhu et al. 2008). A less kinetically 
rigorous estimate of the desorbable fraction can be made by visual inspection of the asymptote in 
an empirically produced graph such as that represented in Figure 2.2 (Hu et al. 2014). An 
aqueous-phase PAH concentration of zero is maintained in order to simulate the instantaneous 
and complete biological uptake of PAH that would occur under ideal biodegradation conditions. 
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In this way, the ideal desorption rate can be determined and compared to the actual (often non-
ideal) rate of biodegradation. Other methods have been used to approximate the bioaccessible 
fraction, including mild solvent extraction, subcritical water extraction, supercritical fluid 
extraction, solubilizing agents, and persulfate oxidation (Cachada et al. 2014) . These methods, 
however, do not directly measure desorption to the aqueous phase under conditions similar to 
bioremediation.  
 
Figure 2.2 Idealized PAH desorption curve. 
2.2.2 Effect of bioavailability/accessibility on bioremediation of PAH-contaminated soil 
Although there are biological factors which can limit the extent of microbial 
biodegradation, it has been hypothesized that bioavailability can limit biodegradation under 
certain conditions. During biological treatment of PAH-contaminated soil it has been observed 
that at times biodegradation rates are nearly equal to ideal desorption rates, suggesting that under 
those circumstances the rate of biodegradation may be limited to the rate of desorption 
(Cornelissen et al. 1998; Huesemann et al. 2004). Under such a scenario, the microbial 
community of the system maintains an underutilized ability to degrade PAHs and desorption is 
believed to be the rate-limiting step of PAH removal.  
Others have noted, however, that the extent of PAH biodegradation can exceed the extent 
of desorption measured with an infinite-sink method (Richardson and Aitken 2011; Hu et al. 
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2014), although the mechanisms by which this can occur are not well understood. Evidence 
suggests that bacteria can enhance PAH desorption by adhering to hydrophobic contaminant 
matrices or through the production of biosurfactants (Mukherji and Ghosh 2012). The rate of 
PAH mass transfer from geosorbent to adherent cells or biofilm may be faster than the rate of 
PAH mass transfer into the bulk aqueous phase. It is also possible that the smaller distances 
between bacteria and geosorbent or the ability of bacteria to enter small soil pores may cause a 
steeper concentration gradient than can be created with SPE resins. 
2.3 Surfactants 
Surfactants are amphiphilic molecules comprising a polar (hydrophilic) “head” and non-
polar (hydrophobic) “tail” as depicted in Figure 2.3. This amphiphilic nature causes surfactants 
to accumulate at the interface of polar and non-polar materials, such as the interface between 
aqueous phase and air or between aqueous phase and a non-polar geosorbent. Surfactants are 
often classified based on the charge of the hydrophilic “head”: cationic, anionic, zwitterionic, or 
nonionic. Surfactants can also be classified based on origin: synthetic or biogenic. The 
hydrophile-lipophile balance (HLB) is a number assigned to a surfactant based on its chemical 
structure. Surfactants having higher HLB numbers are more hydrophilic while surfactants with 
low HLB numbers are more hydrophobic (Rosen 1989). Hydrophobic “tails” are typically 
branched or straight-chain alkanes. In order to maximize energetically favorable hydrogen bond 
interactions, water excludes the hydrophobic tails of surfactant molecules, which tend to 
aggregate on the surface of relatively non-polar geosorbent particles. An important result of this 
accumulation at the interface is the lowering of the free energy of the two-phase system, 
reducing the energy required to create new interfacial area (Myers 1992). Lowering the 
interfacial energy (sometimes referred to as interfacial tension) can increase the equilibrium 
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interfacial surface area and lower energetic barriers to dispersion, two important factors which 
may enhance the rate of HOC desorption from geosorbents.  
 
Figure 2.3 Representative surfactant molecule (Brij 30). 
2.3.1 The critical micelle concentration 
Above a certain aqueous-phase surfactant concentration, known as the critical micelle 
concentration (CMC), the vast majority of additional surfactant added to the system will form 
micelles and the concentration of surfactant monomers will remain relatively constant. Micelles 
in water are aggregates of surfactant in which the hydrophobic tails face inward and the 
hydrophilic heads face outward as depicted in Figure 2.4. Mukerjee and Mysels (1971), however, 
note “the expression critical micelle concentration… is slightly misleading because of the use of 
the singular noun ‘concentration’”. The actual onset of micelle formation will occur over a 
concentration range, the width of which depends on factors such as polydispersivity (formation 
of micelles comprising a variable number of monomers) and purity. Especially for commercial 
surfactants, which are often mixtures of molecules having different tail or head lengths, 
successive micellization of polydisperse monomers results in a wide monomer-micelle transition 
zone (Aboul-Kassim and Simoneit 2001). All that can be said with certainty is that above this 
range the vast majority of additional surfactant is in micelle form.  
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Figure 2.4 Cross section of surfactant micelle. 
2.3.2 Sorption of surfactant to geosorbent 
Surfactants can interact with geosorbents in much the same way as HOC interact with 
geosorbent. Equilibrium distribution of surfactant monomer between aqueous phase and 
geosorbent has been described by both the Langmuir and Freundlich isotherms (Laha et al. 
2009). Since geosorbents can comprise many domains, the kinetics of surfactant sorption will be 
geosorbent-specific. Equilibrium, based on approximately constant aqueous-phase surfactant 
concentration, appears to be reached on the order of hours to days (Liu et al. 1992). For a well-
mixed aqueous slurry of MGP soil, sorption equilibrium of a nonionic surfactant was determined 
to be reached after 48 hours (Aitken et al. 1998; Zhu and Aitken 2010). It is possible, however, 
that continued sorption into domains characterized by much smaller rate constants went 
unobserved due to experimental design or analytical limitations.  
2.3.3 Effect of surfactant on PAH desorption 
Surfactants may increase the rate of PAH desorption through two mechanisms: micellar 
solubilization and direct modification of the contaminant matrix. The first will occur only in the 
presence of micelles, while the second may occur at concentrations above or below the CMC. 
Micellar solubilization refers to the partitioning of HOC molecules into the hydrophobic core of 
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surfactant micelles. Micellar solubilization enhances the rate of desorption in much the same way 
SPE can be said to enhance desorption rates (Section 2.2.1), by maximizing the concentration 
gradient at the soil water interface. Through solubilization, surfactants have been shown to 
increase the apparent solubility of PAHs in soil-free systems at concentrations above the CMC 
(Edwards et al. 1991). In addition to maximizing the concentration gradient, if there is a direct 
interface between micelle and soil, then partitioning directly from soil into micelle may occur. 
Grimberg et al. (1995) described the direct transfer of phenanthrene from a solid phase into 
micelles that form at the solid-aqueous interface. 
Two hypothesized effects of surfactants on the contaminant matrix include increased 
PAH diffusivity and increased geosorbent-aqueous phase interfacial surface area. Diffusivity is a 
bulk property of the geosorbent, which is directly proportional to the rate of HOC diffusion 
within the geosorbent. Yeom et al. (1996) suggested that for PAH-contaminated MGP soil, 
surfactants can sorb to and penetrate the coal tar matrix, causing swelling and an increase in 
PAH diffusivity. The hydrocarbon tail, in particular, may intercalate between coal tar aromatic 
groups to cause swelling of the coal tar.  
Increased geosorbent-aqueous phase interfacial surface area can result from the 
dispersion of geosorbent. Dispersion as it applies to soil and its components refers to the 
breaking-up of particles and the distribution of the finer particles in the aqueous medium. The 
dispersion of non-polar solids and liquids such as black carbon and NAPL requires the creation 
of interfacial area, which is made more energetically favorable by the sorption of surfactant at 
the interface. Increased particle surface area could increase the rate of PAH desorption. 
Surfactants have been shown to enhance the dispersion of hydrophobic solid and liquid particles 
at aqueous-phase concentrations both above and below the reported CMC (Kile and Chiou 1989; 
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Zhang and Miller 1992; Churchill et al. 1995). Kile and Chiou (1989), however, attribute the 
increased dispersion to the successive micellization below the reported CMC. 
Addition of surfactant can modify the wetting behavior of geosorbent domains. 
Wettability describes the tendency of a liquid to spread over a surface and is often described by 
the contact angle, θ, as depicted in Figure 2.5. Sorption of surfactant to a NAPL droplet may 
reduce the wetting of the soil or mineral surface by the NAPL. Dong et al. (2003) showed that 
the contact angle between coal tar and quartz under aqueous phase could be increased by the 
addition of surfactant. Once the contact angle is sufficiency increased, adhesive forces are weak 
enough that the NAPL droplet can be dislodged by the abrasive forces of convective currents, a 
process known as rollback (Deshpande et al. 1999). The dislodged droplet has a greater NAPL-
aqueous phase interfacial surface area through which PAH may desorb.  
 
Figure 2.5 Rollback of NAPL. 
There is evidence, however, that addition of surfactant, particularly cationic surfactants or 
nonionic surfactants with high HLB values, at aqueous-phase concentrations below the CMC 
may increase the HOC soil/water partition coefficient (Edwards et al. 1994; Sun et al. 1995; Lee 
et al. 2000; Zhou and Zhu 2005). Hydrophilic surfactants may have a greater affinity for mineral 
surfaces than for organic surfaces (Lee et al. 2000; Rodríguez-Cruz et al. 2005; Zhou and Zhu 
2007). In particular, cationic surfactants can bind ionically to negatively charged surfaces, such 
as those found in clays (Jones-Hughes and Turner 2005; Wang and Keller 2008). Since HOC are 
likely associated with organic domains, these more hydrophilic surfactants may not be efficiently 
acting on the domains relevant to PAH sorption. Instead, the accumulation of surfactant on these 
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mineral surfaces increases the organic carbon content of the mineral domain, increasing PAH 
sorption to the surface. The soil/water partition coefficient may begin to decrease only after the 
CMC is reached and PAH begin partitioning into micelles. 
2.3.4 Effect of surfactant on bioremediation of PAH-contaminated field soil 
Review articles on the subject of surfactant-enhanced bioremediation indicate that the 
effects of surfactant on PAH biodegradation in aqueous solutions, spiked soil systems, and field-
contaminated soil systems are mixed (Makkar and Rockne 2003; Li and Chen 2009; Elliot et al. 
2011). Systems of pure PAH in aqueous solution or even spiked PAH in clean soil may provide 
more conclusive explanations of experimental results because there are fewer unknown variables 
than in experiments using field-contaminated soil. Experiments using aged, contaminated field 
soil, however, provide direct information on the applicability of surfactant-enhanced 
bioremediation in a complex system.  
 Work using field-contaminated soil indicates that surfactant addition is most beneficial 
for systems in which PAH biodegradation is limited by bioaccessibility. Studies in which 
surfactant-free controls exhibit high PAH removal tend to demonstrate no effect or even 
inhibition of PAH removal as a result of surfactant addition (Deschenes et al. 1996; Kim and 
Weber 2005; Lei et al. 2005; Zhu and Aitken 2010; Bueno-Montes et al. 2011). Studies in which 
surfactant-free controls exhibit lower PAH removal tend to demonstrate positive effects of 
surfactant addition (Tiehm et al. 1997; Di Gennaro et al. 2008; Zhu and Aitken 2010; Bueno-
Montes et al. 2011). If these surfactant-free controls perform poorly because of limited 
bioaccessibility, then surfactant-enhanced desorption may be contributing to improved 
biodegradation. 
Deschenes et al. (1996) found that addition of either an anionic surfactant (sodium 
dodecyl sulfate) or a biosurfactant (Pseudomonas aeruginosa UG2 rhamnolipid) had no effect on 
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the biodegradation of three-ring PAHs, but had a significant negative effect on degradation of 
four-ring PAHs during the treatment of creosote-contaminated soil. Surfactant was added at a 
high and low dose, but the corresponding aqueous-phase surfactant concentration in the 
soil/water system was not reported. The researchers determined that neither surfactant inhibited 
global microbial activity during incubation, that the anionic surfactant was readily biodegraded, 
and cited previous evidence of biosurfactant biodegradation. The authors attributed the negative 
effect to competitive utilization of the surfactant as a carbon source instead of PAHs. This 
competitive effect was not overcome during the course of the incubation. It should be noted that 
competition between the use of a surfactant and PAHs as carbon sources makes sense only if the 
same microorganisms degrade both types of compounds. Otherwise, competition for other 
nutrients or for oxygen could explain the inhibitory effects of surfactants. The removal of 3-ring 
PAHs for both surfactant-amended and surfactant-free incubations reached near 100% removal. 
Removal of 4-ring PAHs in surfactant-free systems was near 90%, while incubations at the high 
surfactant doses had removals as low as 10%.  
Lei et al. (2005) found that addition of a nonionic surfactant (Triton X-100) did not 
enhance PAH biodegradation in contaminated sediment. The study however, tested only a single 
surfactant dose that resulted in an aqueous-phase surfactant concentration below the CMC, the 
exact value of which was not determined. The researchers also noted that in surfactant-amended 
incubations, PAH degradation occurred after a lag phase, during which they hypothesized that 
the surfactant was preferentially degraded. Residual PAH concentrations were similar for 
surfactant-amended and surfactant-free incubations, with individual removal of three- and four-
ring PAHs ranging from 50-80%. 
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Kim and Weber (2005) found that addition of a nonionic surfactant (Tween 80) did not 
enhance phenanthrene biodegradation in creosote-contaminated field soil. Surfactant was added 
at doses corresponding to aqueous-phase surfactant concentrations both above and below the 
CMC. At concentrations above the CMC, apparent liquid-phase phenanthrene concentration 
increased linearly with surfactant dose, suggesting the occurrence of solubilization-induced 
desorption. Similar to results obtained by Lei et al. (2005), a lag period was observed in 
surfactant-containing incubations, after which PAH degradation commenced at a rate 
independent of surfactant dose. The duration of the lag period was found to increase with 
increasing surfactant dose and was attributed to preferential utilization of the surfactant. 
Biodegradation of surfactant was confirmed to occur in soil-free incubations containing microbes 
isolated from the creosote-contaminated soil. Near-complete phenanthrene removal (>99%) was 
achieved for both surfactant-free and surfactant-amended incubations, suggesting that 
bioaccessibility was not a major limiting factor.  
Tiehm et al. (1997) found that addition of nonionic surfactants (Arkopal N-300 and 
Saponegat T-300) enhanced the biodegradation of both high- and low-molecular-weight PAHs in 
MGP soil during column studies. Only one dose sufficient to enhance PAH desorption by 
solubilization was evaluated. Treatment with Saponegat T-300 resulted in greater final PAH 
removal than did treatment with Arkopal N-300. The authors attributed this to the rapid 
biodegradation of Arkopal N-300, which resulted in depletion of dissolved oxygen. The authors 
attributed the enhanced PAH biodegradation to improved bioavailability due to solubilization. 
Surfactant-free incubations were characterized by low PAH removal, less than 30% removal for 
3-ring PAHs and less than 20% for most four- and five-ring PAHs. 
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Di Gennaro et al. (2008) found that the addition of Tween 80 enhanced the 
biodegradation of both high- and low-molecular-weight PAHs during the treatment of PAH-
contaminated landfill soil. Only one dose above the CMC, sufficient to enhance PAH desorption 
by solubilization, was evaluated. The authors attributed the enhanced PAH biodegradation to 
improved bioavailability due to solubilization. Surfactant-free incubations were characterized by 
low PAH removal, less than 20% removal for 3-ring PAHs and less than 10% for most four and 
five-ring PAHs.  
Zhu and Aitken (2010) found that addition of nonionic surfactant (Brij 30) enhanced 
PAH removal during the treatment of MGP soil which had previously undergone biological 
treatment. Addition of surfactant to untreated MGP soil, however, did not enhance PAH 
removal. Unlike previously mentioned studies, the bioaccessible (desorbable) PAH fraction was 
specifically measured using SPE resin. In surfactant-free controls < 5% of total measured PAH 
mass was desorbed from the previously treated soil, demonstrating that the bioaccessibility of the 
PAHs remaining in the treated soil was low. At a dose below that corresponding to the apparent 
CMC in the soil-slurry system, Brij 30 enhanced desorption of most PAHs and significantly 
increased removal of 3- and 4-ring PAHs. Addition of a more hydrophilic surfactant, C12E8, 
however, reduced desorption and did not improve PAH removal at any dose. Poor performance 
of C12E8 was attributed to its higher HLB value and hypothesized tendency to sorb to clay 
minerals rather than organic domains. The authors concluded that surfactant-enhanced 
bioremediation is likely to be most effective for systems in which bioaccessibility would 
otherwise be a limiting factor. 
Bueno-Montes et al. (2011) found that addition of nonionic surfactant (Brij 35) enhanced 
the biodegradation of low- and high-molecular-weight PAH in both an MGP soil which had 
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previously undergone biological treatment and a creosote soil which had not been previously 
treated. For the creosote-contaminated soil, roughly 95% of total measured PAH was in the fast-
desorbing fraction, whereas for the previously remediated MGP soil only 15% of total PAH was 
in the fast-desorbing fraction. One dose corresponding to an aqueous-phase surfactant 
concentration of approximately 25 times the aqueous-phase CMC and sufficient to enhance PAH 
solubilization was employed. The effect on PAH removal was more marked for the MGP soil, 
characterized by low bioaccessibility. For the MGP soil, less than 10% of total measured PAH 
was removed in surfactant-free controls, while over 60% of total measured PAH was removed in 
incubations containing Brij 35. For the creosote-contaminated soil, surfactant enhancement was 
not substantial. Surfactant-free controls experienced PAH removal of 96%, while surfactant-
amended incubations experienced removal of 97%.  
Bueno-Montes et al. (2011) also compared the fraction of pyrene solubilized by 
surfactant to the fraction of pyrene extracted by SPE resin. For MGP soil they found that the 
fraction of pyrene solubilized by surfactant was significantly greater than that extracted by SPE, 
while for the creosote-contaminated soil the two fractions were nearly identical. This suggests 
that surfactant, at least at concentrations above the CMC, can act as more than simply an infinite 
sink for desorbable fractions of PAHs as would be determined with an SPE resin. Surfactant may 
directly interact with the soil causing enhanced PAH desorption. Like Zhu and Aitken (2010), 
the authors concluded that application of surfactant-enhanced bioremediation may be more 
effective for soils with low bioaccessibility, particularly those soils which have already 
undergone biological treatment without surfactant. 
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2.4 Microbial degradation of PAHs 
Given the aims of this proposal, the background is concerned primarily with aerobic PAH 
degradation by bacteria, although there is evidence of anaerobic biodegradation as well as 
biodegradation by fungi (Haritash and Kaushik 2009). Reviews by Sutherland et al. (1995) and 
Elliot et al. (2011) suggest that the major mechanism of PAH biodegradation by bacteria begins 
with the oxidation of an aromatic ring by the dioxygenase enzyme to form cis-dihydrodiols 
(Figure 2.6). The dihydrodiols are dehydrogenated by dehydrogenase enzymes to form 
dihydroxylated intermediates known as catechols or o-diols. In a complete bacterial metabolic 
pathway, the catechol then usually undergoes enzymatic ring cleavage, separation of cleavage 
fragments from the remaining polyaromatic system, and ultimately mineralization to carbon 
dioxide. This process can continue until the remaining portion of the compound has been 
mineralized or may cease at some intermediate step, generating non-mineral products 
(transformation products). Identified transformation products of PAH metabolism include 
dihydrodiols, hydroxy acids, and ortho-quinones. Ortho-quinones are believed to form from the 
non-biological autoxidation of the catechol (dihydroxy-) intermediates (Aitken and Long 2004). 
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Figure 2.6 Biodegradation pathway of PAHs  (Bamforth and Singleton 2005). 
Often bioremediation does not result in complete metabolism of all carbon initially 
present in PAH mass. For purposes of this discussion, complete metabolism is defined as 
mineralization of some fraction of the contaminant carbon and assimilation of the remaining 
carbon into cellular biomass. It is incomplete metabolism that is of primary interest because 
extracellular, non-mineral products may exhibit greater (geno)toxicity than parent compounds. 
There is also evidence that PAH transformation products may inhibit the biodegradation of a 
parent PAH (Kazunga et al. 2001; Juhasz et al. 2002; Holt et al. 2005). The (geno)toxicity of 
remediated soil will depend on both the remaining parent compounds (including classes of 
compounds other than PAHs) and the products of their incomplete metabolism. Addition of 
surfactant during biodegradation may alter the distribution of end products (Auger et al. 1995) 
and have an effect on the resultant soil (geno)toxicity (Joner et al. 2001). 
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2.5 (Geno)toxicity of PAHs 
Non-genotoxic cytotoxic effects of PAHs are caused by direct perturbation of cellular 
membranes by PAH (Sikkema et al. 1995; Schirmer et al. 1998). Given the limited 
bioavailability to vertebrates and relatively high LD50 for PAHs, the primary threat posed to 
human health by PAH-contaminated soil is chronic exposure to genotoxic compounds. A 
chemical or mixture is considered genotoxic if exposure to the chemical or mixture results in 
DNA damage in the observed biological system. A chemical or mixture is considered mutagenic 
if exposure to the chemical or mixture results in genetic mutations in the observed biological 
system. Since genetic mutations are typically the result of unrepaired DNA damage, genotoxicity 
precedes mutagenicity, and experimental evidence of mutagenicity is taken as evidence of 
genotoxicity. The phrase “in the observed biological system” is used to caution the reader that 
whether a chemical or mixture causes a genotoxic effect in a biological system depends on 
properties of the system itself such as complexity (free DNA, prokaryote, eukaryote, 
multicellular, vertebrate, mammal, etc.), the metabolic capabilities of the system, and available 
exposure pathways. PAHs and HACs are indirect-acting genotoxicants which require metabolic 
activation in order to cause DNA damage. The following summary of PAH activation pathways 
is based on reviews by Penning (2010) and Xue and Warshawsky (2005). Three activation 
pathways include the radical cation pathway, the diol epoxide pathway, and the PAH o-quinone 
pathway.  
The radical cation pathway occurs through the peroxidase cycle of cytochrome P450 
(CYP) enzymes. A one-electron oxidation occurs resulting in the generation of a radical cation. 
In the case of benzo[a]pyrene, the radical cation is localized on the C6 position. The radical 
cation may go on to react with nucleophilic centers of DNA, particularly the N7 positions of 
guanine and adenine. These DNA adducts are unstable and undergo spontaneous depurination to 
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form apurinic sites. The tendency of a PAH to form DNA adducts through the radical cation 
pathway depends on its molecular structure, which affects properties such as ionization potential 
and formation of a strongly localized positive charge on a carbon positioned to react with a 
nucleophilic DNA center. If the resulting abasic site is left unrepaired, then replicative 
polymerases will insert an adenine opposite an abasic site, resulting in a transversion mutation. 
The diol epoxide pathway involves the formation of reactive diol epoxides on bay region-
containing PAH through reactions catalyzed by CYP and epoxide hydrolase (EH). 
Benzo[a]pyrene, for example, is transformed into benzo[a]pyrene diol epoxide (BPDE), which 
reacts with nucleophilic centers of DNA, particularly the exocyclic amino groups of guanine and 
adenine, to form bulky stable adducts. Figure 2.7 depicts the diol epoxide activation pathway and 
resultant DNA damage with the major pathway indicated by bold arrows (Xue and Warshawsky 
2005). Other bay region PAHs include chrysene, 5-methylchrysene, phenanthrene, 
benzo[c]phenanthrene, benz[a]anthracene, 7,12-dimethylbenz[a]anthracene, and 
dibenzo[a,l]pyrene. Bay-region nitrogen heterocycles are also metabolized through this pathway. 
Transversion mutations occur if an error-prone bypass polymerase attempts translesion synthesis 
(replication using the damaged template strand without repair) of the adducted DNA (Rechkoblit 
et al. 2002; Zhang et al. 2002). 
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Figure 2.7 Diol epoxide metabolic activation of benzo[a]pyrene (Xue and Warshawsky 2005). 
The o-quinone pathway involves the formation of redox active o-quinones from non-K-
region (-)-R,R-trans-dihydrodiols such as the 7R,8R-benzo[a]pyrene dihydrodiol depicted in 
Figure 2.7. The reaction is catalyzed by dihydrodiol dehydrogenase enzymes. These o-quinones 
can form DNA adducts or become involved in futile redox cycling which generate reactive 
oxygen species (ROS). o-Quinones are 1,4-Michael acceptors, which form stable adducts with 
nucleophilic centers of DNA, particularly exocyclic amino groups of guanine and adenine, and 
unstable depurinating adducts with the N7 of guanine or adenine. ROS such as superoxide 
radical anion and hydrogen peroxide are transformed to the highly reactive hydroxyl radical 
through the Fenton reaction. The hydroxyl radical can modify bases, causing DNA mismatches 
during replication. For example, deoxyguanosine can be oxidized to 8-oxo-deoxyguanosine, 
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which pairs with adenosine rather than cytosine, resulting in a transversion mutation. The 
hydroxyl radicals can also cause DNA stand breaks by abstraction of sugar hydrogens.  
2.5.1 Methods for measuring (geno)toxicity of PAH-contaminated soil 
Several methods have been utilized to evaluate (geno)toxicity of PAH-contaminated soil 
before and after bioremediation. Studies typically analyze soil organic-solvent extracts (whole or 
fractionated), organic compounds desorbed during SPE (bioaccessible/desorbable fraction), or 
aqueous soil leachates (bioavailable fraction). These methods have the general aim of assessing 
the extent to which the soil is a risk to higher organisms in the environment, particularly humans. 
Positive results of an assay are taken as evidence of potential genotoxicity in higher organisms. 
Additionally, the assays described below are quantitative and an assessment of the effect of 
bioremediation on soil (geno)toxicity can be made. It has been argued, however, that methods 
evaluating whole soil extracts overestimate the potential impact on higher organisms due to the 
limited bioavailability of contaminants (Alexander 2000). Also, when components of a mixture 
extracted from contaminated soil are fractionated, they may exhibit different genotoxic effects 
(Park et al. 2008). This effect can make attributing whole extract genotoxicity to particular 
components difficult.  
Bacterial assays applied to PAH-contaminated soils undergoing bioremediation include 
reverse mutation assays (Hughes et al. 1998; Sayles et al. 1999; Mendonca and Picado 2002; 
Sasek et al. 2003; Lemieux et al. 2009) and SOS chromotest (Haeseler et al. 1999). Eukaryotic 
tests include the micronucleus test (Baudgrasset et al. 1993), the comet assay (Gandolfi et al. 
2010), and the DT-40 chicken lymphocyte assay (Hu et al. 2012). Many of these assays require 
augmentation with exogenous mammalian metabolic activation systems, particularly rat liver 
extract (S9 supernatant) to assess the impact of indirect-acting genotoxicants.  
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Traditional bacterial reverse mutation assays, such as the Ames assay, utilize auxotrophs 
which have been genetically engineered (mutated) to be unable to synthesize an essential amino 
acid such as tryptophan or histidine. As a result of exposure to genotoxicants, reverse mutations 
may occur which have the effect of restoring the ability of the bacteria to synthesize the amino 
acid. Formation and growth of these revertants in a medium not supplemented with the amino 
acid is taken as evidence of genotoxicity. Particular auxotroph strains can be engineered to be 
reverted by either frameshift or base substitution mutations. The mutatoxTM assay is also a 
reverse mutation assay. It utilizes a bioluminescent marine bacterium with a mutation that 
eliminates bioluminesce. Genotoxic compounds can cause a reverse mutation, restoring 
bioluminescence (Ulitzur 1982). Kwan et al. (1990) cite the manual provided by the 
manufacturer of the assay, writing that the assay is sensitive to (a) DNA damaging agents, (b) 
DNA intercalating agents, (c) direct mutagens which either cause base substitution or are frame-
shift agents, and (d) DNA synthesis inhibitors. 
SOS chromotest is a bacterial functional-assay that detects the bacterial SOS response to 
genotoxic chemicals. DNA damage which causes exposure of single-stranded DNA during 
attempted replication is believed to induce the bacterial SOS response (Friedberg 2006). The 
assay utilizes bacteria in which induction of the SOS response also causes expression of genes 
that affect some measurable property such as β-galactosidase activity (Quillardet and Hofnung 
1985).  
The micronucleus test evaluates the ability of a chemical or mixture to cause the 
formation of micronuclei in plant or mammalian cells (Barile 2008). Chemicals that cause DNA 
strand breaks can cause fragments of DNA to separate from the chromosome, forming 
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micronuclei (Timbrell 2009). The comet assay evaluates the ability of a chemical or mixture to 
cause single and double DNA strand breaks in eukaryotic cells (Burlinson 2012).  
In a reverse genetic approach, the DT40 assay utilizes a eukaryotic chicken B 
lymphocyte-cell line and isogenic mutants. Cell lines engineered to be deficient in a particular 
DNA repair- or damage-tolerance protein are exposed to the chemical or mixture of interest. The 
parental cell line, not deficient in any proteins, is also exposed to the chemical or mixture. The 
LC50 is the concentration of a substance that, after incubation with cells, results in final viable 
cell count equal to half the viable cell count observed in a substance-free control. A protein-
deficient cell line may be more sensitive (lower LC50) to a chemical or mixture than the parental 
cell line. This is taken as evidence that the chemical or mixture is capable of causing DNA 
damage that would otherwise be repaired or tolerated by pathways in which the protein is 
involved. Two proteins with particular relevance to PAH-induced genotoxicity are the Rad54 
and Rev1 proteins. Rad54 facilitates strand exchange during homologous recombination repair, 
which is used to repair double strand breaks (Sonoda et al. 2006). These double-stand breaks can 
be formed when a replication fork “collapses” upon encountering a single-strand break. Single-
strand breaks could be the result of either direct oxidative damage to the sugar-phosphate 
backbone or arise during base excision repair of other DNA damage (Friedberg 2006). Rev1 is a 
“scaffold protein” which recruits DNA bypass polymerase to the stalled replication fork caused 
by DNA adducts and abasic sites (Friedberg 2006; Penning 2011) and has polymerase function 
as well (Goodman 2002). These two proteins are implicated in repair or tolerance of damage 
caused by the major types of PAH-induced genotoxicity: strand breaks caused by oxidative stress 
(Rad54), and adduction of DNA by stable or depurinating adducts (Rev1). Additionally, there is 
evidence that the DT40 cell line is capable of metabolic activation of PAHs such as 
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benzo[a]pyrene (Hu et al. 2012) and methods using S9 fractions for activation can also be 
applied (Hashimoto et al. 2015).  
Two common methods to assess the cytotoxicity of PAH-contaminated soil are the 
Microtox assay and seed germination assay. Microtox uses a bioluminescent strain of the Vibrio 
fischeri bacterium. The reduction in bioluminescence upon exposure to a chemical mixture 
diluted into aqueous solution is taken as evidence of toxicity (Johnson 2005). The seed 
germination assay involves directly planting seeds in a contaminated soil sample and then 
counting the number of seedlings (Banks and Schultz 2005). Also, the DT40 assay using the 
parental cell line can be used as an indicator of cytotoxicity. 
2.5.2 Incomplete PAH metabolism during biodegradation and its effect on soil (geno)toxicity 
Given all the variables involved in bioremediation (source material, bioremediation 
method and duration, etc.), the residual contaminant levels and (geno)toxicity of the treated soil 
vary from case to case. It can be said with confidence, however, that the reduction of measured 
parent PAH compound in contaminated soil does not always correspond to an observed 
reduction in soil (geno)toxicity (Hughes et al. 1998; Gillespie et al. 2007; Lemieux et al. 2009; 
Hu et al. 2012; Chibwe et al. 2015). The genotoxicity of contaminated field soil is not explained 
to a major extent by the level of 16 EPA PAH (Larsson et al. 2013) The (geno)toxicity of 
remediated soil will depend on the remaining parent compounds (including other classes of 
contaminants) and the products of incomplete metabolism. Both removal of chemicals mitigating 
(geno)toxicity and formation of (geno)toxic chemicals in greater amount or potency may impact 
the (geno)toxicity of the treated soil. Even aged soils that have not been the target of a concerted 
bioremediation effort will contain PAHs as well PAH transformation products, which 
presumably formed during natural attenuation or were present in the original contaminant matrix 
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(Lundstedt et al. 2003). Addition of surfactant during bioremediation may alter the distribution 
of end products and have an effect on the resultant soil (geno)toxicity.  
There is evidence supporting the genotoxicity of select PAH bacterial transformation 
products. Zielinska-Park et al. (2004) found that PAH o-quinones, pyrene-(4,5)-quinone and 
fluoranthene-(2,3)-quinone, bacterial metabolites of pyrene and fluoranthene respectively 
(Kazunga and Aitken 2000; Kazunga et al. 2001), caused oxidative DNA damage in vitro. The 
transformation products were assayed using calf thymus DNA and HeLa S3 cells. The 
researchers speculated that during biodegradation, bacteria may metabolically activate PAHs, 
such as pyrene, which might not otherwise be activated to an appreciable extent by mammalian 
metabolic systems. This bacterial activation transforms relatively non-genotoxic PAHs such as 
pyrene into redox active o-quinones. 
Pagnout et al. (2006) evaluated the (geno)toxicity of several parent PAHs (pyrene, 
fluoranthene, and phenanthrene) and their unidentified metabolites produced in an aqueous 
incubation by a bacterial culture isolated from soil. For all PAHs, after biodegradation the 
mixture of metabolites was not toxic to any of the organisms assayed. In general biodegradation 
was found to reduce the (geno)toxicity of the incubations. Changes in the type of genotoxicity 
observed before and after biodegradation were noted. For example, the parent compounds pyrene 
and phenanthrene required S9 activation in order to exert a genotoxic effect in the Ames assay, 
while their transformation products exhibited genotoxicity only in the absence of S9 activation. 
This suggests that bacteria may transform indirect-acting genotoxicants, such as PAH, into 
direct-acting genotoxicants. The relative sensitivity of an assay to direct- vs. indirect-acting 
genotoxicants may have an impact on the reported change in genotoxicity of a remediated soil.  
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Studies measuring the (geno)toxicity of PAH-contaminated soil before and after 
bioremediation have demonstrated varying effects. Most studies reporting a reduction in 
(geno)toxicity of soil involved soil treatment by land-farming (Baudgrasset et al. 1993; Sayles et 
al. 1999; Mendonca and Picado 2002) or composting (Sasek et al. 2003; Gandolfi et al. 2010). 
Hu et al. (2012) found a reduction of toxicity and genotoxicity of solvent extracts from soil in a 
laboratory column simulating long-term in situ bioremediation. It is possible that long-term 
treatment is needed to achieve reductions in (geno)toxicity. 
Haeseler et al. (1999) treated soil from a former manufactured-gas plant in a slurry-phase 
bioreactor. Treatment reduced the leaching capacity of the soil and leachate from treated soil was 
less toxic and genotoxic than leachate from untreated soil. Toxicity was evaluated using 
Microtox and genotoxicity using SOS chromotest with and without S9 activation.  
Hu et al. (2014) found that slurry-phase bioreactor treatment of MGP soil, although 
unable to significantly reduce the toxicity or genotoxicity of whole-soil-solvent extracts, was 
able to reduce the toxicity and genotoxicity of the desorbable fraction. Toxicity and genotoxicity 
were evaluated using the DT40 assay with the Rad54-/- DNA-repair-deficient mutant. The slight 
increase in whole soil genotoxicity was attributed to the formation of non-desorbable genotoxic 
compounds. Addition of surfactant to slurry-phase treatment may enhance desorption of these 
otherwise non-desorbable genotoxic compounds, potentially increasing their rate of 
biodegradation. 
Evaluating the same source soil and bioremediation process as Hu et al. (2014), Chibwe 
et al. (2015) assayed both whole and fractionated soil solvent-extracts using the DT40 assay. 
Solvent extracts of treated and untreated soil were fractionated to separate compounds based on 
polarity. Slurry-phase bioreactor treatment, despite removing substantial amount of PAHs, 
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increased whole-soil genotoxicity and substantially increased the genotoxicity of the more polar 
fractions. The authors attributed the increase in genotoxicity to the formation of unidentified 
hydroxylated and carboxylate transformation products of 3- and 4-ring PAHs, which would 
likely be present in the more polar fractions. 
Other studies reporting an increase or no change in the (geno)toxicity of soil undergoing 
bioremediation include creosote-contaminated soil treated by land-farming (Gillespie et al. 2007) 
and creosote-contaminated soil undergoing several bioremediation techniques including 
bioslurry, biopile, compost, and land-farming (Hughes et al. 1998). In a companion study 
toHughes et al. (1998), Brooks et al. (1998) evaluated the genotoxicity of fractionated extracts of 
the treated soil using a bacterial reversion assay with and without S9 activation. The 19 PAHs 
investigated were detected in only three of the 16 mutagenic fractions. Other compounds 
identified in the mutagenic fractions were mainly nitrogen heterocycles (azaarenes) as well as 
some sulfur and oxygen heterocycles.  
Perhaps the most informative studies are those that evaluate temporal changes in 
genotoxicity during bioremediation. These studies demonstrate that there are fluctuations in the 
magnitude and mechanisms of genotoxicity during the course of bioremediation. Lemieux et al. 
(2009) used a Salmonella reverse mutation assay with and without S9 activation to examine 
temporal changes in the genotoxicity of fractionated extracts of an MGP soil undergoing slurry-
phase bioremediation. The study incorporated bacterial mutants capable of detecting frameshift 
and base-pair substitutions. Although whole-soil- solvent-extracts were not assayed, two 
fractions were evaluated, a nonpolar neutral fraction containing PAHs, alkyl-PAHs, and S- and 
O-heterocycles and a semipolar aromatic fraction containing N-heterocycles and oxy-PAHs. The 
genotoxicity of the nonpolar fraction without S9 activation for frameshift mutants was greater 
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after bioremediation, suggesting the formation of direct-acting genotoxicants capable of causing 
frameshift mutations. The mutagenicity of the semipolar aromatic fraction with and without S9 
activation was greater after bioremediation. In a companion study, Lundstedt et al. (2003) 
performed a thorough chemical analysis of the soil undergoing bioremediation and observed the 
accumulation of two oxy-PAH metabolites, 1-acenapthone and 4-oxypyrene-5-one. Although 
Lemieux et al. (2009) found no evidence of the genotoxicity of 4-oxypyrene-5-one, it is 
conceivable that other compounds which are genotoxic may accumulate during bioremediation. 
Using the DT40 assay, Hu et al. (2012) found that toxicity and genotoxicity of whole-
soil-extracts initially decreased, but then increased during bioslurry treatment. They also found 
that after controlling for the total concentration of extractable organic mass, the relationship 
between soil toxicity and PAH concentration was no longer significant. This suggests that other 
chemicals in addition to the selection of EPA priority PAH measured in the study contributed to 
soil toxicity. 
Other studies have observed the accumulation of PAH transformation products, 
particularly oxy-PAHs, during bioremediation of field-contaminated soil (Saponaro et al. 2002) 
or artificially contaminated soil (Wischmann and Steinhart 1997). Addition of surfactant may 
enhance the rate of early steps in PAH metabolism by bacteria, causing a bottleneck and 
accumulation of compounds that may affect the observed (geno)toxicity of the soil.
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CHAPTER 3: EFFECT OF CONVENTIONAL BIOREACTOR TREATMENT ON THE 
REMOVAL AND BIOAVAILABILITY OF OXY-PAHS IN CONTAMINATED SOIL 
3.1 Introduction 
As part of a broader study to evaluate the bioavailability and biodegradability of 
genotoxic constituents in contaminated soil (Hu et al. 2014), I determined the effect of 
bioremediation on the removal and bioavailability of four selected oxygenated polycyclic 
aromatic hydrocarbons (oxy-PAHs) in contaminated soil. Oxy-PAHs are of concern because 
some are known to exhibit toxic or genotoxic effects (Bolton et al. 2000; Zielinska-Park et al. 
2004; Luo et al. 2011), and may also inhibit the biodegradation of parent PAHs (Kazunga and 
Aitken 2000; Kazunga et al. 2001). The sources of oxy-PAH in contaminated soil could be the 
same as the parent PAHs, such as coal tar, although they could also be formed in-situ by 
microbial or photochemical oxidation of the parent compounds (Lundstedt et al. 2007). Net 
increases of some oxy-PAHs have been observed during bioremediation (Lundstedt et al. 2003) 
and others have inferred the formation of oxy-PAH based on ratios of oxy-PAH to parent PAH 
(Wilcke et al. 2014). In this study, contaminated soil from a former manufactured-gas plant site 
in Salisbury, NC was treated in an aerobic, slurry-phase bioreactor. A former student in our lab, 
Jing Hu, used sorptive resins to evaluate desorption from the soil as an estimate of bioavailability 
(Hu et al. 2014). I developed a liquid chromatography-mass spectrometry (LC-MS/MS) method 
to quantify four oxy-PAHs: 9-fluorenone (FLO), 9,10-phenanthrenequinone (PQ), 9,10-
anthraquinone (AQ), and benz[a]anthracene-7,12-dione (BAQ) in solvent extracts of the soil and 
sorptive resins. These four oxy-PAHs were selected for study based on their known occurrence 
  
  
39 
in contaminated soils and sediments and on their commercial availability. Additionally, the 
solubilities of the oxy-PAHs in phosphate buffer were determined.  
3.2 Methods 
3.2.1 Bioreactor operation 
Bioreactor operation is described in greater detail in Hu et al. (2014). Contaminated soil 
from a former manufactured gas plant site (feed soil) was treated in a continuously stirred, semi-
continuous, laboratory-scale aerobic bioreactor. Every seven days, 20% of the treated slurry was 
replaced with a slurry of feed soil. Soil was sampled at several time points throughout this 7-day 
cycle. Soil extraction and sorptive resin methods are presented in Hu et al. (2014).  
3.2.2 LC-MS/MS method 
Soil solvent-extracts and extracts of the sorptive resins provided by Jing Hu were 
analyzed by LC-MS/MS. LC-MS/MS analysis was performed using a Thermo Scientific TSQ 
Quantum Ultra Triple Quadrupole Mass Spectrometer (Thermo Fisher Scientific, Waltham, MA, 
USA) with a Thermo Scientific Atmospheric Pressure Chemical Ionization (APCI) source, a 
Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA), and a Waters BEH C18 
UPLC Column (1.7 µm, 2.1 x 50 mm). 
The chromatographic separation was based on the method for separation of diketones 
provided in Delhomme et al. (2008), scaled to the column dimensions described above using a 
method transfer calculator. The column temperature was maintained at 35°C, and the sample 
injection volume was 10 µL. The mobile phase consisted of deionized water and LC-MS-grade 
methanol. The mobile phase was initially 30% methanol for 2.07 minutes followed by a linear 
increase to 75% methanol over 2.72 minutes and was held at 75% methanol for 2.95 minutes at a 
flow rate of 0.294 mL/min. Then, at a flow rate of 0.5 mL/min, the mobile phase was increased 
linearly to 100% methanol over 0.45 minutes and held at 100% methanol for 3.81 minutes. 
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Finally, at a flow rate of 0.294 mL/min, the mobile phase was decreased linearly to 30% 
methanol over 0.20 minutes and held at 30% methanol for 2.8 minutes. 
Both electrospray ionization (ESI) and positive and negative APCI chemical ionization 
were tested on AQ. Similar to observations by Delhomme et al. (2008), APCI negative 
ionization was the most effective ionization method for AQ and BAQ, while APCI positive 
ionization was most effective for PQ. Although ESI was determined to be the most effective 
ionization method for FLO by Grosse and Letzel (2007), APCI positive was used to ionize FLO 
so that it could be quantified in the same chromatographic run as the other analytes. 
Ultimately, AQ and BAQ were quantified in APCI negative ionization mode using the 
molecular ions m/z=208 and m/z=258, respectively. PQ and FLO were quantified in APCI 
positive ionization mode using the precursor to fragment ion transition m/z= 209 > 152 and m/z= 
181 > 153, respectively. Quantification of each compound was performed according to the 
corresponding standard curve constructed form external standards.  
3.2.3 Spike and recovery validation 
Preliminary spike/recovery validation experiments were completed using AQ. Triplicate 
3-g aliquots of feed soil were spiked with AQ dissolved in acetone (89.7 µg in 500 µL) and 
extracted as described in Hu et al. (2014); the mass of spiked AQ was approximately equal to the 
mass of AQ present in the original feed soil. An additional 3 replicates were extracted without 
spiking AQ. The total mass of AQ in the samples was quantified and a recovery of the spiked 
mass was determined. The average recovery was 81% ± 7%.  
Anthraquinone-D8 (AQ-D8) was demonstrated to be a useful recovery surrogate for the 
extraction procedure, but was not utilized beyond preliminary experiments because soil extracts 
were to be used for toxicity testing and the addition of spiked compounds was undesirable. AQ-
D8 was quantified in APCI negative ionization mode using the molecular ion m/z=216. In 
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preliminary experiments, triplicate 3-g wet weight aliquots of feed and treated soil were spiked 
with 52 µg of AQ-D8 delivered in 500 µL of acetone immediately before extraction. Average 
recovery of AQ-D8 spiked into feed and treated soil was 90% ± 2% and 84% ± 2% respectively. 
3.2.4 Solubility of oxy-PAHs in phosphate buffer 
Approximately 10 mg of one of the oxy-PAHs was added to a 25-mL glass vial with 
PTFE-lined screwcap; for each oxy-PAH, triplicate vials were prepared. Phosphate buffer (20 
mL, 5-mM total phosphate, pH 7.5) was then added to each vial. The buffer consisted of the 
following salts dissolved in deionized water: potassium phosphate monobasic, potassium 
phosphate dibasic, sodium phosphate monobasic, sodium phosphate dibasic and had a final 
concentration of 5-mM phosphate, 2.5-mM sodium, and 2.5-mM potassium. The vials were put 
on a wrist-action shaker in the dark at a constant temperature of 25°C. At 24 and 48 hours the 
tubes were taken off the shaker and the solids allowed to settle. Approximately 5-mL aliquots 
were removed from each tube and filtered using a glass syringe and stainless steel filter housing 
fitted with a 0.02 µm alumina membrane filter (Whatman Anodisc). Filtrates were then diluted 
into methanol for LC-MS/MS analysis.  
3.2.5 Chromatographic method improvement 
Chromatographic methods can be adjusted to provide better peak separation for specific 
sample matrices. In the case of the soil solvent-extracts, background interference was substantial. 
Separation of analyte peaks from background was improved by using a longer column and a less 
steep elution gradient. The effect is illustrated in Figure 3.1. 
The updated chromatographic method used a BEH C18 1.7µm (2.1x100mm) column. The 
mobile phase was initially30% methanol for 2.10 minutes followed by a linear increase to 60% 
methanol over 2.90 minutes and was held at 60% methanol for 5 minutes at a flow rate of 0.275 
mL/min. Then, the methanol was increased to 75% over 2 minutes and held at 75% for 8 
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minutes. Methanol was then increased linearly to 100% over 1 minute and held at a flow rate of 
0.4 mL/min for 4 minutes. Finally mobile phase was decreased linearly to initial conditions and 
held for 3 minutes before the next injection. This updated LC method was used to quantify the 
four oxy-PAHs in soil samples described in Chapter 5 of this dissertation. 
 
Figure 3.1 Portion of chromatogram during which PQ elutes in (a) the original chromatographic 
method and (b) the updated chromatographic method. Shaded portion is PQ peak. 
3.3 Results and discussion 
The effect of bioremediation on the desorption and removal of oxy-PAHs is described in 
detail in Hu et al. (2014). In summary, concentrations of the four oxy-PAHs in untreated feed 
soil ranged from < 1 mg/kg (PQ) to 18 mg/kg (AQ). Bioremediation resulted in the removal of 
72% of total measured oxy-PAHs (Table 3.1) and substantially reduced the desorbable fraction 
of oxy-PAHs (Figure 3.2). For all measured oxy-PAHs, the percent removed during treatment 
exceeded the desorbable fraction in the feed soil, suggesting that biodegradation was not limited 
to the initial desorbable fraction. Removal in excess of measured abiotic desorption was also 
observed for PAHs in Hu et al. (2014) and during long-term simulated in-situ treatment of the 
same contaminated soil (Richardson and Aitken 2011). This difference could be caused by 
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microbially-enhanced desorption through the secretion of biosurfactants or through direct uptake 
of PAH by bacteria attached to the contaminant matrix (Mukherji and Ghosh 2012), or it could 
be a result of differences between bacteria and sorptive resins in the physical accessibility to 
PAHs in micropores of soil aggregates.  
Table 3.1 Concentration of oxy-PAHs in feed and treated soils and corresponding removals.a 
Oxy-PAH Feed (µg/g) Treated (µg/g) Removal (%) 
PQ 0.858 ± 0.054 0.282 ± 0.014 67.2 ± 2.6 
FLO 1.43 ± 0.11 0.577 ± 0.062 59.6 ± 5.3 
AQ 18.3 ± 0.4 4.71 ± 0.08 74.3 ± 0.8 
BAQ 1.70 ± 0.09 0.752 ± 0.006 55.9 ± 2.3 
Total oxy-PAH 22.3 ± 0.5 6.32 ± 0.16 71.6 ± 1.0 
a Values represent means and standard deviation of triplicates. 
 
Figure 3.2 Effect of bioremediation on desorption of oxy-PAH from contaminated soil . Data 
from Hu et al. (2014). 
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The solubilities of the oxy-PAHs in phosphate buffer are presented in Table 3.2. In 
general, measured solubilities agreed within an order of magnitude with values found in the 
literature. There is limited information on the aqueous solubility of oxy-PAHs. The Handbook of 
Aqueous Solubilities (Yalkowsky 2003) listed only AQ, with a reference to Eik-Nes et al. 
(1954). The Reaxys (2015) database reported the solubility of PQ to be 7.5 mg/L but references 
Knox and Will (1919), which does not appear to discuss PQ. The NIH database ChemIDplus 
(2015) also reports 7.5 mg/L, but the link to the source was broken as of this writing (date 
accessed: 07/02/2015). 
Table 3.2 Measured solubility of oxy-PAHs and reported values in the literature.
 Solubility (mg/L) 
Compound 24 hoursa 48 hoursa 
Literature 
solubility 
PQ 4.04 ± 0.16 4.25 ± 0.16 7.5b 
FLO 14.8 ± 0.1 15.1 ± 0.4 25.3b (EST) 
AQ 0.108 ± 0.008 0.106 ± 0.015 1.35b,c , 0.125d 
BAQ 0.101 ± 0.001 0.105 ± 0.003 0.289b (EST) 
a Values represent means and standard deviations of triplicates. b ChemIDplus (2015),c Eik-Nes 
et al. (1954), d Walker (1993). EST, reported as estimated solubility in ChemIDplus.
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CHAPTER 4: SCREENING NONIONIC SURFACTANTS FOR ENHANCED 
BIODEGRADATION OF POLYCYCLIC AROMATIC HYDROCARBONS 
REMAINING IN SOIL AFTER CONVENTIONAL BIOLOGICAL TREATMENT 
4.1 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are a class of compounds that are of 
environmental and public health concern because of their known or suspected toxicity and 
genotoxicity and their frequent occurrence at contaminated sites (ATSDR 1995). Bioremediation 
is one option for the treatment of PAH-contaminated systems such as soil and sediment, but its 
efficacy may be limited by incomplete removal of the target PAHs (Aitken and Long 2004).  
Due to their hydrophobicity, PAHs are often strongly associated with non-polar soil 
domains such as soil organic matter, combustion residue, and non-aqueous-phase liquids, and 
therefore may be unavailable to degrading microorganisms. Studies measuring PAH desorption 
from soil into the aqueous phase suggest that the fast-desorbing or bioaccessible fraction of a 
PAH can be a qualitative, if not quantitative, indicator of biodegradation potential in field-
contaminated soil (Cornelissen et al. 1998; Huesemann et al. 2004; Richardson and Aitken 
2011). The addition of surfactants has been proposed as a means of enhancing the bioavailability 
of PAHs to degrading microorganisms as reviewed in Makkar and Rockne (2003), Li and Chen 
(2009), and Elliot et al. (2011) ,but previous studies have led to conflicting conclusions on the 
effects of surfactants on the biodegradation of PAHs in field-contaminated soils or in spiked 
soils. 
Surfactants can increase the rate of PAH desorption from a geosorbent through two 
mechanisms: micellar solubilization and direct modification of the contaminant matrix. Micellar 
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solubilization involves partitioning of PAHs into surfactant micelles at aqueous-phase surfactant 
concentrations above the critical micelle concentration (CMC), increasing the rate of desorption 
by maximizing the concentration gradient between the geosorbent and aqueous phase (Grasso et 
al. 2001). Significant sorption of surfactant to soil, however, necessitates larger surfactant doses 
to reach the CMC in the aqueous phase of soil/water systems (Liu et al. 1992). As opposed to 
solubilization, modification of the contaminant matrix can occur at concentrations above and 
below the CMC. Surfactants have been shown to increase desorption of PAHs from 
contaminated field soil at doses corresponding to aqueous-phase surfactant concentrations less 
than the CMC (sub-CMC doses) in the soil/water system (Zhu and Aitken 2010; Frutos et al. 
2011). Hypothesized effects of surfactants on the contaminant matrix include increased PAH 
diffusivity (Yeom et al. 1996), and increased geosorbent interfacial surface area caused by 
wetting (Dong et al. 2003) and dispersion of non-polar matrices (Kile and Chiou 1989; Zhang 
and Miller 1992; Churchill et al. 1995). Additionally, sorption of surfactant to bacteria can 
increase the adherence of bacteria to a geosorbent, potentially increasing the rate of PAH 
desorption directly into biofilms or adherent cells (Mohanty and Mukherji 2008; Mohanty and 
Mukherji 2012; Zhang and Zhu 2014). 
Previous research on field-contaminated soil suggests that surfactant addition is most 
beneficial for systems in which PAH biodegradation is limited by low bioaccessibility. This 
would be the case, for example, with soil treated in a conventional bioremediation system for 
which residual PAH concentrations might exceed cleanup targets (Zhu and Aitken 2010). Studies 
in which surfactant-free controls achieve substantial PAH removal tend to demonstrate no 
improvement or even inhibition of PAH removal as a result of surfactant addition (Deschenes et 
al. 1996; Kim and Weber 2005; Lei et al. 2005; Zhu and Aitken 2010; Bueno-Montes et al. 
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2011). Studies in which surfactant-free controls exhibit negligible PAH removal, however, tend 
to demonstrate positive effects of surfactant addition (Tiehm et al. 1997; Di Gennaro et al. 2008; 
Zhu and Aitken 2010; Bueno-Montes et al. 2011). If these surfactant-free controls perform 
poorly due to limited PAH bioaccessibility, then surfactant-enhanced desorption may explain 
improved biodegradation. Although there is a cost savings associated with using less surfactant, 
there has been limited work on surfactant-amended bioremediation of PAH-contaminated field 
soil at sub-CMC doses (Kim and Weber 2005; Lei et al. 2005; Zhu and Aitken 2010). 
The objective of the present study was to investigate the effect of sub-CMC surfactant 
doses on the bioremediation of PAH-contaminated soil from a former manufactured-gas plant 
(MGP) site which had already undergone biological treatment in a slurry-phase bioreactor. We 
evaluated five relatively hydrophobic nonionic surfactants (hydrophile-lipophile balance [HLB] 
≤ 10) based on our previous study in which the hydrophobic surfactant, Brij 30, enhanced 
desorption and biodegradation more than the hydrophilic surfactant, C12E8 (Zhu and Aitken 
2010). In this study, we hypothesized that surfactants of similar hydrophobicity but different 
hydrophilic moieties (Figure 4.1) might influence the microbial community and, therefore, PAH 
removal as well as the toxicity of the soil. We evaluated the effect of surfactant amendment on 
desorption and biodegradation of residual PAHs and for the three most effective surfactants we 
also evaluated the effect of treatment on soil (geno)toxicity. 
4.2 Materials and methods 
4.2.1 Materials 
PAH standards for high performance liquid chromatography (HPLC) analysis (EPA 610 
PAH mixture and individual PAHs), Brij 30, Span 20, and polyoxyethylene sorbitol hexaoleate 
(POESH), Tenax® TA beads (60/80 mesh), and dimethyl sulfoxide (DMSO) were obtained from 
Sigma-Aldrich (St. Louis, MO, U.S.A.). Ecosurf™ EH-3 (EH-3) was obtained from Chemical 
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Marketing Concepts (New Milford, CT, U.S.A.). R-95™ rhamnolipid biosurfactant (R-95) was 
obtained from AGAE Technologies (Corvallis, OR, U.S.A.). Properties of the surfactants are 
summarized in Table 4.1. SnakeSkin™ Dialysis Tubing (10,000 MWCO, 22-mm diameter) was 
obtained from Thermo Scientiﬁc (Rockford, IL, U.S.A.). PAH standards for gas 
chromatography-mass spectrometry (GC-MS) were obtained from Accustandard Inc. (New 
Haven, CT, U.S.A.) All solvents were HPLC grade and were obtained from either Fisher 
Scientific (Pittsburgh, PA, U.S.A.) or VWR International (Radnor, PA, U.S.A.). 
4.2.2 Bioreactor operation 
Contaminated soil used in this study was collected from a former manufactured-gas plant 
site in Salisbury, North Carolina, processed, and characterized as described elsewhere 
(Richardson and Aitken 2011; Hu et al. 2012). The soil was treated in a continuously stirred, 
semi-continuous, laboratory-scale aerobic bioreactor. The bioreactor was made of stainless steel, 
has a working volume of approximately 2 L, a solids content of 15% (w/w), and average solids 
retention time of 35 days. Every seven days, 20% of the treated slurry was replaced with a slurry 
of untreated (feed) soil in a pH 7.5 buﬀer containing 5-mM phosphate and 2.5-mM ammonium 
nitrate. Treated slurry was centrifuged at 3900 RPM for 20 minutes, the supernatant discarded, 
and the centrifuged bioreactor-treated soil used in the experiments described below. Moisture 
content of the centrifuged soil was determined in triplicate by heating 1-g wet-weight aliquots of 
soil to dryness in preweighed ceramic crucibles over a Bunsen burner until a stable value of dry 
mass could be obtained. Typical soil moisture content was approximately 45% (w/w).  
4.2.3 Surfactant dose selection 
The CMC of each surfactant in phosphate buffer (5 mM, pH 7.5) was measured by 
following surface tension as a function of surfactant concentration. Because surfactants sorb to 
soil, it was necessary to evaluate surfactant doses (mass surfactant per mass dry weight soil) 
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required to achieve the CMC in soil/buffer slurries as a basis for selecting sub-CMC doses for 
each surfactant. The surfactant was added to bioreactor-treated soil in a 15% (w/w) slurry in 
phosphate buffer (5 mM, pH 7.5). The aqueous-phase surfactant concentration and percent total 
pyrene solubilized as a function of dose were determined for each surfactant as described in 
Supporting Information. Pyrene was chosen as a representative PAH because of its presence at 
liquid-phase concentrations above the lower limit of quantification (LLOQ) for a wide range of 
surfactant doses. At aqueous-phase surfactant concentrations below the apparent CMC, liquid-
phase PAH concentrations are low because solubilization is negligible. Based on these results, 
two doses (referred to as higher and lower) below the apparent CMC in the soil-slurry system 
were selected for each surfactant (Table 4.1); the lower dose was equal to 1/3 the higher dose. 
The higher dose of R-95, however, was slightly above the nominal CMC. For Brij 30, Span 20, 
EH-3, and R-95 the selected doses corresponded to less than 1% of total pyrene solubilized in the 
liquid phase of the slurry (Figure A.1 and Figure A.2). For POESH the selected doses 
corresponded to less than 6% of total initial pyrene solubilized in the liquid phase of the slurry.  
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Table 4.1 Properties of surfactants tested and doses used. 
Surfactant Alternative names HLB 
CMCa 
(mg/L) 
Dose (mg/g-dry soil) 
Higher Lower 
Brij 30 
Brij L4, Polyethylene glycol dodecyl 
ether, Polyoxyethylene (4) lauryl ether 
9.7 18 12 4 
Span 20 Sorbitan monolaurate 8.7 17 15 5 
EH-3 none 7.9 680 60 20 
POESH 
Poly(ethylene glycol) sorbitol 
hexaoleate, Polyoxyethylene sorbitol 
hexaoleate 
10 260 24 8 
R-95 
3-((6-deoxy-2-O-(6-deoxy-alpha-L-
mannopyranosyl)-alpha-L-
mannopyranosyl)oxy)-Decanoic acid 
1-(carboxymethyl)octyl ester 
10 38 9 3 
a CMC measured in phosphate buffer. 
 
Figure 4.1 Structures of tested surfactants  a EH-3 is an alcohol ethoxylate (similar to Brij 30) 
with a proprietary structure. 
4.2.4 PAH desorption 
Desorption of PAHs from bioreactor-treated soil during surfactant-amended treatment 
was evaluated using Tenax beads as an infinite sink. Incubations with each surfactant were 
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prepared in triplicate for the lower and higher doses and in quadruplicate for no-surfactant 
controls. The experiment required a mass of bioreactor-treated soil larger than that produced by 
the bioreactor in a single week. Therefore, incubations were set up over multiple weeks using 
separate batches of bioreactor-treated soil, each analyzed for PAH concentrations in triplicate. 
No-surfactant controls were prepared for each batch of bioreactor-treated soil. Incubations were 
prepared by adding 2-g dry weight bioreactor-treated soil to 30-mL glass centrifuge tubes with 
polytetrafluoroethylene (PTFE)-lined septa screw caps. Surfactant stock solution in phosphate 
buffer (pH 7.5) was added to give the desired surfactant dose. Additional phosphate buffer was 
added to give a final solids content of 15% (w/w). The headspace in each incubation tube was 
purged with nitrogen and the tubes were put on a rotary shaker at 275 RPM for 48 hours in the 
dark to allow sorption of the surfactant to the soil with minimal aerobic biodegradation of 
surfactant and PAHs.  
After 48 hours of anaerobic incubation, an additional 10 mL of phosphate buffer and 0.1 
g of Tenax beads contained in dialysis tubing knotted at both ends were added to each 
incubation. Prior to use, Tenax beads were cleaned by Soxhlet extraction in 50:50 
acetone:hexane for 12 to 16 hours, rinsed with methanol, and air dried. It was necessary to 
contain the Tenax in dialysis tubing because Tenax did not float in surfactant-containing 
incubations, which is how it would be recovered in conventional desorption experiments (Zhu et 
al. 2008). Work by Hu et al. (2014) demonstrated that this dialysis tubing does not impact PAH 
desorption measurements. After adding the dialysis tubing to each incubation tube, the 
headspaces were purged with nitrogen again. The incubation tubes were then returned to the 
orbital shaker for a period of seven days, which has been shown to be sufficient to approach 
equilibrium for this soil (Hu et al. 2014). 
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After seven days, the dialysis tubing was removed from each incubation tube and rinsed 
with deionized water to dislodge any soil adhering to the tubing. Each Tenax-containing dialysis 
tube was then slit and the Tenax along with the tubing was added to 15-mL glass vials with 
PTFE-lined septa and screw caps. The Tenax was extracted overnight with 10 mL methanol on 
an orbital shaker (275 RPM). The extracts were then vacuum-filtered through 0.2-µm nylon 
membrane filter and volumized to 25 mL with acetonitrile. Some extracts were concentrated 
under a gentle stream of nitrogen to bring the concentrations of PAHs above their quantification 
limits. Tenax solvent-extracts were then analyzed by HPLC to determine the masses of desorbed 
PAHs. The incubation tubes containing the higher dose for each surfactant were centrifuged and 
residual PAH concentrations in the post-desorption soil pellet measured. The sum of the residual 
mass of a given PAH in the soil pellet plus the mass sorbed to the Tenax was compared to the 
initial mass in the bioreactor-treated soil to calculate a recovery for each PAH in the higher-dose 
incubations.  
There were several conditions for which the PAH mass desorbed in some replicates was 
below the method LLOQ. An average and standard deviation of mass desorbed for an individual 
PAH with at least two replicates above the LLOQ were calculated using Cohen’s maximum 
likelihood estimator method (Cohen 1959; Berthouex 1994). Individual PAHs with less than two 
replicates above the LLOQ for a condition are listed as <LLOQ (Cohen’s method is not 
applicable to conditions with less than two uncensored observations).  
4.2.5 PAH biodegradation 
A preliminary biodegradation experiment was conducted by setting up incubations over 
multiple weeks (one surfactant per week) using separate batches of bioreactor-treated soil, each 
analyzed for PAH concentrations in six replicates; three of the replicates were spiked with a 
known amount of anthracene-D10 as a recovery surrogate while the other three were used for 
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toxicity testing as described below. For each surfactant, incubations were prepared at both the 
lower and higher doses. A no-surfactant control and an azide-inhibited control with surfactant at 
the higher dose were prepared in parallel for each surfactant. Incubations under each condition 
were prepared by adding 1.6-g dry weight bioreactor-treated soil to each of five 30-mL glass 
centrifuge tubes with PTFE-lined septa and screw caps. Surfactant stock solution in bioreactor 
buffer was added to deliver the target surfactant dose. The inhibited controls were spiked with 1 
mL of 50-g/L sodium azide solution for a final nominal sodium azide concentration of 4.2 g/L. 
Bioreactor buffer was then added to give a final solids content of 15% (w/w). 
All incubations were purged with nitrogen and put on an orbital shaker at 275 RPM for 
48 hours in the dark to allow surfactant to sorb to the soil with minimal aerobic biodegradation 
of surfactant or PAH. After 48 hours, incubations were kept on the orbital shaker for an 
additional 14 days and uncapped daily for five minutes to allow air into the incubation vessel. 
All incubations were then centrifuged and the soil pellets extracted and analyzed for PAHs. The 
supernatants from each higher-dose surfactant incubation were syringe-filtered through 0.8-µm 
polycarbonate membrane filters and analyzed for PAHs.  
Results from the preliminary biodegradation experiment were used to select the best-
performing surfactants and their doses for direct comparison with a single batch of soil removed 
from the bioreactor (referred to below as the followup biodegradation experiment). Incubations 
were prepared and analyzed as described above for the preliminary experiment, except the liquid 
phase of the incubation at the lower dose of Brij 30 was also analyzed for PAHs. 
4.2.6 Soil extraction and PAH analysis 
Bioreactor-treated soil (~3g wet weight per replicate) and incubation soil pellets were 
extracted in their centrifuge tubes by mixing with 10-g sodium sulfate and extracting overnight 
twice, each time with 10-mL acetone and 10-mL dichloromethane as described elsewhere 
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(Richardson et al. 2011). Soil solvent-extracts, Tenax solvent-extracts, and incubation 
supernatants (liquid-phase) were analyzed for the concentrations of 14 PAHs denoted in the 
footnote of Table A.1 by HPLC with fluorescence detection as described elsewhere (Richardson 
et al. 2011). Unless noted otherwise, “total PAH” refers to the sum of these 14 PAHs. Soil 
solvent-extracts of selected conditions (no-surfactant control, lower dose of Brij 30, and higher 
doses of POESH and Span 20) from the followup biodegradation experiment were analyzed for 
additional PAHs and alky-PAHs by GC-MS as described in Appendix A. Extraction and analysis 
of the feed soil for the bioreactor is also described in Appendix A. Concentrations of PAHs in the 
feed soil are provided in Table A.1 and Table A.2 and concentrations of PAHs in the bioreactor-
treated soil for the preliminary biodegradation experiments are provided in Table A.3. 
4.2.7 (Geno)toxicity 
The effects of surfactant amendment on soil toxicity and genotoxicity were evaluated 
using solvent extracts from the followup biodegradation experiment. For each condition, 8-mL 
aliquots from each of the five replicate extracts for a given condition were combined in a 
preweighed vial and evaporated to dryness under a gentle stream of nitrogen. For bioreactor-
treated soil prior to surfactant addition, triplicate aliquots (not spiked with anthracene-D10) were 
extracted and 12.5 mL of each extract were combined and evaporated to dryness under a gentle 
stream of nitrogen. Residue mass was then determined gravimetrically. Toxicities of the residues 
reconstituted in DMSO were evaluated in triplicate using a 96-well plate-based DT40 chicken 
lymphocyte DNA-damage response assay adapted from Ridpath et al. (2011) and Hu et al. 
(2012). Dose ranges were sufficient to bracket the LC50 of the residue. The Rad54-/- and Rev1-/- 
DNA-repair deficient mutants were tested alongside the isogenic DT40 parental cell line because 
of their reported sensitivity to soil residue in previous experiments (Hu et al. 2012). The Rad54-/- 
knock-out is deficient in the homologous recombination DNA repair pathway, while the Rev1-/- 
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knock-out is deficient in the translesion synthesis pathway. LC50 values (mg residue/mL in-well 
media) were calculated by fitting the log concentration vs % survival in GraphPad Prism version 
6.05 for Windows. The LC50 values measured for residue mass were converted to an equivalent 
soil LC50 (mg soil/mL in-well media). Relative LC50’s for each mutant cell line (LC50 of the 
mutant divided by the LC50 of the parental cell line) were calculated as a measure of 
genotoxicity, as described elsewhere (Hu et al. 2012). 
A followup experiment was conducted to assess the effect of POESH at the higher dose 
on the (geno)toxicity of bioreactor-treated soil independent of PAH biodegradation or potential 
surfactant biodegradation. Biodegradation was minimized by incubating bioreactor-treated soil 
anaerobically and by omitting ammonium nitrate in the buffer; a nitrogen headspace was 
maintained for the duration of the incubation. In parallel, bioreactor-treated soil was also 
incubated with POESH at the higher dose under aerobic conditions. No-surfactant controls were 
also incubated under both aerobic and anaerobic conditions. Five replicates were prepared for 
each condition as described above for the preliminary biodegradation experiment and evaluated 
for (geno)toxicity. 
4.2.8 Data analysis 
Statistical analysis was conducted with SAS Enterprise Guide 6.1 (SAS Institute, Cary, 
NC, U.S.A.). For each PAH, a comparison of mass desorbed (µg) in the no-surfactant control 
with each surfactant-containing condition was conducted with two-sample t-tests (two-tail, 
homoscedastic, α = 0.05). To identify enhanced PAH removal, multiple comparisons (one-way 
ANOVA followed by Tukey’s Studentized, range test α=0.05) among all treatments were 
performed using the final soil concentrations of each PAH. Comparisons were made between the 
LC50 and relative LC50’s of bioreactor-treated soil with those of each treatment using two-sample 
t-tests (two-tail, homoscedastic, α = 0.05). The standard deviations of percent desorbed and 
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percent removal were calculated by propagation of error using the means and standard deviations 
of the data used in the calculations. 
4.3 Results 
4.3.1 PAH desorption 
The effect of two surfactant doses below the CMC on desorption of residual PAHs from 
soil previously treated in a slurry-phase bioreactor was evaluated. At these doses the majority of 
surfactant is sorbed to the soil and solubilization is not expected to be a major mechanism of 
PAH mobilization. Incubation of the bioreactor-treated soil with all surfactants resulted in 
modest increases in total PAH desorption compared to no-surfactant controls (Figure 4.2). 
Percent individual PAH masses desorbed for Brij 30 are depicted in Figure 4.3. In general, low-
molecular-weight PAHs (2- or 3-rings), with the exception of naphthalene, were desorbed to a 
greater extent than were the high-molecular-weight PAHs. For example, over 50% of 
acenaphthene was desorbed by Brij 30 at the higher dose, while no more than 6% of any 
measured 4-, 5-, or 6-ring PAH was desorbed. Desorption trends of individual PAHs for the 
remaining surfactants were similar. Concentrations of PAHs in the bioreactor-treated soil 
samples used in desorption experiments and percent masses desorbed for all conditions are 
provided in Table A.4-Table A.6.  
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Figure 4.2 Cumulative desorption of total PAH mass from bioreactor-treated soil after seven 
days in the absence of surfactant or in the presence of five different surfactants, each added at 
two doses designated “lower” and “higher” as defined in Materials and Methods. Bars represent 
means and standard deviations of three replicates for surfactant conditions and four replicates for 
no-surfactant controls. An asterisk indicates a significant difference (α=0.05) between the mass 
of PAH desorbed in a treatment and no-surfactant control.  
 
Figure 4.3 Cumulative desorption of PAHs from bioreactor-treated soil after seven days in the 
absence of surfactant or in the presence Brij 30. ; the inset shows the data for the three indicated 
compounds on a finer scale. Abbreviations are defined in Table A.1. Other notes as in Figure 4.2. 
PAHs for which there were no significant differences (BkF, BaP, DBA, and BgP) between no-
surfactant and both doses are not shown. 
 
Recoveries of individual PAHs ranged from 60-107% (Table A.7). For the lower 
recoveries, it is possible that nitrogen purging did not sufficiently inhibit PAH biodegradation. 
Also, it is not known how the likely sorption of surfactant impacts the capacity of Tenax to serve 
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as an infinite sink. Given these limitations, the results can be interpreted as semi-quantitative 
evidence of the ability of surfactants to enhance PAH desorption at doses below the apparent 
CMC in the soil-slurry system. 
4.3.2 PAH biodegradation 
Biodegradation of residual PAHs in the treated soil from a slurry-phase bioreactor was 
evaluated at the two selected doses for each surfactant. All surfactants except R-95 rhamnolipid 
significantly increased total PAH removal from the bioreactor-treated soil relative to the no-
surfactant control (Figure 4.4). POESH had the greatest effect, resulting in removal of 50% of 
total PAH. Significant dose-dependent effects were observed for both Brij 30 and POESH. While 
the lower dose of Brij 30 enhanced total PAH removal relative to the controls, the higher dose 
did not. Brij 30, Span 20, and POESH were particularly effective at enhancing the removal of 4- 
and 5-ring PAHs (Figure 4.5-Figure 4.7) and therefore were chosen for further evaluation in a 
followup experiment. Individual PAH removals for EH-3 and R-95 can be found in Figure 4.8 
and Figure 4.9 respectively. 
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Figure 4.4 Effect of surfactants on residual total PAH from bioreactor-treated soil  after 16 days. 
Surfactant doses are as defined in Materials and Methods. “Inhibited” refers to controls to which 
sodium azide was added. Bars represent means and standard deviations of five replicates for all 
surfactants except Span 20 (four replicates). Conditions for which there was not a significant 
difference (α=0.05) in final PAH concentration detected by Tukey's method are assigned the 
same letter. Bars for which no letters are shown are implicitly designated “a”.  
 
Figure 4.5 Effect of Brij 30 on biodegradation of residual PAHs  from bioreactor-treated soil  
after 16 days. Abbreviations are defined in Table A.1. PAHs for which there were no significant 
differences between no-surfactant and lower and higher conditions are not shown. Other notes as 
in Figure 4.4. 
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Figure 4.6 Effect of Span 20 on biodegradation of residual PAHs from bioreactor-treated soil 
after 16 days. Notes as in Figure 4.5. 
 
Figure 4.7 Effect of POESH on biodegradation of residual PAHs from bioreactor-treated soil 
after 16 days. Notes as in Figure 4.5. 
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Figure 4.8 Effect of EH-3 on biodegradation of residual PAHs from bioreactor-treated soil after 
16 days. Notes as in Figure 4.5. 
 
Figure 4.9 Effect of R-95 on biodegradation of residual PAHs from bioreactor-treated soil after 
16 days. Notes as in Figure 4.5. 
Both doses of Brij 30 and POESH, and the higher dose of Span 20, were evaluated in the 
followup experiment. Compared to no-surfactant controls, surfactant addition did not 
significantly improve removal of 2-ring PAHs. Of the 3-ring PAHs, only phenanthrene 
biodegradation was significantly improved with surfactant addition for both doses of Brij 30 and 
the higher dose of POESH. All three surfactants enhanced the removal of 4-ring PAHs, although 
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the higher dose of Brij 30 enhanced the removal of only fluoranthene and chrysene (Figure 4.10). 
All three surfactants enhanced the removal of 5-ring PAHs except dibenzo[a,h]anthracene. Brij 
30 at the higher dose, however, either had no significant effect or a significantly negative effect 
on the removal of 5-ring PAHs. At the end of the incubations, individual concentrations of the 14 
PAHs measured by HPLC in the liquid phase were below LLOQ’s, corresponding to no more 
than 5% of the initial mass of any individual PAH.  
 
Figure 4.10 Effect of Brij 30, POESH, and Span 20 on residual 4- and 5-ring PAHs from 
bioreactor-treated soil after 16 days. Abbreviations are defined in Table A.1. Bars represent 
means and standard deviations of five replicates. Asterisks indicate PAHs designated by EPA as 
probable human carcinogens. PAHs for which there were no significant differences between no-
surfactant controls and all surfactant-conditions are not shown. †BeP measured by GC-MS and 
not measured in Brij 30 higher or POESH lower. Other notes as in Figure 4.4.  
GC-MS analysis of selected conditions from the followup biodegradation experiment 
revealed increased removal of additional PAHs with surfactant addition. Removals of 
benzo[e]pyrene (Figure 4.10), alkylated 2- and 3-ring PAHs (Figure A.3), and alkylated 4-ring 
PAHs (Figure 4.11) were significantly enhanced upon surfactant addition. Concentrations of 
individual PAHs in the followup experiment for the bioreactor-treated soil and soils treated 
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further with or without surfactant are provided in Table A.8. Overall PAH removals relative to 
the feed soil for the bioreactor and followup experiments are provided in Table A.9 to illustrate 
the combined impact of bioreactor treatment plus surfactant amendment as a secondary treatment 
step. 
 
Figure 4.11 Effect of Brij 30, POESH, and Span 20 on biodegradation of residual alkylated 4-
ring PAHs from bioreactor-treated soil after 16 days. Other notes as in Figure 4.10.  
4.3.3 (Geno)toxicity 
The effects of surfactant amendment on bioreactor-treated soil toxicity (LC50) and 
genotoxicity (relative LC50) were assessed. Solvent extracts from the followup biodegradation 
experiment were evaluated using the DT40 DNA-damage response assay. All treatments except 
POESH at the higher dose significantly increased soil toxicity to the parental cell line (Figure 
4.12a). Treatment without surfactant significantly decreased soil genotoxicity as evaluated with 
both mutant cell lines (Figure 4.12b). Brij 30 at the lower dose significantly reduced the 
genotoxicity as measured using the Rad54-/- mutant. Treatment with POESH at the higher dose 
significantly increased soil genotoxicity as evaluated with the Rev1-/- mutant. 
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Figure 4.12 Effect of incubation of bioreactor-treated soil with selected surfactants in the 
followup PAH biodegradation experiment on (geno)toxicity. (a) Toxicity to the parental DT40 
cell line, and (b) genotoxicity as determined by relative LC50 values (mutant LC50/parental LC50) 
using the DNA repair-deficient mutants Rad54-/- and Rev1-/-. Bars represent means and standard 
deviations of three experiments. An asterisk indicates a significant difference (α=0.05) for a 
given cell line between a treatment and bioreactor-treated soil. BTS, bioreactor-treated soil; NS, 
no-surfactant control; P, POESH, B, Brij 30; S, SPAN 20; L, lower surfactant dose; H, higher 
surfactant dose.  
To assess whether POESH could have a significant effect on observed soil genotoxicity 
in the absence of biodegradation, we evaluated the effect of incubating bioreactor-treated soil 
with POESH at the higher dose under conditions intended to minimize biodegradation of the 
PAHs and/or the surfactant (anaerobic incubation without nitrogen amendment). No more than 
20% of any individual PAH was removed for the POESH anaerobic condition (Figure A.4) and 
no significant increase in toxicity or genotoxicity was observed (Figure A.5). In pairwise 
comparisons with the bioreactor-treated soil before POESH addition, however, neither treatment 
without surfactant nor treatment with POESH aerobically had a significant effect on soil toxicity 
or genotoxicity. Since this was contrary to the results of the initial (geno)toxicity experiment, we 
conducted the DT40 bioassay side-by-side with archived solvent extracts of bioreactor-treated 
soil, no-surfactant controls, and higher-dose POESH amendment (aerobic) from both 
experiments. In this reevaluation the increase in toxicity to the parental DT40 cell line for the no-
surfactant controls was observed for both experiments (Figure 4.13c). The reduction of 
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genotoxicity associated with the no-surfactant controls was observed in the Rad54-/- mutant for 
both experiments but was observed in Rev1-/- only for the initial (geno)toxicity experiment 
(Figure 4.13a,b). Higher-dose POESH treatment was associated with a slight, but statistically 
significant, increase in genotoxicity to Rad54-/- only in the followup (geno)toxicity experiment.  
 
Taken together, the initial and followup (geno)toxicity experiments suggest that further 
treatment without surfactant increased soil toxicity, but generally reduced genotoxicity. 
Treatment with POESH at the higher dose was associated either with no significant change or a 
slight increase in soil genotoxicity. 
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Figure 4.13 (Geno)toxicity of soil from the 
initial and followup (geno)toxicity 
experiments as evaluated a second time  
with archived solvent extracts. Bioreactor 
refers to bioreactor-treated soil. (a) LC50 of 
soil to DT40 parental cell line. (b) Relative 
LC50 of soil to Rad54-/- mutant. (c) 
Relative LC50 of soil to Rev1-/- mutant. 
Bars represent means and standard 
deviations of four experiments. An asterisk 
indicates a significant difference (α=0.05) 
between a treatment and bioreactor-treated 
soil.  
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4.4 Discussion 
Although surfactant addition to contaminated soil has been suggested as a means of 
enhancing the biodegradation of hydrophobic contaminants such as PAHs, most studies do not 
articulate that the concept is most relevant to the fraction of a given compound that is relatively 
non-bioavailable or non-bioaccessible. We previously reported that the nonionic surfactant Brij 
30 substantially improved the desorption and biodegradation of residual PAHs from 
contaminated soil that had already undergone aerobic treatment in a slurry-phase bioreactor (Zhu 
and Aitken 2010). In this study, we extended the concept by comparing five nonionic surfactants 
of similar hydrophobicities but with different hydrophilic moieties on the removal of residual 
PAHs from a different contaminated soil after bioreactor treatment. 
Incubation of the bioreactor-treated soil with all surfactants at sub-CMC doses resulted in 
modest increases in PAH desorption but substantial increases in total PAH biodegradation for all 
surfactants except the R-95 rhamnolipid biosurfactant. The surfactants Brij 30, Span 20, and 
POESH were particularly effective at enhancing removal of 4- and 5-ring PAHs, including five 
of the seven PAHs designated by EPA as human carcinogens.  
We specifically evaluated sub-CMC doses of each surfactant, at which micellar 
solubilization of PAHs would be negligible. Enhanced desorption of PAHs at surfactant doses 
below the apparent CMC in the soil slurry system is consistent with other studies treating field-
contaminated soil (Yeom et al. 1996; Zhu and Aitken 2010; Frutos et al. 2011). Luthy et al. 
(1997) described the three major components in PAH-contaminated soil as soil organic matter 
(SOM), combustion residue, and non-aqueous-phase liquids (NAPLs). Common NAPLs found at 
PAH-contaminated sites include coal tar, creosote, and petroleum products such as oil or diesel 
fuel (Mueller 1996). We assume that relatively hydrophobic nonionic surfactants sorb to these 
domains in contaminated soil and alter the contaminant matrix in a way that favors desorption or 
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other means of increasing microbial access to PAHs. Yeom et al. (1996) treated coal tar-
contaminated soil with several surfactants, including Brij 30, and found substantial increases in 
phenanthrene desorption under conditions corresponding to aqueous-phase surfactant 
concentrations below the CMC. The authors attributed this to increased PAH diffusivity within 
the coal-tar matrix. 
During further treatment with or without surfactant, total PAH removal far exceeded the 
amount desorbed. The difference between desorption and removal was particularly striking for 
the 4- and 5-ring PAHs. Large differences between measured PAH desorption and removal have 
been observed in previous studies of bioremediation (Richardson and Aitken 2011; Hu et al. 
2014) and during surfactant-enhanced bioremediation specifically (Zhu and Aitken 2010). While 
the impact of surfactant on the functionality of Tenax as an infinite sink was not investigated in 
this study, an infinite-sink method at best can measure only abiotic desorption into the aqueous 
phase. Evidence suggests that bacteria can enhance PAH desorption by adhering to hydrophobic 
contaminant matrices (Mukherji and Ghosh 2012). The rate of PAH mass transfer from 
geosorbent to adherent cells or biofilm may be faster than the rate of PAH mass transfer into a 
bulk aqueous phase. It is also possible that the smaller distances between bacteria and geosorbent 
or the ability of bacteria to enter small soil pores may cause a steeper concentration gradient than 
can be created with solid resins.  
The surfactants we evaluated may have enhanced the rate of PAH biodegradation by 
increasing the interaction of bacteria with PAH-containing soil compartments. This could occur 
through increased geosorbent interfacial surface area onto which bacteria may adhere or through 
modification of cell- or soil-surface properties to favor adhesion. Surfactants can alter cell 
surface hydrophobicity in ways that can either promote or inhibit bacterial adhesion (Zhang and 
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Zhu 2014). Rhamnolipids in particular have a concentration-depend effect on cell attachment to 
both hydrophilic and hydrophobic surfaces (Nickzad and Déziel 2014).  
While the two doses of Brij 30 led to comparable PAH desorption, the higher dose led to 
significantly less PAH removal. This suggests that factors other than abiotic PAH desorption 
affected biodegradation. In previous work, addition of Brij 30 at doses well above the CMC 
enhanced only the removal of 3-ring PAHs, while lower doses also enhanced removal of 4- and 
5-ring PAHs (Zhu and Aitken 2010). It is possible that differences in PAH removal reflect 
differences in the microbial community. In the earlier study, there was a reduction in relative 
abundance of known pyrene degraders at the supra-CMC dose of Brij 30 compared to 
incubations without surfactant and incubations at sub-CMC doses (Zhu et al. 2010).  
In work to be published elsewhere, incubations of bioreactor-treated soil under the Brij 
30 lower and higher, POESH higher, and no-surfactant conditions were set up to evaluate the 
effect of surfactant treatment on the bacterial community (Singleton et al. in prep.). Bacterial 
communities were analyzed by denaturing gradient gel electrophoresis (DGGE) and 16S rRNA 
gene high-throughput sequencing. These methods demonstrated the substantial effect of 
surfactant addition on the bacterial community and revealed the similarity of bacterial 
communities under conditions with enhanced PAH removal (Brij 30 lower and POESH higher). 
DGGE banding patterns indicated that the bacterial communities of the bioreactor-treated 
soil and soil treated further without surfactant were similar. The communities from each 
surfactant-amended condition were different from each other and from those of the bioreactor-
treated soil and soil treated further without surfactant. Notably, there were also substantial 
differences in the banding patterns of Brij 30 lower and Brij 30 higher indicating that surfactant 
dose had an effect on the bacterial community.  
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Sequencing results were processed and visualized using non-metric multidimensional 
scaling (NMDS). NMDS revealed similarities in the bacterial communities of Brij 30 lower and 
POESH higher (conditions with enhanced PAH removal) and major differences between these 
two conditions and the Brij 30 higher condition (low PAH removal). NMDS also confirmed the 
similarity of the bioreactor-treated soil community and the community after further treatment 
without surfactant and their differences from surfactant-amended conditions. Overall, our results 
confirm the hypothesis that sub-CMC surfactant addition can enhance PAH desorption and 
biodegradation in soils in which PAH bioaccessibility is limited. While we did not evaluate any 
surfactant with an HLB value greater than 10, sub-CMC doses of more-hydrophilic surfactants 
tested in previous studies did not enhance biodegradation (Kim and Weber 2005; Lei et al. 2005; 
Zhu and Aitken 2010). More-hydrophilic surfactants may have a lower affinity for the 
hydrophobic PAH-containing soil compartments, so that the CMC may be reached before a 
substantial amount of surfactant interacts with these compartments. 
The genotoxicity of the bioreactor-treated soil determined in this study is consistent with 
our previous studies treating the same contaminated source soil (Hu et al. 2012; Hu et al. 2014). 
The Rad54-/- and Rev-/- mutants used in this study are deficient in the Rad54 and Rev1 proteins, 
respectively. These two proteins are implicated in the repair or tolerance of damage caused by 
the major types of PAH-induced genotoxicity: strand breaks caused by oxidative stress or during 
base excision repair of other DNA damage (Rad54), and adduction of DNA by stable or 
depurinating adducts (Rev1) (Friedberg 2006; Penning 2011). In general, however, increased 
PAH removal from the bioreactor-treated soil did not correspond to a reduction in soil toxicity or 
genotoxicity. Amendment with POESH at the higher dose removed substantial amounts of 4- and 
5-ring PAHs, including some considered to be human carcinogens, yet had either no effect or 
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caused a slight increase in genotoxicity. Meanwhile, further treatment of the bioreactor-treated 
soil without surfactant removed less than 30% of any 4- or 5-ring PAH, but resulted in a 
significant reduction in soil genotoxicity. This finding may imply that an increased residence 
time led to the removal of genotoxic constituents present in the treated soil obtained from the 
bioreactor. Overall, the (geno)toxicity of remediated soil will depend both on the remaining 
parent compounds and the formation or removal of any products of incomplete metabolism. The 
bioavailability of any genotoxic metabolites formed as a result of biological treatment of 
contaminated soil must also be taken into account when evaluating the efficacy of 
bioremediation (Hu et al. 2014). The bioavailability of residual contaminants at the end of 
incubations with surfactants, however, was not evaluated in the present study.  
This work demonstrated the effectiveness of surfactant-amended treatment for enhanced 
biodegradation of the residual, less bioaccessible fraction of PAHs in soil after primary treatment 
in a conventional bioreactor. Employing this two-stage treatment process could increase the 
likelihood of meeting site cleanup goals, which are typically based on the concentrations of 
PAHs in the soil independent of their bioavailability or bioaccessibility. The observation that 
parent PAH removal did not necessarily correspond to a reduction in genotoxicity, however, 
highlights the need for further research to identify genotoxic products to improve risk assessment 
and remediation strategies. 
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CHAPTER 5: IMPROVING PAH BIODEGRADATION IN CONTAMINATED SOIL 
THROUGH SECOND-STAGE TREATMENT IN A SURFACTANT-AMENDED 
BIOREACTOR 
5.1 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are among the top 10 contaminants of concern 
at Superfund sites in the U.S. (ATSDR 2011). Over 600 current sites on the U.S. Environmental 
Protection Agency (EPA) National Priorities List are contaminated with PAHs, of which over 
400 contain PAH-contaminated soil (EPA 2015). Bioremediation is one option for the treatment 
of PAH contaminated soil, but can be limited by the incomplete removal of target PAHs (Aitken 
and Long 2004), which can lead to failure to meet site-specific cleanup goals.  
Due to their hydrophobicity, PAHs are often strongly associated with non-polar soil 
domains such as soil organic matter, combustion residue, and non-aqueous-phase liquids, and 
therefore may be unavailable to degrading microorganisms (Cornelissen et al. 1998; Huesemann 
et al. 2004; Richardson and Aitken 2011). A 1993 US EPA case study concluded that slurry-
phase bioreactor treatment could be used to effectively remediate PAH-contaminated soil but 
that “effective desorption of compounds from weathered soil can be an intractable problem” 
(USEPA 1993). Application of surfactants has been proposed to enhance the bioavailability of 
PAHs to degrading organisms with the goal of increasing PAH removal in contaminated soils 
and is the subject of several review articles (Makkar and Rockne 2003; Li and Chen 2009; 
Cameotra and Makkar 2010; Elliot et al. 2011; Bustamante et al. 2012). Surfactants can increase 
the rate of PAH desorption from soil at aqueous-phase concentrations both above (Tiehm et al. 
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1997; Grasso et al. 2001) and below (Yeom et al. 1996; Zhu and Aitken 2010; Frutos et al. 
2011) their critical micelle concentrations (CMC). 
Previous research on field-contaminated soil suggests that surfactant addition is most 
beneficial for systems in which PAH biodegradation is limited by low bioaccessibility. This 
would be the case, for example, with soil treated in a conventional bioremediation system for 
which residual PAH concentrations might exceed cleanup targets (Zhu and Aitken 2010; Bueno-
Montes et al. 2011). Studies in which surfactant-free controls exhibit negligible PAH removal, 
tend to demonstrate positive effects of surfactant addition (Tiehm et al. 1997; Di Gennaro et al. 
2008; Zhu and Aitken 2010; Bueno-Montes et al. 2011). If these surfactant-free controls perform 
poorly due to limited PAH bioaccessibility, then surfactant-enhanced desorption may explain 
improved biodegradation. Although there is a cost savings associated with using less surfactant, 
there has been limited work on surfactant-amended bioremediation of PAH-contaminated field 
soil at doses corresponding to aqueous phase surfactant concentrations below the CMC in the 
soil slurry system (sub-CMC doses) (Kim and Weber 2005; Lei et al. 2005; Zhu and Aitken 
2010). 
We recently screened five nonionic surfactants at sub-CMC doses on the test-tube scale 
for their ability to enhance the biodegradation of the residual PAHs remaining in soil after 
bench-scale aerobic, slurry-phase bioremediation (Adrion et al. in prep.). Polyoxyethylene 
sorbitol hexaoleate (POESH) surfactant was most effective at enhancing the removal of the 
residual high-molecular-weight (HMW) PAHs compared to further incubation for the same 
amount of time without surfactant. Despite substantial removal of PAHs, including 5 of the 7 
PAHs considered probable human carcinogens by EPA, POESH-amended treatment was 
associated with an increase in soil genotoxicity. In this study we expand on our previous work by 
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utilizing POESH at sub-CMC doses to treat effluent from the slurry-phase bioreactor in a 
second-stage batch bioreactor to which POESH was added. The objectives of the present study 
were to evaluate the reproducibility of the two-stage treatment concept at larger than test-tube 
scale; to compare two different residence times in the second-stage bioreactor; to quantify the 
effect of two-stage treatment on the removal of selected oxy-PAHs; and to evaluate the effect of 
two-stage treatment on soil toxicity and genotoxicity.  
5.2 Materials and methods 
5.2.1 Experimental design 
In our previous work screening the effects of different nonionic surfactants on PAH 
removal from soil after treatment in a semi-continuous, slurry-phase bioreactor (Adrion et al. in 
prep.), a POESH dose of 24 mg/g dry soil corresponded to an aqueous-phase surfactant 
concentration well below the CMC (260 mg/L) and a negligible fraction of total PAH mass 
present in the aqueous phase after surfactant addition. We selected the same dose of POESH to 
implement the two-stage treatment concept in the present study. 
In the previous screening experiments, the slurry removed from the bioreactor was 
centrifuged, resuspended in fresh buffer, and amended with surfactant at the test-tube scale; 
tubes were shaken vigorously on an orbital shaker. In the present study, the whole slurry 
removed as effluent from the bioreactor (i.e., not centrifuged and resuspended in buffer) served 
as influent to a second-stage, batch bioreactor to which POESH was added; mixing was 
accomplished with a metal stir bar on a magnetic mixer. To permit sorption of the surfactant to 
the soil before commencing aerobic biodegradation (Zhu and Aitken 2010; Adrion et al. in 
prep.), the surfactant-amended slurry in the second-stage reactor was mixed under a continuous 
stream of N2 for 48 hours before aerobic conditions were established. 
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Three trials of second-stage batch treatment were conducted at a residence time of 7 days, 
and three trials were conducted at a residence time of 12 day. Residence times were chosen 
based on preliminary test-tube scale experiments indicating that most PAH removal (Figure B.1) 
and changes in genotoxicity (Figure B.2) occurred between day 3 and day 21. For each trial, a 
different batch of effluent soil-slurry from the first-stage bioreactor was used (6 different batches 
altogether). Because the first-stage bioreactor was operated in a manner that produced effluent 
once a week (described below), the trials were conducted over six consecutive weeks; trials at 7-
day residence time were alternated with the trials at 12-day residence time. 
5.2.2 Chemicals 
PAH standards (EPA 610 PAH mixture and individual PAHs), 9,10-
phenanthrenequinone (PQ), 9,10-anthraquinone (AQ), polyoxyethylene sorbitol hexaoleate 
(POESH), and dimethyl sulfoxide (DMSO) were obtained from Sigma-Aldrich (St. Louis, MO, 
USA) . 9-fluorenone (FLO) and benz[a]anthracene-7,12-quinone (BAQ) were purchased from 
Acros Organics (Morris Plains, NJ, USA). All other solvents were high-performance liquid 
chromatography (HPLC) grade and were obtained from either Fisher Scientific (Pittsburgh, PA, 
U.S.A.) or VWR International (Radnor, PA, U.S.A.). 
5.2.3 First-stage treatment 
Contaminated soil used as feed for the first-stage bioreactor was collected from a former 
manufactured-gas plant (MGP) site in Salisbury, North Carolina, processed, and characterized as 
described elsewhere (Richardson and Aitken 2011; Hu et al. 2012). Feed soil underwent first-
stage treatment in a semi-continuous, laboratory-scale aerobic bioreactor. The bioreactor was 
made of stainless steel, had a working volume of approximately 2 L, a solids content of 15% 
(w/w), and average solids retention time of 35 days. Every seven days, 400 mL of the treated 
slurry was replaced with a slurry of feed soil in a pH 7.5 buﬀer containing 5-mM phosphate and 
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2.5-mM ammonium nitrate (bioreactor buffer). Each week, 100 mL of the effluent slurry was 
analyzed for PAHs and oxy-PAHs as described below. The remaining 300 mL of effluent slurry 
served as influent to the second-stage bioreactor. 
5.2.4 Preliminary experiments 
We conducted a preliminary experiment to test the selected dose of POESH at test-tube 
scale using whole slurry from the first-stage bioreactor, rather than centrifuged slurry that had 
been resuspended in buffer, to ensure that the sorptive properties of the soil had not changed 
since the previous screening experiments (Adrion et al. in prep.). Slurry from the first-stage 
bioreactor was centrifuged at 3900 rpm for 30 minutes and the supernatant was collected. A 
2.08-g (dry weight) aliquot of the centrifuged soil was added to each of triplicate 30-mL glass 
centrifuge tubes with PTFE-lined silicon septa screw-caps. POESH (50 mg) was added to each 
tube. Supernatant was then added back to each of the tubes to bring the solids content to 15% 
(w/w). The tube headspace was evacuated and replaced with nitrogen, then the tube was put on 
an orbital shaker at 275 rpm for 48 hours. After 48 hours, the tubes were centrifuged at 3900 rpm 
for 30 minutes. The supernatants were syringe-filtered through 0.8-µm polycarbonate membrane 
filters and analyzed for pyrene concentration by HPLC and surfactant concentration by 
measuring surface tension as described in (Adrion et al. in prep.). 
5.2.5 Second-stage treatment 
Two second-stage batch bioreactors were set up in parallel to accommodate treatment of 
the weekly effluent removed from the first-stage bioreactor. Each second-stage bioreactor was a 
1-L glass filter flask, fitted with a stainless steel tube piercing a silicon stopper at the top of the 
flask to provide gas input to the headspace; the side-arm was left open to allow gas to escape. 
Every week, 300 mL of first-stage treated slurry was transferred to a second-stage 
reactor. The slurry was stirred on a magnetic stir plate using a 3.2-cm metal stir-bar at 
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approximately 750 rpm. To add surfactant, 1.34 g of POESH was added to a 30-mL glass 
centrifuge tube and mixed with 10 mL of deionized water before being transferred to the second-
stage reactor; this mass corresponded to a dose of 24-mg POESH per g dry soil. An additional 10 
mL of deionized water was then used to rinse the remaining mass of POESH into the reactor. 
The surfactant-amended slurry was allowed to mix under a stream of nitrogen delivered through 
the gas tube at a flow rate of 60 mL/min for 48 hours. After 48 hours, a 10-mL aliquot of slurry 
was removed from the reactor while mixing using a glass pipette, transferred to a 30-mL glass 
centrifuge tube with PTFE-lined cap, and centrifuged at 3900 rpm for 30 minutes. The 
supernatant was syringe-filtered through a 0.8-µm polycarbonate membrane filter to measure the 
aqueous-phase surfactant and pyrene concentrations as described in (Adrion et al. in prep.). 
After the 48-hour anoxic mixing period, the nitrogen flow was discontinued and air was 
delivered continuously through the gas tube for the duration of the aerobic treatment period 
(either an additional 7 days or 12 days, as explained above).  
5.2.6 Slurry extraction and analysis 
Slurry from the first- and second-stage bioreactors was centrifuged at 3900 rpm for 30 
minutes. For each batch of slurry, a single 10-mL aliquot of the supernatant was syringe-filtered 
through a 0.8-µm polycarbonate membrane filter to measure the aqueous-phase surfactant and 
PAH concentrations as described in (Adrion et al. in prep.). Four 3-g aliquots of the wet 
centrifuged soil were each mixed with 10 g of sodium sulfate and solvent-extracted overnight 
twice, each time with 10 mL of acetone and 10 mL of dichloromethane, and analyzed for 14 
PAHs by HPLC with fluorescence detection as described elsewhere (Richardson et al. 2011). 
Four oxy-PAHs were analyzed by liquid chromatography-mass spectrometry as described in 
Chapter 3 of this dissertation. Soil moisture content was determined in triplicate by heating 1-g 
wet weight aliquots of centrifuged soil in aluminum weigh dishes at 105°C for 24 hours. 
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Untreated soil used to feed the first-stage bioreactor was prepared for analysis by slurrying in 
bioreactor buffer, centrifuging, and extracting the centrifuged soil as described above.  
Concentrations of PAHs and oxy-PAHs in the feed soil and bioreactor treated soils are provided 
in Table A.1-Table A.3. 
5.2.7 (Geno)toxicity analysis 
The effects of the two-stage treatment process on soil toxicity and genotoxicity were 
evaluated using the solvent extracts from the first-stage and second-stage treated slurries and 
from the untreated feed slurry. For each soil slurry sample, 10-mL aliquots from each of the four 
replicate solvent extracts were combined in a preweighed vial and evaporated to dryness under a 
gentle stream of nitrogen. Residue mass was then determined gravimetrically. Toxicity of the 
residues reconstituted in DMSO was evaluated in triplicate using a 96-well plate-based DT40 
chicken lymphocyte DNA-damage response assay adapted from Ridpath et al. (2011) and Hu et 
al. (2012). The untreated feed soil was evaluated in quadruplicate. The Rad54-/- and Rev1-/- 
DNA-repair deficient mutants were tested alongside the isogenic DT40 parental cell line because 
of their reported sensitivity to soil residue in previous experiments (Hu et al. 2012; Adrion et al. 
in prep.). The Rad54-/- knock–out is deficient in the homologous recombination DNA repair 
pathway, while the Rev1-/- knock-out is deficient in the translesion synthesis pathway. LC50 
values (mg residue/mL in-well fluid) were calculated by fitting the log residue concentration vs 
% survival in GraphPad Prism version 6.05 for Windows. The LC50 values as measured in 
residue mass were converted to equivalent soil LC50 values (mg soil/mL in-well fluid). The 
relative LC50 for each mutant cell line (LC50 of the mutant divided by the LC50 of the parental 
cell line) was calculated as a measure of genotoxicity as described in Hu et al. (2012). Values of 
relative LC50 less than 1.0 are indicative of genotoxicity.  
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5.2.8 Data analysis 
Averages and standard deviations of percent removals (summary statistics) for each trial 
were calculated through propagation of error using the concentrations of PAHs and oxy-PAHs in 
the second-stage treated soil and in the corresponding batch of first-stage treated soil. All 
statistical analysis was done in SAS Enterprise Guide 6.1 (SAS Institute, Cary, NC, U.S.A.). 
Comparisons of concentrations of PAHs and oxy-PAHs in soil before and after second-stage 
treatment were conducted using two-sample t-tests (two-tail, homoscedastic, α = 0.05). To 
compare removals among all the trials; for each PAH, a one-way ANOVA followed by Tukey’s 
Studentized range test (α=0.05) was conducted using summary statistics of percent removal. 
One-sample t-tests were conducted on each value of relative LC50 for the feed soil and first-stage 
treated soil to determine whether the values were significantly different than 1.0 (two-tail, 
homoscedastic, α = 0.05). Comparisons were made between the LC50’s and relative LC50’s of 
second-stage treated soil with those of the corresponding first-stage treated soil for each trial 
using two-sample t-tests (two-tail, homoscedastic, α = 0.05). 
5.3 Results 
5.3.1 Preliminary experiments 
A preliminary test-tube scale experiment was conducted to confirm that adding POESH 
to whole slurry removed from the first-stage bioreactor would be similar to our observations in 
prior work (Adrion et al. in prep.), in which the slurry from the first-stage bioreactor was 
centrifuged and the soil resuspended in fresh buffer. The aqueous-phase POESH concentration 
after48 hours of anoxic mixing was 3.4 ± 0.6 mg/L, well below the CMC, and the pyrene 
concentration was less than the lower limit of quantification (LLOQ) of 29 µg/L. However, both 
aqueous-phase POESH and pyrene concentrations were substantially higher after 48 hours of 
anoxic mixing in the second-stage bioreactors than in the test-tube scale incubations (Table 5.1), 
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although in all trials the aqueous-phase POESH concentrations were below the nominal CMC. 
After 48 hours of anoxic mixing in the second-stage bioreactors, pyrene was consistently present 
at aqueous-phase concentrations above its reported pure-compound solubility in water (Mackay 
1992), thus indicating solubilization of pyrene. By the end of all trials, however, all aqueous-
phase surfactant concentrations were less than the LLOQ of 3.3 mg/L. Likewise at the end of all 
trials, individual aqueous-phase PAH and oxy-PAH concentrations were less than their 
respective LLOQ’s; this corresponded to PAH and oxy-PAH masses present in the aqueous-
phase less than 3% of the residual mass in the first-stage treated soil except for ACE, which was 
less than 12%.  
Table 5.1 Aqueous-phase surfactant and pyrene concentrations after 48 hours  of anoxic mixing 
of first-stage bioreactor effluent prior to starting aerobic conditions in the second-stage 
bioreactor. 
 7-day 12-day 
Trial POESH (mg/L) Pyrene (µg/L) POESH (mg/L) Pyrene (µg/L) 
1 135 157* 62 89 
2 172 559* 196 612* 
3 135 265* 68 288* 
Mean ± S.D. 147 ± 21 327* ± 208 108 ± 76 330* ± 264 
An asterisk indicates liquid-phase pyrene concentration in excess of its pure-compound aqueous 
solubility of 132 µg/L (Mackay 1992). S.D. is standard deviation. 
5.3.2 PAH and oxy-PAH removal 
First-stage treatment of PAH-contaminated soil removed substantial amounts of PAHs 
and oxy-PAHs, as shown in Table B.4 and Table B.5. Second-stage batch treatment with the 
nonionic surfactant POESH for either 7 or 12 days resulted in substantial removal of the residual 
PAHs and oxy-PAHs remaining in the effluent from the first-stage bioreactor (Figure 5.1). 
Removal was most substantial for the 4-ring PAHs (FLA, PYR, BaA, and CHR). Removal of 
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naphthalene was low (<20%) and not consistently significant. Second-stage treatment removed 
significant amounts of the 5-ring PAHs (BbF, BkF, and BaP), but removal was more variable 
across trials than for the other PAHs. For the 5-ring DBA, removal was low (<20%) and not 
consistently significant. The 6-ring BgP, which had the highest concentration of any measured 
PAH in the first-stage bioreactor effluent, was not significantly removed in any second-stage 
trial.  
Comparing removals between the two residence times, differences were most substantial 
for the 5-ring PAHs, BbF, BkF and BaP (Figure 5.2). Cumulative removals relative to the 
untreated feed soil for the combined first- and second-stage treatment are presented in Table B.4 
and Table B.5 to illustrate the overall impact of the two-stage treatment concept. 
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Figure 5.1 Effect of second-stage treatment on residual PAHs and oxy-PAHs  in effluent from 
the first-stage bioreactor at a residence time of (a) 7 days and (b) 12 days. Asterisks indicate 
probable human carcinogens. Bars represent means and standard deviations of four replicate 
extractions. Compounds for which there was not a significant difference in concentration after 
second-stage treatment in at least 2 out of 3 trials are not shown (α=0.05). Abbreviations are 
defined in Table B.1. NS indicates a trial for which the concentration was not significantly 
different after second-stage treatment.  
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Figure 5.2 Effect of second-stage residence time on the removal of selected 5-ring PAHs. Bars 
represent means and standard deviation of four replicate extractions. For each PAH, conditions 
for which there was not a significant difference (α=0.05) in removal detected by Tukey's method 
are assigned the same letter. Numbers below the bars correspond to the three trials at a given 
residence time.  
5.3.3 (Geno)toxicity 
Cytotoxicity and genotoxicity were determined with the DT-40 chicken lymphocyte 
assay; cytotoxicity was evaluated with the parental cell line and genotoxicity with the DNA 
repair-deficient mutants, Rad54-/- and Rev1-/-. All second-stage trials reduced the cytotoxicity of 
the soil relative to the first-stage effluent (Figure 5.3a). The average relative LC50’s of the first-
stage treated soil across the 6 trials were 0.71 ± 0.08 for the Rad54-/- mutant and 0.79 ± 0.09 for 
the Rev1-/- mutant. Both relative LC50 values were significantly less than 1.0, indicating that the 
effluent from the first-stage bioreactor was genotoxic. Relative to first-stage treated soil, all 
second-stage trials at the 7-day residence time increased genotoxicity as measured with the Rev1-
/- mutant (Figure 5.3c). Only trial 2 of the 7-day treatment trials significantly increased 
genotoxicity as measured with the Rad54-/- mutant (Figure 5.3b). Trials 1 and 2 of the 12-day 
second-stage treatment significantly increased genotoxicity as measured with both mutants, 
while no significant effect was observed in trial 3. In general, both first- and second-stage 
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treatment increased the genotoxicity of soil, a result that was not substantially improved with 
increased second-stage treatment time from 7 days to 12 days. There was insufficient evidence of 
genotoxicity for the untreated feed soil as measured with either of the DT-40 mutant cell lines 
because the relative LC50’s were not statistically significantly different than 1.0 (Figure 5.3b,c). 
 
 
5.4  Discussion 
Although the addition of surfactants has been suggested as a means of enhancing the 
biodegradation of hydrophobic contaminants such as PAHs in soil, few studies have emphasized 
that the benefits are most likely to be manifested in systems limited by low bioaccessibility. In 
separate studies using PAH-contaminated soils from two different sites, we reported that 
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Figure 5.3 Effect of first- and second-stage 
treatment on (geno)toxicity.  (a) Toxicity to the 
parental DT40 cell line, and genotoxicity as 
determined by relative LC50 values (mutant 
LC50/parental LC50) using the DNA repair-deficient 
mutants Rad54-/- (b) and Rev1-/- (c). X-axis labels 
refer to the residence time and trial at that residence 
time. FS is untreated feed soil for the first-stage 
bioreactor. Bars represent means and standard 
deviations of three experiments, except FS which is 
from four experiments. An asterisk indicates a 
significant difference (α=0.05) between first and 
second-stage treatment. 
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nonionic surfactants substantially improved the desorption and biodegradation of residual PAHs 
from contaminated soil that had already undergone aerobic treatment in a lab-scale bioreactor 
(Zhu and Aitken 2010; Adrion et al. in prep.). We have consistently found the fraction of PAHs 
remaining after first-stage treatment to be of low bioaccessibility (Zhu and Aitken 2010; Hu et 
al. 2014; Adrion et al. in prep.) and in previous studies found that further treatment without 
surfactant led to limited PAH removal (Zhu and Aitken 2010; Adrion et al. in prep.). In this 
study, we extended the concept by evaluating the reproducibility of a semi-continuous two-stage 
treatment process at the bench-scale.  
Additional PAH removal observed during POESH-amended treatment of effluent slurry 
from the first-stage bioreactor was consistent with our previous study, particularly the substantial 
removal of 4-ring PAHs (Adrion et al. in prep.). In addition to the PAHs, removal of the four 
oxy-PAHs we evaluated was also enhanced by the addition of POESH. Oxy-PAHs are of 
concern because some are known to exhibit toxic or genotoxic effects (Chesis et al. 1984; Bolton 
et al. 2000; Zielinska-Park et al. 2004; Luo et al. 2011), and may also inhibit the biodegradation 
of parent PAHs (Kazunga and Aitken 2000; Kazunga et al. 2001). Of these four compounds, AQ 
was present in the initial (untreated) soil at the highest concentration, 24 µg/g (Table B.1); 
overall removal of AQ in the two-stage process was 95% (Table B.4 and Table B.5). 
Despite the fact that the oxy-PAHs were more desorbable than the unsubstituted PAHs in 
the effluent soil from the first-stage bioreactor (Hu et al. 2014), the addition of POESH appeared 
to improve their bioaccessibility as well. Although none of the oxy-PAHs increased in 
concentration, net increases of some oxy-PAHs have been observed during bioremediation 
(Lundstedt et al. 2003) and researchers have inferred the formation of oxy-PAH based on ratios 
of oxy-PAH to parent compound (Wilcke et al. 2014). 
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The most substantial removal of 3- and 4-ring PAHs occurred within the first week of 
second-stage treatment, as evidenced by the limited differences between 7-day and 12-day batch 
treatment. Extending the residence time of the second-stage bioreactor to 12 days from 7 days 
led to greater average removal of the 5-ring compounds BbF, BkF, and BaP, although variability 
in the data (particularly in trial 2) made statistical comparisons less conclusive. As discussed in 
our previous work, we assume that POESH sorbs to and facilitates PAH desorption from the 
non-polar domains found in MGP soil (e.g., coal tar and black carbon) (Adrion et al. in prep.). 
Hypothesized effects of surfactants on these soil domains include increased PAH diffusivity 
within the coal-tar matrix (Yeom et al. 1996), increased interfacial surface area caused by 
wetting (Dong et al. 2003), and dispersion of non-polar matrices (Kile and Chiou 1989; Zhang 
and Miller 1992; Churchill et al. 1995). It is also possible that surfactants can influence the 
release of soil organic matter with which PAHs associate (Markiewicz et al. 2013). 
There were unidentified factors affecting aqueous-phase surfactant and PAH 
concentrations during second-stage treatment. Preliminary test-tube-scale incubations with whole 
slurry form the first-stage bioreactor agreed well with our previous test-tube scale work (Adrion 
et al. in prep.), suggesting that the greater aqueous-phase surfactant concentration observed in 
the larger-scale, second-stage reactor could be due to the method of mixing. Mixing in the test-
tube-scale incubations (orbital shaking) was more turbulent than that achieved during second-
stage treatment using a magnetic stir bar. The second trials of both the 7- and 12-day residence 
times had higher aqueous-phase surfactant and PAH concentrations at 48 hours, and this may 
have affected PAH removal (trial 2 had lower PAH removal than trials 1 and 3 in each case). 
Because adequate interaction of the surfactant with the solid phase is important before 
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commencing aerobic treatment (Zhu and Aitken 2010), the adequacy of mixing is an important 
issue to consider for scale-up in the two-stage treatment concept. 
It is also possible that the liquid phase of the effluent from the first-stage bioreactor 
influenced the liquid-phase behavior of POESH and/or PAHs in the second-stage bioreactor 
during the anoxic mixing period. In our earlier work at test-tube scale (Zhu and Aitken 2010; 
Adrion et al. in prep.), the liquid-phase from the first-stage bioreactor was replaced with fresh 
buffer before the surfactant was added. The liquid phase of the first-stage bioreactor slurry could 
contain dissolved or colloidal organic matter that can act like a surfactant (reducing surface 
tension) and can facilitate the apparent solubilization of hydrophobic compounds (Akkanen et al. 
2005; Grolimund and Borkovec 2005; Markiewicz et al. 2013). However, if such factors did 
influence the apparent liquid-phase concentrations of POESH and/or PAHs in the second-stage 
bioreactor, we would have expected to observe this effect in the preliminary experiment at test-
tube scale (i.e., it should have been independent of mixing intensity). 
The increased genotoxicity resulting from treatment of the feed soil in the first-stage 
bioreactor observed in this study is consistent with our previous studies on the same 
contaminated source soil (Hu et al. 2012; Hu et al. 2014). The Rad54-/- and Rev1-/- mutants used 
in this study are deficient in the Rad54 and Rev1 proteins, respectively. These two proteins are 
implicated in the repair or tolerance of damage caused by the major types of PAH-induced 
genotoxicity: strand breaks caused by oxidative stress (Rad54), and adduction of DNA by stable 
or depurinating adducts (Rev1) (Friedberg 2006; Penning 2011). Although second-stage 
treatment removed substantial amounts of 4- and 5-ring PAHs, including some considered to be 
human carcinogens, second-stage treatment consistently increased genotoxicity relative to the 
effluent soil removed from the first-stage bioreactor. 
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Overall, the genotoxicity of remediated soil will depend both on the remaining parent 
compounds and the formation or removal of any products of incomplete microbial metabolism. 
Reduction of parent-PAH concentrations does not always correspond to a reduction in 
genotoxicity (Hughes et al. 1998; Gillespie et al. 2007; Lemieux et al. 2009; Hu et al. 2012). 
Because second-stage treatment made the soil less cytotoxic, but more genotoxic, it is possible 
that surfactant treatment causes transformation of cytotoxic compounds that are not genotoxic 
themselves into genotoxic products. For example, Zielinska-Park et al. (2004) found that 
bacterial transformation products such as pyrene- and fluoranthene-quinones can cause oxidative 
DNA damage in vitro using calf thymus DNA and HeLa S3 cells. The authors speculated that 
during biodegradation, bacteria may metabolically activate PAHs, such as pyrene, which might 
not otherwise be activated to an appreciable extent by mammalian metabolic systems. Such 
bacterial activation can, therefore, transform relatively non-genotoxic PAHs such as pyrene, or 
other non-genotoxic contaminants in the soil, into redox active products. 
This work demonstrated the effectiveness of a semi-continuous two-stage process for the 
treatment of PAH-contaminated soil. In the first stage, soil was treated in a bioreactor without 
surfactant in order to remove the most readily bioaccessible fractions of PAHs and oxy-PAHs. 
Effluent from the first-stage bioreactor was further treated in a second stage, comprising bench-
scale batch, surfactant-amended bioreactors that removed substantial amounts of the residual 
PAHs and oxy-PAHs. The observation that parent PAH removal did not necessarily correspond 
to a reduction in genotoxicity, however, highlights the need for further research to identify 
genotoxic products to improve risk management and remediation strategies. Increasing the 
residence time of the second-stage bioreactor from 7 days to 12 days had limited effect on 
removal of the targeted contaminants except for several five-ring PAHs. Overall, the two-stage 
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treatment concept we evaluated may be a promising method of maximizing the removal of PAHs 
during bioremediation. Factors to consider for scale-up include the adequacy of initial anoxic 
mixing and the effect of residence time in both stages. Although we found from screening 
experiments (Adrion et al. in prep.) that the optimum surfactant was POESH, in other cases the 
optimum surfactant and its dose may be site-specific, and therefore should be evaluated in 
preliminary bench-scale treatability studies.
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CHAPTER 6: CONCLUSIONS AND RECOMMENDATIONS 
6.1 Conclusions 
The primary goal of this work was to improve the bioremediation of PAH-contaminated 
soil by screening several surfactants for enhanced biodegradation of the PAHs remaining in soil 
after conventional bioreactor-treatment. A secondary goal was to investigate the effect of 
surfactant-amended treatment on soil toxicity and genotoxicity. Conclusions for the specific aims 
of this research project are outlined below: 
Aim 1: Evaluate the effect of conventional bioreactor treatment on the removal and 
bioavailability of oxy-PAHs in contaminated soil. 
An LC-MS/MS method was developed to quantify four oxy-PAHs in solvent extracts of 
soil and SPE resins. In collaboration with a former student in our lab, the method was used to 
quantify the concentrations and desorbable fractions of oxy-PAHs in soil before and after 
bioreactor treatment. Bioremediation removed substantial amounts of oxy-PAHs and reduced the 
desorbable fractions. For all measured oxy-PAHs, the percent removed during treatment 
exceeded the desorbable fraction in the untreated soil, suggesting that biodegradation was not 
limited to the initial desorbable fraction. The LC-MS/MS method was also used to determine the 
aqueous solubility of the four oxy-PAHs and to evaluate the effect of surfactant-amended 
treatment on the removal of oxy-PAHs in Aim 3. 
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Aim 2: Screen nonionic surfactants for enhanced biodegradation of PAHs remaining in soil after 
conventional bioreactor treatment. 
Five nonionic surfactants (Brij 30, Span 20, Ecosurf™ EH-3, polyoxyethylene sorbitol 
hexaoleate, and R-95™ rhamnolipid biosurfactant) were evaluated for their ability to enhance 
PAH desorption and biodegradation in contaminated soil after it had been treated in an aerobic, 
slurry-phase bioreactor. Surfactant doses were selected to correspond to aqueous-phase 
concentrations below the critical micelle concentration in the soil-slurry system. The effect of 
surfactant amendment on soil (geno)toxicity was also evaluated for Brij 30, Span 20, and 
POESH using the chicken DT40 B-lymphocyte cell line and two of its isogenic DNA-repair-
deficient mutants. Compared to no-surfactant controls, incubation of the bioreactor-treated soil 
with all surfactants resulted in modest increases in PAH desorption as measured with an infinite-
sink desorption method. All of the surfactants except R-95 substantially increased PAH 
biodegradation in the bioreactor-treated soil relative to the no-surfactant control. POESH had the 
greatest effect, resulting in removal of 50% of total measured PAHs. Brij 30, Span 20, and 
POESH were particularly effective at enhancing biodegradation of four- and five-ring PAHs, 
including five of the seven compounds designated as probable human carcinogens, with 
removals up to 80%. Surfactant treatment also significantly enhanced the removal of alkyl-
PAHs. All treatments except POESH at the optimum dose for PAH removal significantly 
increased soil cytotoxicity. Only the no-surfactant control and Brij 30 at the optimum dose 
significantly decreased soil genotoxicity to both mutant cell lines. Despite removing substantial 
amounts of 4- and 5-ring PAHs, including 5 of the 7 considered probable human carcinogens, 
POESH treatment either had no effect on genotoxicity or caused a slight increase in genotoxicity.  
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Aim 3: Implement second-stage treatment of PAH-contaminated soil in a surfactant-amended 
bioreactor and evaluate its performance. 
In Aim 2, POESH was identified as the optimum among the five surfactants for 
enhancing PAH removal, especially the high-molecular-weight PAHs (4- and 5-ring 
compounds). In Aim 3 the concept was extended by treating the effluent from the slurry-phase 
bioreactor in a second-stage batch reactor to which POESH was added. Batch treatment was 
conducted in three trials at a residence time of 7 days and three trials at a residence time of 12 
days. Surfactant-amended treatment removed substantial amounts of the PAHs and oxy-PAHs 
remaining after conventional slurry-phase bioremediation, including more than 80% of residual 
4-ring PAHs. The most substantial PAH removal occurred within the first week of treatment. 
Surfactant-amended treatment consistently made the soil less cytotoxic, but in most trials 
increased the genotoxicity of the soil. 
6.2 Recommendations for future work 
Further research could investigate the cause of limited PAH removal beyond the first 
week of second-stage treatment. For example, increased removal could be limited by low 
bioavailability of parent PAHs. The desorbable fractions after second-stage treatment with 
surfactant could be measured using SPE methods or selective extraction with cyclodextrin for 
example. Further removal could also be limited by the accumulation of inhibitory transformation 
products of PAHs or other compounds. This possibility could be investigated by identifying 
compounds that accumulate during bioremediation. It is also possible that further removal could 
be limited by the availability of primary substrates that are needed during the cometabolism of 
PAHs. 
The second goal of this work was to evaluate the effect of surfactant-amended treatment 
on the (geno)toxicity of the soil. A strength of the DT40 bioassay is its ability to identify the 
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specific types of DNA damage caused by a chemical, especially direct-acting genotoxicants. 
Although PAHs primarily require metabolic activation in order to exert genotoxic effects, we 
chose the Rad54-/- and Rev1-/- mutants because of their previously reported sensitivity to the soil 
used in this study. Future research could use the method of S9 metabolic preactivation developed 
for the DT40 assay (Hashimoto et al. 2015). S9 preactivation is meant to simulate the xenobiotic 
metabolism which occurs in the liver; however, some have argued that the S9 mixture 
composition is biased toward activating enzymes rather than detoxifying enzymes (Gad 2003). 
Preactivated soil residue may more accurately represent the mixture of chemicals that cause 
genotoxicity in humans and therefore may be a better measurement of risk. Additional research 
could also identify the compounds responsible for the increase in genotoxicity that occurred 
during conventional bioreactor treatment and during second-stage treatment with POESH.  
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APPENDIX A: SUPPORTING INFORMATION FOR CHAPTER 4 
Procedure for measuring surfactant soil/water partitioning and pyrene solubilization 
Incubations of each surfactant with bioreactor-treated soil were prepared in duplicate for 
ten doses, including a no-surfactant dose. Incubations were prepared by adding 1-g dry weight 
bioreactor-treated soil to 15-mL glass crimp-top vials with PTFE-lined septa. Surfactant stock 
solution in phosphate buffer (pH 7.5) was added to give the desired surfactant doses. Additional 
phosphate buffer was added to give a final solids content of 15% (w/w). Incubation vials were 
purged with nitrogen and then put on a wrist-action shaker in the dark. Because the experiment 
required a mass of bioreactor-treated soil larger than that produced by the bioreactor in a single 
week, incubations were set up over multiple weeks using separate batches of bioreactor-treated 
soil. Each batch was analyzed for pyrene concentration in triplicate. After two days, which was 
sufficient to reach apparent equilibrium liquid-phase surfactant and pyrene concentrations based 
on preliminary experiments (data not shown), incubation vials were centrifuged and the liquid 
phase was syringe-filtered through a 0.8-µm polycarbonate membrane. The surface tension of 
the ﬁltrate was analyzed with a Du Nouy tensiometer (CSC Scientiﬁc Co., Inc. Fairfax, VA) after 
necessary dilutions were made to obtain a ﬁnal surface tension corresponding to a concentration 
below the CMC. The concentration of surfactant in the filtrate was calculated using calibration 
curves of surface tension vs. the log of surfactant concentration. Liquid-phase pyrene 
concentration for each dose was determined by diluting the liquid phase into acetonitrile and 
analyzing by HPLC as described elsewhere (Richardson et al. 2011). The percent total pyrene 
mass in the liquid phase was calculated using the mass of pyrene in the liquid phase at day 2 
divided by the mass of pyrene in the bioreactor-treated soil added at the time of incubation setup. 
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Procedure for extraction and analysis of feed soil 
To measure the concentration of the 14 EPA priority-pollutants PAHs analyzed by HPLC 
(denoted in the footnotes to Table A.1), 28-g wet-weight feed soil was slurried in bioreactor 
buffer to make a 15% (w/w) slurry. The slurry was passed through a 2-mm screen (comparable 
to the procedure for feeding the reactor), collected, and centrifuged at 3900 RPM for 20 minutes. 
Aliquots (3-g wet weight) of centrifuged soil were transferred to each of six 30-mL glass 
centrifuge tubes with PTFE-lined septa with screwcaps. Three tubes were spiked with a known 
amounts of anthracene-D10 as a recovery surrogate. Sodium sulfate (10 g) was mixed into each 
tube and the soil was extracted overnight twice (each time with 10-mL acetone and 10-mL 
dichloromethane) and analyzed for PAH concentrations by HPLC as described elsewhere 
(Richardson et al. 2011).  
For the remaining PAHs, feed soil was extracted using the QuEChERS method. Briefly, 
5-g wet-weight feed soil was added to each of three 50-mL centrifuge tubes. The soil was spiked 
with 100-µL 10-µg/mL recovery surrogates (naphthalene-D8, acenaphthene-D10, chrysense-D12, 
and perylene-D12) in acetonitrile and shaken vigorously for 3 min. Then 5-mL water was added 
and shaken vigorously for 3 min. Then 12-mL acetonitrile and QuEChERS AOAC salt packet 
(Agilent 5982-5755) was added and the tubes vigorously shaken for 3 min. Tubes were then 
centrifuged for 3500 RPM for 10 min. 5-mL of the supernatant was transferred to a 15-mL 
dispersive SPE tube (Agilent 5982-5158) and shaken for 3 minutes, centrifuged at 3500 RPM for 
10 min and filtered through a 0.45µm PVDF syringe filter. 
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GC-MS analysis procedure 
QuEChERS extracts of the feed soil and solvent-extracts from the followup 
biodegradation experiment (after filtering through sodium sulfate to remove residual water) were 
analyzed by GC-MS for additional PAHs and alkyl-PAHs as described elsewhere (Luellen and 
Shea 2002).  
Table A.1 Concentrations of Priority PAHs in feed soil.a 
EPA Priority PAH Abbreviation 
Concentration 
(µg/g dry soil) 
Naphthalene NAP 22.9 ± 3.0 
Acenaphthylene ACY 11.0 ± 0.5 
Acenaphthene ACE 9.81 ± 0.71 
Fluorene FLU 4.95 ± 0.67 
Phenanthrene PHN 99.4 ± 5.1 
Anthracene ANT 9.03 ± 0.83 
Fluoranthene FLA 67.1 ± 4.1 
Pyrene PYR 108 ± 6 
Benz[a]anthracene BaA 39.2 ± 3.6 
Chrysene CHR 61.9 ± 3.1 
Benzo[b]fluoranthene BbF 24.4 ± 1.8 
Benzo[k]fluoranthene BkF 12.0 ± 1.0 
Benzo[a]pyrene BaP 29.8 ± 2.7 
Indeno[1,2,3-cd]pyrene IDP 15.7 ± 0.9 
Dibenz[a,h]anthracene DBA 2.01 ± 0.21 
Benzo[g,h,i]perylene BgP 25.5 ± 2.2 
Total EPA priority PAHsb Σ 16 PAH 542 ± 11 
Total carcinogenic PAHsb Σ Carc. PAH 185 ± 6 
a Values represent means and standard deviations. The 14 PAHs measured by HPLC were NAP, 
ACE, FLU, PHN, ANT, FLA, PYR, BaA, CHR, BbF, BkF, BaP, DBA, and BgP. All other 
PAHs were measured by GC-MS. For feed soil only, values measured by HPLC are from 6 
replicates and by GC-MS are from triplicates. b Standard deviation of totals calculated by 
propagation of error. Bolded compounds are EPA probable human carcinogens.  
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Table A.2 Concentrations of other PAHs in feed soil.a 
Other PAH Abbreviation 
Concentration 
(µg/g dry soil) 
2-Methylnaphthalene 2MNAP 7.30 ± 0.98 
1-Methylnaphthalene 1MNAP 6.22 ± 0.79 
Biphenyl BIP 0.77 ± 0.08 
2,6-Dimethylnaphthalene DMNAP 7.29 ± 0.35 
Dibenzofuran DBF 0.64 ± 0.07 
2,3,5-Trimethylnaphthalene TMNAP BDL 
C1-Naphthalenes C1-NAP 13.7 ± 1.8 
C2-Naphthalenes C2-NAP 33.5 ± 1.9 
C3-Naphthalenes C3-NAP 43.4 ± 1.4 
C4-Naphthalenes C4-NAP 16.9 ± 0.1 
1-Methylfluorene 1MFLU 3.34 ± 0.19 
C1-Fluorenes C1-FLU 10.8 ± 1.2 
C2-Fluorenes C2-FLU 13.2 ± 0.9 
Dibenzothiophene DBT 0.45 ± 0.06 
C1-Dibenzothiophene C1-DBT 1.76 ± 0.04 
C2-Dibenzothiophene C2-DBT 2.30 ± 0.09 
C3-Dibenzothiophene C3-DBT 1.70 ± 0.17 
1-Methylphenanthrene 1MPHN 122 ± 3 
C1-Phenanthrenes/Anthracenes C1-PHN/ANT 264 ± 1 
C2-Phenanthrenes/Anthracenes C2-PHN/ANT 181 ± 4 
C3-Phenanthrenes/Anthracenes C3-PHN/ANT 83.3 ± 2.2 
C4-Phenanthrenes/Anthracenes C4-PHN/ANT 11.2 ± 0.5 
C1-Fluoranthenes/Pyrene C1-FLA/PYR 53.5 ± 2.0 
C2-Fluroanthrene/Pyrene C2-FLA/PYR 21.4 ± 1.0 
C3-Fluoranthrene/Pyrene C3-FLA/PYR 12.1 ± 0.3 
Retene RET 148 ± 4 
C1-Chrysenes C1-CHR 33.1 ± 0.9 
C2-Chrysenes C2-CHR 11.0 ± 0.6 
C3-Chrysenes C3-CHR 3.27 ± 0.17 
C4-Chrysenes C4-CHR 0.98 ± 0.04 
Benzo[e]pyrene BeP 18.2 ± 0.9 
Perylene PER 4.99 ± 0.33 
Coronene COR 3.18 ± 0.14 
a “BDL” indicates below detection limit. Other Notes as in Table A.1.
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Table A.3 Concentrations of PAHs in the bioreactor-treated soil samples used in the preliminary biodegradation and followup 
(geno)toxicity experiments.a 
PAH 
Initial biodegradation experiments bioreactor-treated soil (µg/g) Follow-up 
(geno)toxicity 
bioreactor-treated 
soil (µg/g) 
Brij 30 Span 20 EH-3 POESH R-95 
NAP 22.3 ± 2.1 18.7 ± 2.1 22.7 ± 1.0 19.8 ± 2.9 19.2 ± 0.4 22.4 ± 0.9 
ACE 3.4 ± 0.3 1.5 ± 0.2 2.9 ± 0.3 1.4 ± 0.4 1.9 ± 0.4 2.1 ± 0.3 
FLU 2.0 ± 0.2 1.5 ± 0.1 2.3 ± 0.2 1.9 ± 0.3 1.7 ± 0.2 2.3 ± 0.7 
PHN 30.5 ± 3.5 24.1 ± 2.2 35.0 ± 3.5 27.2 ± 6.0 27.6 ± 2.7 33.5 ± 5.0 
ANT 3.1 ± 0.2 2.6 ± 0.2 3.6 ± 0.3 3.0 ± 0.4 2.8 ± 0.2 3.6 ± 0.9 
FLA 18.3 ± 1.3 15.9 ± 1.1 21.3 ± 1.6 16.5 ± 2.1 17.1 ± 0.8 23.1 ± 3.0 
PYR 31.7 ± 2.1 26.4 ± 2.3 34.9 ± 2.1 29.7 ± 4.1 29.3 ± 0.9 35.7 ± 4.2 
BaA 15.6 ± 1.3 15.1 ± 1.5 18.1 ± 1.4 14.1 ± 1.4 15.7 ± 0.6 18.4 ± 2.0 
CHR 24.5 ± 1.6 15.9 ± 2.3 28.9 ± 1.3 22.3 ± 2.7 25.8 ± 0.9 20.4 ± 2.3 
BbF 13.4 ± 0.6 11.6 ± 0.8 14.8 ± 0.8 12.0 ± 1.5 13.2 ± 0.5 13.8 ± 0.7 
BkF 6.7 ± 0.4 6.1 ± 0.3 6.6 ± 0.1 5.6 ± 0.3 6.3 ± 0.2 7.1 ± 0.3 
BaP 18.7 ± 1.4 15.7 ± 1.1 20.7 ± 1.4 15.4 ± 1.7 17.5 ± 0.8 18.6 ± 1.4 
DBA 1.4 ± 0.1 1.1 ± 0.2 1.4 ± 0.3 1.2 ± 0.2 1.2 ± 0.1 1.3 ± 0.2 
BgP 24.7 ± 1.8 24.0 ± 3.6 26.4 ± 2.7 21.3 ± 2.8 24.0 ± 1.3 24.2 ± 1.7 
Total PAH 216 ± 13 180 ± 12 239 ± 13 191 ± 24 203 ± 6 227 ± 19 
a Data represent means and standard deviations of six replicates. Abbreviations are defined in Table A.1. 
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Table A.4 PAH mass desorbed for incubations with Brij 30 and concentration of PAHs in bioreactor-treated soil used to prepare 
desorption incubations.  
PAH 
Bioreactor-
treated soil (µg/g) 
Mass Desorbed (%) 
No Surfactant Brij 30 lower Brij 30 higher 
NAP 20.6 ± 0.1 0.27 ± 0.27a 2.57 ± 0.61* 2.95 ± 0.40* 
ACE 1.9 ± 0.3 1.38 ± 1.06a 34.5 ± 6.1* 52.3 ± 9.8* 
FLU 1.8 ± 0.2 0.25 ± 0.17a 13.0 ± 1.5* 19.2 ± 7.9* 
PHN 37.3 ± 0.3 0.11 ± 0.03 3.27 ± 0.31* 9.60 ± 6.47* 
ANT 3.7 ± 0.2 0.09 ± 0.04a 5.46 ± 0.44* 8.08 ± 1.84* 
FLA 22.1 ± 0.3 0.15 ± 0.09 4.54 ± 0.12* 5.24 ± 0.43* 
PYR 37.5 ± 0.8 0.15 ± 0.08 3.81 ± 0.18* 4.41 ± 0.42* 
BaA 12.7 ± 0.2 0.17 ± 0.13 1.48 ± 0.11* 1.79 ± 0.37* 
CHR 16.9 ± 0.8 0.13 ± 0.10 1.15 ± 0.13* 1.30 ± 0.17* 
BbF 12.0 ± 0.1 0.09 ± 0.08a 0.26 ± 0.14 0.37 ± 0.16* 
BkF 7.5 ± 0.1 0.11 ± 0.10 0.22 ± 0.12 0.30 ± 0.14 
BaP 23.0 ± 0.5 0.10 ± 0.09 0.19 ± 0.07 0.25 ± 0.13 
DBA 2.2 ± 0.1 <0.20 <0.40 <0.40 
BgP 25.3 ± 1.0 0.07 ± 0.13a 0.05 ± 0.05a 0.10 ± 0.07 
Total PAHb 225 ± 2 0.14 ± 0.04 2.56 ± 0.09* 4.11 ± 1.08* 
a Cohen’s Maximum Likelihood Estimate was used to account for one or more replicates below the lower limit of quantification 
(LLOQ). “Less than” values are below LLOQ. b Total PAH percent mass desorbed does not include mass of individual PAH below the 
LLOQ. “Lower” and “higher” refer to surfactant doses described in Materials and Methods. An asterisk indicates a significant 
difference (α=0.05) in mass desorbed (µg) between a treatment and no-surfactant control. Abbreviations are defined in Table A.1. 
  
99 
Table A.5 PAH mass desorbed for incubations with Span 20 and POESH and concentration of PAHs in bioreactor-treated soil used to 
prepare desorption incubations.a 
PAH 
Bioreactor-treated 
soil (µg/g) 
Mass Desorbed (%) 
No surfactant Span 20 lower Span 20 higher POESH lower POESH higher 
NAP 22.4 ± 0.9 0.32 ± 0.06 1.21 ± 0.42* 1.36 ± 0.14* 0.90 ± 0.42* 1.26 ± 0.11* 
ACE 3.2 ± 0.2 1.05 ± 0.23 4.28 ± 1.91* 9.68 ± 1.60* 3.01 ± 2.14a 8.49 ± 1.66* 
FLU 2.5 ± 0.1 0.21 ± 0.08 1.63 ± 0.71* 3.54 ± 0.51* 0.89 ± 0.82a 2.71 ± 0.35* 
PHN 40.2 ± 1.7 0.10 ± 0.03 0.45 ± 0.37 0.67 ± 0.09* 0.41 ± 0.33 0.85 ± 0.17* 
ANT 4.0 ± 0.3 0.08 ± 0.02 0.30 ± 0.33a 0.62 ± 0.13* 0.31 ± 0.31a 0.83 ± 0.18* 
FLA 24.0 ± 1.1 0.12 ± 0.03 0.88 ± 0.41* 2.43 ± 0.34* 0.51 ± 0.31* 1.77 ± 0.31* 
PYR 40.0 ± 2.4 0.12 ± 0.02 0.68 ± 0.34* 1.50 ± 0.12* 0.31 ± 0.19 1.10 ± 0.31* 
BaA 19.5 ± 1.3 0.06 ± 0.01 0.27 ± 0.08* 0.58 ± 0.09* 0.18 ± 0.05* 0.46 ± 0.08* 
CHR 23.6 ± 0.9 0.07 ± 0.06 0.18 ± 0.12 0.47 ± 0.09* 0.10 ± 0.06a 0.36 ± 0.06* 
BbF 14.6 ± 1.5 0.04 ± 0.00 <0.12 <0.12 <0.12 0.11 ± 0.02* 
BkF 7.9 ± 0.4 0.03 ± 0.00 0.09 ± 0.02* 0.14 ± 0.03* 0.05 ± 0.01* 0.08 ± 0.01* 
BaP 20.1 ± 1.4 0.03 ± 0.01 0.10 ± 0.02* 0.14 ± 0.02* 0.07 ± 0.03* 0.09 ± 0.01* 
DBA 1.5 ± 0.2 <0.15 <0.60 <0.60 <0.60 <0.60 
BgP 24.6 ± 1.7 0.02 ± 0.00 <0.04 <0.04 <0.04 <0.04 
Total PAHb 248 ± 8 0.10 ± 0.01 0.46 ± 0.09* 0.90 ± 0.05* 0.33 ± 0.08* 0.84 ± 0.07* 
a Notes as in Table A.4.  
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Table A.6 PAH mass desorbed for incubations with R-95 and EH-3 and concentration of PAHs in bioreactor-treated soil used to 
prepare desorption incubations.a 
PAH 
Bioreactor-
treated soil 
(µg/g) 
Mass Desorbed (%) 
No Surfactant R-95 lower R-95 higher EH-3 lower EH-3 higher 
NAP 28.4 ± 3.3 0.17 ± 0.03a 0.26 ± 0.10 0.55 ± 0.22* 1.25 ± 0.16* 2.40 ± 1.10* 
ACE 2.7 ± 0.4 <0.83 1.69 ± 1.08 4.33 ± 1.38 30.0 ± 9.3 21.6 ± 5.1 
FLU 2.7 ± 0.2 <0.16 <0.16 1.05 ± 0.54 6.66 ± 2.76 11.5 ± 2.9 
PHN 47.9 ± 1.3 0.04 ± 0.02 0.07 ± 0.00 0.15 ± 0.11 1.32 ± 0.34* 3.40 ± 1.92* 
ANT 4.8 ± 0.5 <.05 0.07 ± 0.01 0.20 ± 0.09 5.97 ± 0.76 4.81 ± 0.98 
FLA 29.6 ± 2.6 0.04 ± 0.01 0.13 ± 0.08 0.48 ± 0.25* 3.69 ± 1.80* 1.82 ± 0.24* 
PYR 54.9 ± 5.0 0.04 ± 0.01 0.10 ± 0.05 0.29 ± 0.14* 2.93 ± 1.39* 1.28 ± 0.23* 
BaA 24.7 ± 2.2 0.03 ± 0.01 0.04 ± 0.02 0.15 ± 0.06* 2.06 ± 2.48 0.43 ± 0.04* 
CHR 38.1 ± 4.6 <0.02 <0.02 0.10 ± 0.03 1.55 ± 1.91 0.33 ± 0.05 
BbF 18.6 ± 2.6 <0.05 <0.02 0.06 ± 0.04a 0.89 ± 1.37 0.11 ± 0.05a 
BkF 9.1 ± 0.4 0.02 ± 0.01a 0.02 ± 0.01 0.06 ± 0.02* 0.78 ± 1.23 0.07 ± 0.01* 
BaP 27.4 ± 2.0 0.02 ± 0.01a 0.03 ± 0.00 0.05 ± 0.02 0.69 ± 1.08 0.07 ± 0.01* 
DBA 1.8 ± 0.2 <0.25 <0.25 <0.25 <0.50 <0.50 
BgP 32.1 ± 2.7 <0.01 <0.01 <0.01 <0.02 <0.02 
Total PAHb 323 ± 26 0.03 ± 0.00 0.08 ± 0.02 0.24 ± 0.05* 2.01 ± 0.46* 1.53 ± 0.33* 
a Notes as in Table A.4. 
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Table A.7 PAH mass recovered from higher-dose surfactant desorption incubations.a 
PAH 
Mass Recovered (%) 
Brij 30 Span 20 EH-3 POESH R-95 
NAP 89.8 ± 2.4 83.5 ± 7.7 85.0 ± 12.9 84.1 ± 12.7 84.1 ± 12.7 
ACE 107 ± 21 77.7 ± 12.6 84.5 ± 15.5 83.3 ± 12.1 72.1 ± 22.9 
FLU 98.3 ± 16.2 76.9 ± 13.8 104 ± 17 82.0 ± 9.2 83.0 ± 10.7 
PHN 95.1 ± 12.2 68.1 ± 11.7 68.3 ± 18.0 73.9 ± 11.8 67.9 ± 10.3 
ANT 97.0 ± 6.2 64.9 ± 9.9 103 ± 20 69.6 ± 7.5 67.6 ± 11.8 
FLA 105 ± 2 74.2 ± 9.4 106 ± 18 79.6 ± 6.3 62.5 ± 11.7 
PYR 97.9 ± 2.6 65.7 ± 9.1 90.8 ± 9.6 69.3 ± 5.1 60.3 ± 11.8 
BaA 107 ± 4 80.2 ± 10.8 101 ± 19 90.1 ± 6.1 66.5 ± 12.5 
CHR 99.0 ± 6.3 70.6 ± 6.8 98.9 ± 15.0 73.3 ± 6.1 77.0 ± 18.1 
BbF 102 ± 4 79.7 ± 13.4 104 ± 19 93.1 ± 9.7 88.2 ± 17.2 
BkF 102 ± 3 80.2 ± 10.5 101 ± 7 90.4 ± 7.1 86.6 ± 9.2 
BaP 98.9 ± 3.4 80.6 ± 11.0 96.5 ± 11.2 90.1 ± 9.6 83.4 ± 10.5 
DBA 96.7 ± 8.1 84.9 ± 20.8 94.4 ± 13.2 91.8 ± 12.2 82.3 ± 17.7 
BgP 98.4 ± 4.7 77.6 ± 12.9 94.5 ± 10.7 91.5 ± 14.3 84.1 ± 10.5 
a Values represent means and standard deviations of triplicates. Abbreviations are defined in 
Table A.1. 
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Table A.8 Concentrations of PAHs in followup biodegradation experiment.a  
PAH 
Concentration (µg/g) 
Bioreactor 
treated 
No 
surfactant 
Brij 30 
lower 
Brij 30 
higher 
POESH 
lower 
POESH 
higher 
Span 20 
higher 
NAP 20.8 ± 1.3 17.3 ± 1.3 17.1 ± 1.3 17.2 ± 0.8 19.3 ± 0.8 18.1 ± 1.3 19.3 ± 1.2 
ACY 12.3 ± 0.4 10.9 ± 1.0 10.4 ± 2.8 - - 12.6 ± 0.5 12.7 ± 0.9 
ACE 2.08 ± 0.31 1.48 ± 0.44 1.21 ± 0.23 1.30 ± 0.19 1.63 ± 0.34 1.25 ± 0.28 1.74 ± 0.36 
FLU 1.64 ± 0.21 1.41 ± 0.22 1.14 ± 0.08 1.10 ± 0.12 1.52 ± 0.26 1.20 ± 0.14 1.54 ± 0.22 
PHN 27.1 ± 2.4 20.5 ± 2.6 16.5 ± 2.1 14.1 ± 0.6 20.1 ± 1.9 16.4 ± 1.1 19.9 ± 2.1 
ANT 2.97 ± 0.23 2.34 ± 0.24 1.93 ± 0.18 1.87 ± 0.09 2.33 ± 0.21 2.06 ± 0.35 2.45 ± 0.42 
FLA 17.8 ± 0.8 13.1 ± 1.3 5.47 ± 0.86 9.46 ± 0.83 8.05 ± 0.81 4.97 ± 0.47 8.35 ± 1.87 
PYR 30.2 ± 1.5 22.7 ± 2.0 9.12 ± 0.80 25.2 ± 1.9 13.4 ± 1.3 7.52 ± 0.61 12.7 ± 2.0 
BaA 15.4 ± 0.9 12.1 ± 1.1 4.93 ± 0.43 13.3 ± 0.8 6.85 ± 0.77 3.84 ± 0.37 6.61 ± 1.18 
CHR 24.4 ± 1.1 18.8 ± 1.8 7.02 ± 0.39 15.4 ± 0.7 9.76 ± 1.18 4.62 ± 0.52 8.59 ± 1.09 
BbF 13.7 ± 1.0 11.4 ± 0.6 8.23 ± 0.29 12.8 ± 0.6 6.73 ± 0.59 5.65 ± 0.52 6.89 ± 0.80 
BkF 6.63 ± 0.33 5.53 ± 0.33 3.63 ± 0.10 6.29 ± 0.25 3.32 ± 0.26 2.00 ± 0.23 3.15 ± 0.50 
BaP 16.7 ± 0.9 13.9 ± 0.9 11.7 ± 0.1 15.4 ± 0.5 9.27 ± 0.90 8.21 ± 1.03 9.47 ± 1.24 
IDP 15.0 ± 1.2 13.9 ± 0.7 13.0 ± 3.9 - - 15.2 ± 1.1 15.5 ± 2.0 
DBA 0.99 ± 0.12 0.81 ± 0.08 0.90 ± 0.11 1.05 ± 0.10 0.64 ± 0.22 0.72 ± 0.18 0.59 ± 0.13 
BgP 23.0 ± 0.6 21.4 ± 1.7 20.9 ± 0.5 20.8 ± 1.1 22.1 ± 1.1 21.1 ± 1.2 23.2 ± 1.2 
Σ 16 PAHb 231 ± 4 188 ± 5 133 ± 6 - - 125 ± 3 153 ± 5 
Σ Carc. PAHb 92.8 ± 2.3 76.6 ± 2.5 49.4 ± 3.9 - - 40.2 ± 1.7 50.8 ± 3.0 
2MNAP 7.04 ± 0.50 6.10 ± 0.92 5.21 ± 1.39 - - 6.41 ± 0.68 6.33 ± 0.54 
1MNAP 4.17 ± 0.17 3.48 ± 0.52 2.83 ± 0.80 - - 3.31 ± 0.31 3.51 ± 0.25 
BIP 0.83 ± 0.03 0.70 ± 0.09 0.62 ± 0.16 - - 0.72 ± 0.07 0.84 ± 0.06 
DMNAP 2.61 ± 0.11 1.96 ± 0.17 1.56 ± 0.36 - - 1.94 ± 0.13 4.38 ± 4.79 
DBF 0.52 ± 0.04 0.43 ± 0.04 0.38 ± 0.11 - - 0.46 ± 0.05 0.55 ± 0.06 
TMNAP 1.38 ± 0.11 1.01 ± 0.08 0.54 ± 0.08 - - 0.68 ± 0.01 0.97 ± 0.19 
C1-NAP 12.5 ± 0.6 10.4 ± 1.3 8.89 ± 2.44 - - 10.6 ± 0.9 11.1 ± 0.6 
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Table A.8 (continued)  
C2-NAP 13.5 ± 0.7 10.4 ± 1.4 8.10 ± 2.00 - - 9.68 ± 0.47 11.4 ± 1.4 
C3-NAP 10.7 ± 0.6 7.47 ± 0.93 5.08 ± 1.09 - - 5.79 ± 0.29 7.39 ± 1.34 
C4-NAP 4.57 ± 0.22 3.18 ± 0.40 1.57 ± 0.34 - - 1.72 ± 0.12 2.33 ± 0.38 
1MFLU 1.05 ± 0.04 0.75 ± 0.11 0.53 ± 0.11 - - 0.62 ± 0.03 0.77 ± 0.09 
C1-FLU 4.48 ± 0.28 2.71 ± 1.26 2.96 ± 0.71 - - 3.35 ± 0.20 3.91 ± 0.36 
C2-FLU 5.77 ± 0.44 5.01 ± 0.49 3.10 ± 0.81 - - 3.79 ± 0.27 4.12 ± 0.34 
DBT BDL BDL BDL - - BDL BDL 
C1-DBT 0.70 ± 0.04 0.44 ± 0.26 0.18 ± 0.18 - - 0.16 ± 0.21 0.49 ± 0.04 
C2-DBT BDL BDL BDL - - BDL BDL 
C3-DBT BDL BDL BDL - - BDL BDL 
1MPHN 34.4 ± 1.6 22.4 ± 3.0 10.5 ± 1.8 - - 11.5 ± 0.6 16.2 ± 2.5 
C1-PHN/ANT 78.3 ± 4.9 53.7 ± 6.7 29.1 ± 6.3 - - 32.5 ± 1.1 41.1 ± 5.3 
C2-PHN/ANT 67.6 ± 3.9 47.1 ± 4.7 20.4 ± 4.5 - - 20.7 ± 1.1 27.7 ± 3.2 
C3-PHN/ANT 38.4 ± 1.5 28.5 ± 3.7 10.3 ± 2.4 - - 9.13 ± 0.48 13.9 ± 1.7 
C4-PHN/ANT BDL BDL BDL - - BDL BDL 
C1-FLA/PYR 28.4 ± 1.3 21.4 ± 2.1 10.4 ± 2.6 - - 9.17 ± 0.75 13.0 ± 1.9 
C2-FLA/PYR 14.6 ± 0.5 11.9 ± 1.5 8.10 ± 2.12 - - 7.63 ± 0.47 8.57 ± 0.66 
C3-FLA/PYR 8.77 ± 0.42 7.28 ± 0.85 5.24 ± 1.29 - - 4.83 ± 0.17 5.31 ± 0.31 
RET 74.8 ± 3.1 54.8 ± 5.9 16.5 ± 4.0 - - 10.9 ± 0.7 20.5 ± 2.8 
C1-CHR 16.5 ± 0.9 13.5 ± 1.1 5.44 ± 1.34 - - 3.61 ± 0.44 6.56 ± 0.51 
C2-CHR 8.94 ± 0.54 7.36 ± 0.57 4.56 ± 1.23 - - 2.87 ± 0.37 3.84 ± 0.32 
C3-CHR 5.27 ± 0.22 4.46 ± 0.49 3.58 ± 1.00 - - 3.37 ± 0.36 3.14 ± 0.27 
C4-CHR BDL BDL BDL - - BDL BDL 
BeP 10.7 ± 0.7 9.25 ± 0.66 5.09 ± 1.30 - - 2.57 ± 0.31 4.82 ± 0.76 
PER 4.35 ± 0.41 3.97 ± 0.31 3.51 ± 0.97 - - 3.99 ± 0.31 4.07 ± 0.35 
COR 3.99 ± 0.14 3.57 ± 0.22 3.22 ± 0.91 - - 3.77 ± 0.29 3.79 ± 0.68 
a Values represent means standard deviations of five replicates. “-“ indicates not determined. “BDL” indicates below detection limit 
.Other notes as in Table A.1. 
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Table A.9 Overall removal of PAHs in treatments relative to feed soil.a 
PAH 
Removal relative to untreated feed soil (%) 
Bioreactor 
alone 
No 
Surfactant 
Brij 30 lower 
Brij 30 
higher 
POESH 
lower 
POESH 
higher 
Span 20 
higher 
NAP 9.26 ± 13.2 24.6 ± 11.3 25.3 ± 11.2 24.8 ± 10.4 15.4 ± 11.5 20.9 ± 11.7 15.6 ± 12.2 
ACY -11.2 ± 6.1 1.19 ± 9.72 5.50 ± 25.3 - - -13.9 ± 6.6 -15.3 ± 9.7 
ACE 78.8 ± 3.6 84.9 ± 4.7 87.7 ± 2.5 86.8 ± 2.2 83.4 ± 3.7 87.3 ± 3.0 82.3 ± 3.8 
FLU 66.9 ± 6.2 71.6 ± 5.9 76.9 ± 3.5 77.7 ± 3.9 69.3 ± 6.7 75.7 ± 4.3 68.9 ± 6.2 
PHN 72.7 ± 2.8 79.4 ± 2.8 83.4 ± 2.2 85.8 ± 1.0 79.8 ± 2.2 83.5 ± 1.4 80.0 ± 2.3 
ANT 67.1 ± 3.9 74.1 ± 3.6 78.6 ± 2.8 79.4 ± 2.1 74.3 ± 3.3 77.1 ± 4.4 72.9 ± 5.3 
FLA 73.5 ± 2.0 80.5 ± 2.2 91.8 ± 1.4 85.9 ± 1.5 88.0 ± 1.4 92.6 ± 0.8 87.6 ± 2.9 
PYR 71.9 ± 2.0 78.9 ± 2.1 91.5 ± 0.9 76.6 ± 2.2 87.5 ± 1.3 93.0 ± 0.7 88.2 ± 2.0 
BaA 60.8 ± 4.3 69.0 ± 4.0 87.4 ± 1.6 66.1 ± 3.7 82.5 ± 2.5 90.2 ± 1.3 83.1 ± 3.4 
CHR 60.6 ± 2.7 69.6 ± 3.3 88.7 ± 0.9 75.1 ± 1.7 84.2 ± 2.1 92.5 ± 0.9 86.1 ± 1.9 
BbF 43.8 ± 5.8 53.2 ± 4.4 66.3 ± 2.8 47.5 ± 4.7 72.4 ± 3.2 76.8 ± 2.7 71.7 ± 3.9 
BkF 44.7 ± 5.3 53.9 ± 4.7 69.7 ± 2.6 47.5 ± 4.8 72.3 ± 3.1 83.3 ± 2.3 73.7 ± 4.7 
BaP 43.9 ± 5.9 53.3 ± 5.1 60.7 ± 3.5 48.2 ± 4.9 68.9 ± 4.1 72.4 ± 4.3 68.2 ± 5.0 
IDP 4.54 ± 9.44 11.4 ± 6.8 17.5 ± 25.0 - - 3.47 ± 8.82 1.84 ± 13.99 
DBA 50.7 ± 7.8 59.9 ± 6.0 55.2 ± 7.3 47.8 ± 7.3 68.3 ± 11.3 64.2 ± 9.6 70.8 ± 7.1 
BgP 9.83 ± 8.03 16.2 ± 9.9 17.9 ± 7.2 18.2 ± 8.2 13.4 ± 8.5 17.2 ± 8.5 8.92 ± 9.11 
Σ 16 PAH 57.5 ± 1.1 65.4 ± 1.2 75.4 ± 1.1 - - 76.9 ± 0.7 71.8 ± 1.1 
Σ Carc. PAH 49.8 ± 2.0 58.6 ± 1.9 73.3 ± 2.3 - - 78.2 ± 1.2 72.6 ± 1.9 
2MNAP 3.54 ± 14.6 16.5 ± 16.9 28.6 ± 21.3 - - 12.2 ± 15.0 13.3 ± 13.8 
1MNAP 32.9 ± 8.9 44.1 ± 11.0 54.5 ± 14.1 - - 46.9 ± 8.4 43.6 ± 8.2 
BIP -8.12 ± 11.4 8.95 ± 14.82 18.7 ± 22.3 - - 5.70 ± 12.9 -8.94 ± 13.4 
DMNAP 64.2 ± 2.3 73.2 ± 2.7 78.6 ± 5.1 - - 73.3 ± 2.2 39.9 ± 65.7 
DBF 18.4 ± 10.4 32.2 ± 9.7 40.0 ± 19.0 - - 27.2 ± 11.2 13.5 ± 13.3 
TMNAP NC NC NC - - NC NC 
C1-NAP 9.30 ± 12.7 24.4 ± 13.6 35.3 ± 19.7 - - 22.9 ± 12.1 19.2 ± 11.4 
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Table A.9 (continued)  
C2-NAP 59.7 ± 3.1 68.9 ± 4.5 75.8 ± 6.1 - - 71.1 ± 2.2 66.0 ± 4.6 
C3-NAP 75.4 ± 1.6 82.8 ± 2.2 88.3 ± 2.5 - - 86.6 ± 0.8 83.0 ± 3.1 
C4-NAP 72.9 ± 1.3 81.2 ± 2.4 90.7 ± 2.0 - - 89.8 ± 0.7 86.2 ± 2.2 
1MFLU 68.5 ± 2.2 77.5 ± 3.4 84.1 ± 3.3 - - 81.5 ± 1.5 76.8 ± 3.1 
C1-FLU 58.4 ± 5.2 74.8 ± 12.0 72.5 ± 7.2 - - 68.9 ± 3.8 63.8 ± 5.1 
C2-FLU 56.3 ± 4.4 62.1 ± 4.5 76.6 ± 6.3 - - 71.4 ± 2.8 68.9 ± 3.3 
DBT NC NC NC - - NC NC 
C1-DBT 60.3 ± 2.6 75.2 ± 14.9 89.7 ± 10.2 - - 91.1 ± 12.1 72.4 ± 2.1 
C2-DBT NC NC NC - - NC NC 
C3-DBT NC NC NC - - NC NC 
1MPHN 71.8 ± 1.5 81.7 ± 2.5 91.4 ± 1.5 - - 90.6 ± 0.5 86.7 ± 2.1 
C1-PHN/ANT 70.3 ± 1.9 79.7 ± 2.5 89.0 ± 2.4 - - 87.7 ± 0.4 84.4 ± 2.0 
C2-PHN/ANT 62.6 ± 2.3 73.9 ± 2.7 88.7 ± 2.5 - - 88.5 ± 0.7 84.6 ± 1.8 
C3-PHN/ANT 53.9 ± 2.2 65.8 ± 4.5 87.7 ± 2.9 - - 89.0 ± 0.6 83.3 ± 2.0 
C4-PHN/ANT NC NC NC - - NC NC 
C1-FLA/PYR 47.0 ± 3.1 60.0 ± 4.2 80.6 ± 4.8 - - 82.9 ± 1.5 75.8 ± 3.6 
C2-FLA/PYR 31.6 ± 4.1 44.5 ± 7.5 62.1 ± 10.1 - - 64.3 ± 2.8 59.9 ± 3.6 
C3-FLA/PYR 27.7 ± 4.0 40.0 ± 7.1 56.8 ± 10.7 - - 60.2 ± 1.7 56.2 ± 2.8 
RET 49.6 ± 2.4 63.0 ± 4.1 88.9 ± 2.7 - - 92.7 ± 0.5 86.1 ± 1.9 
C1-CHR 50.2 ± 3.0 59.4 ± 3.6 83.6 ± 4.1 - - 89.1 ± 1.4 80.2 ± 1.6 
C2-CHR 18.7 ± 6.6 33.0 ± 6.3 58.5 ± 11.4 - - 73.8 ± 3.7 65.1 ± 3.5 
C3-CHR -61.0 ± 10.7 -36.4 ± 16.7 -9.43 ± 31.0 - - -3.12 ± 12.2 4.13 ± 9.55 
C4-CHR NC NC NC - - NC NC 
BeP 41.4 ± 4.9 49.2 ± 4.4 72.0 ± 7.3 - - 85.9 ± 1.9 73.5 ± 4.4 
PER 12.8 ± 10.0 20.3 ± 8.2 29.6 ± 20.1 - - 20.0 ± 8.1 18.4 ± 8.8 
COR -25.5 ± 7.1 -12.3 ± 8.7 -1.33 ± 29.0 - - -18.6 ± 10.6 -19.4 ± 22.0 
a Values represent means and standard deviations calculated through propagation of error. “-“ indicates not determined. “NC” indicates 
removal not calculated because concentration in feed soil or concentration in treated soil was below the detection limit. Other notes as 
in Table A.1. 
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Figure A.1 Aqueous-phase surfactant 
concentration (○) and corresponding 
percent total pyrene mass in liquid 
phase as a function (●) of surfactant 
dose  for five surfactants incubated 
with bioreactor-treated soil. Points 
represent means and standard 
deviations of duplicates. Doses for 
which the corresponding pyrene level 
is not displayed had levels below the 
method LLOQ of 0.1%. 
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Figure A.2 Data from Figure A.1 in 
the low range of surfactant dose only. 
Dashed horizontal line represents the 
CMC as measured in phosphate 
buffer. Arrows denote higher dose 
selected for desorption and 
biodegradation experiments.
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Figure A.3 Effect of Brij 30, POESH, and Span 20 in followup biodegradation experiment on 
residual alkylated 2- and 3-ring PAHs from bioreactor-treated soil after 16 days. “Lower” and 
“higher” refer to doses described in Materials and Methods. Bars represent means and standard 
deviations of five replicates. Conditions for which there was not a significant difference (α=0.05) 
in final PAH soil-concentration detected by Tukey's method are assigned the same letter. Bars 
for which no letter is shown are implicitly designated “a”. PAHs for which there were no 
significant differences between no-surfactant controls and all surfactant conditions are not 
shown.  
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Figure A.4 Effect of anaerobic incubation with POESH on the biodegradation of residual PAHs 
from bioreactor-treated soil after 16 days. “Higher” refers to the higher dose as described in 
Materials and Methods. Bars represent means and standard deviations of four replicates. 
 
Figure A.5 Effect of anaerobic incubation with POESH on (geno)toxicity of bioreactor treated 
soil  after 16 days (referred to in the text as the followup (geno)toxicity experiment). (a) LC50 of 
soil for parental DT40 cell line. (b) Relative LC50’s of soil for Rad54-/- and Rev1-/- mutants. Bars 
represent means and standard deviations of three experiments. In pairwise t-tests, no condition is 
significantly different (α=0.05) than the bioreactor-treated soil (BTS). NS, no-surfactant; NSA, 
no-surfactant anaerobic; PH, POESH higher; PHA, POESH higher anaerobic.  
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APPENDIX B: SUPPORTING INFORMATION FOR CHAPTER 5 
Preliminary time-course experiment 
A preliminary experiment was conducted to choose appropriate batch residence times for 
second-stage treatment. Effluent from the first-stage bioreactor was dosed with POESH (24-
mg/g-dry soil) in quadruplicate 30-mL glass centrifuge tubes with PTFE-lined silicone-septa 
screwcaps and incubated under nitrogen for 48 hours, after which the caps were opened to allow 
air into the headspace, following the methods in Adrion et al. (in prep.). POESH-containing 
incubations were sacrificed at 3, 7, 14, 21 and 28 days, and incubations without POESH were 
sacrificed at 21 days. PAH removal and soil (geno)toxicity were measured as described in 
Section 5.2.6. Results are shown for PAH removal in Figure B.1 and for (geno)toxicity in Figure 
B.2.  
 
Figure B.1 Effect of incubation with POESH over time on PAHs remaining after first-stage 
bioreactor treatment.  NS day 21, no-surfactant control day 21; Day 3-28; incubations with 
POESH  
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Figure B.2 Effect of incubation of first-stage treated soil with POESH over time on 
(geno)toxicity.  (a) Toxicity to the parental DT40 cell line, and (b) genotoxicity as determined by 
relative LC50 values (mutant LC50/parental LC50) using the DNA repair-deficient mutants Rad54-
/- and Rev1-/-. Bars represent means and standard deviations of three experiments. NS, no-
surfactant control; P, POESH. 
Table B.1 Concentrations of PAHs and Oxy-PAHs measured in untreated bioreactor feed soil.a 
Compound Abbreviation 
Concentration 
(µg/g dry soil) 
Naphthalene NAP 21.9 ± 1.7 
Acenaphthene ACE 8.0 ± 1.1 
Fluorene FLU 5.0 ± 0.9 
Phenanthrene PHN 92.7 ± 16.8 
Anthracene ANT 8.5 ± 0.7 
Fluoranthene FLA 64.8 ± 4.2 
Pyrene PYR 105.3 ± 5.9 
Benz[a]anthracene BaA 39.7 ± 2.3 
Chrysene CHR 47.6 ± 1.5 
Benzo[b]fluoranthene BbF 23.5 ± 1.5 
Benzo[k]fluoranthene BkF 11.6 ± 0.6 
Benzo[a]pyrene BaP 28.2 ± 1.7 
Dibenz[a,h]anthracene DBA 2.1 ± 0.1 
Benzo[g,h,i]perylene BgP 25.5 ± 3.7 
9,10-phenanthrenequinone PQ 1.1 ± 0.1 
9-fluorenone FLO 1.2 ± 0.3 
9,10-anthraquinone  AQ 23.5 ± 2.0 
Benz[a]anthracene-7,12-quinone  BAQ 2.0 ± 0.0 
a Values represent means and standard deviations of four replicate extractions.
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Table B.2 Concentrations of PAHs and Oxy-PAHs after first-stage treatment and 7-day second-stage treatment.a 
Compound 
Concentration (µg/g dry soil) 
7 day trial 1 7 day trial 2 7 day trial 3 
First stage Second stage First stage Second stage First stage Second stage 
NAP 19.5 ± 0.2 17.7 ± 0.7 20.0 ± 0.8 18.4 ± 1.3 18.8 ± 1.0 17.1 ± 0.7 
ACE 1.77 ± 0.13 0.86 ± 0.11 1.63 ± 0.16 0.48 ± 0.17 2.50 ± 0.06 1.10 ± 0.10 
FLU 1.53 ± 0.04 0.89 ± 0.05 1.76 ± 0.04 0.96 ± 0.07 1.70 ± 0.12 0.90 ± 0.03 
PHN 25.2 ± 2.0 11.3 ± 0.5 25.3 ± 1.1 10.8 ± 0.8 25.0 ± 0.8 9.78 ± 0.42 
ANT 2.63 ± 0.12 1.46 ± 0.05 2.75 ± 0.15 1.57 ± 0.18 2.67 ± 0.10 1.43 ± 0.06 
FLA 17.4 ± 0.6 2.90 ± 0.15 17.7 ± 1.1 3.94 ± 0.47 18.2 ± 0.3 2.61 ± 0.08 
PYR 30.0 ± 1.0 4.42 ± 0.20 30.0 ± 1.2 3.87 ± 0.42 30.6 ± 0.4 3.66 ± 0.13 
BaA 14.4 ± 0.8 2.78 ± 0.20 16.9 ± 0.9 8.63 ± 1.37 15.7 ± 0.7 2.81 ± 0.12 
CHR 23.2 ± 0.9 3.15 ± 0.68 20.8 ± 1.4 10.6 ± 1.0 18.5 ± 1.3 3.52 ± 0.16 
BbF 12.7 ± 0.4 8.78 ± 0.33 12.7 ± 0.6 10.7 ± 0.9 12.6 ± 0.6 8.94 ± 0.52 
BkF 6.40 ± 0.18 3.89 ± 0.13 6.21 ± 0.29 5.13 ± 0.38 6.15 ± 0.15 4.41 ± 0.18 
BaP 15.1 ± 0.4 9.89 ± 0.49 22.2 ± 2.2 17.4 ± 2.7 15.4 ± 0.6 9.95 ± 0.61 
DBA 1.44 ± 0.07 1.22 ± 0.10 1.59 ± 0.16 1.45 ± 0.32 1.30 ± 0.04 1.25 ± 0.33 
BgP 22.4 ± 0.8 20.9 ± 0.9 22.7 ± 1.3 20.2 ± 2.4 19.4 ± 0.4 18.6 ± 2.0 
PQ 0.28 ± 0.02 0.14 ± 0.01 0.23 ± 0.02 0.12 ± 0.02 0.27 ± 0.06 0.14 ± 0.02 
FLO 0.60 ± 0.02 0.48 ± 0.06 0.59 ± 0.07 0.46 ± 0.03 0.60 ± 0.04 0.43 ± 0.05 
AQ 3.30 ± 0.32 1.16 ± 0.09 3.32 ± 0.45 1.24 ± 0.23 3.44 ± 0.48 1.01 ± 0.19 
BAQ 0.80 ± 0.09 0.56 ± 0.11 0.76 ± 0.09 0.40 ± 0.02 0.71 ± 0.11 0.43 ± 0.07 
a Values represent means and standard deviations of four replicate extractions. Abbreviations are defined in Table B.1. 
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Table B.3 Concentrations of PAHs and Oxy-PAHs after first-stage treatment and 12-day second-stage treatment.a 
Compound 
Concentration (µg/g dry soil) 
12 day trial 1 12 day trial 2 12 day trial 3 
First stage Second stage First stage Second stage First stage Second stage 
NAP 18.0 ± 0.6 16.8 ± 0.3 19.0 ± 1.8 16.7 ± 1.5 19.4 ± 0.4 16.4 ± 0.6 
ACE 1.64 ± 0.12 0.87 ± 0.09 1.59 ± 0.22 0.46 ± 0.07 2.60 ± 0.09 1.02 ± 0.08 
FLU 1.41 ± 0.06 0.85 ± 0.04 1.59 ± 0.13 0.85 ± 0.06 1.79 ± 0.18 0.86 ± 0.04 
PHN 23.6 ± 1.2 11.0 ± 0.3 24.4 ± 2.3 9.51 ± 0.73 26.1 ± 0.7 9.61 ± 0.27 
ANT 2.45 ± 0.08 1.46 ± 0.04 2.63 ± 0.25 1.40 ± 0.12 3.00 ± 0.11 1.37 ± 0.04 
FLA 16.3 ± 0.4 2.82 ± 0.07 16.9 ± 1.7 2.26 ± 0.18 19.0 ± 0.6 2.29 ± 0.11 
PYR 27.7 ± 0.8 4.55 ± 0.13 29.4 ± 2.9 3.09 ± 0.15 31.8 ± 0.6 3.37 ± 0.11 
BaA 12.9 ± 1.3 2.17 ± 0.57 13.6 ± 6.1 2.83 ± 0.14 16.2 ± 0.6 2.31 ± 0.04 
CHR 21.0 ± 4.9 3.42 ± 0.87 19.6 ± 2.1 3.45 ± 0.29 19.1 ± 1.4 2.70 ± 0.10 
BbF 12.0 ± 0.5 5.51 ± 0.25 12.5 ± 1.4 8.88 ± 0.50 13.0 ± 0.4 7.47 ± 0.27 
BkF 5.96 ± 0.15 1.88 ± 0.07 6.07 ± 0.70 4.11 ± 0.15 6.51 ± 0.20 3.19 ± 0.09 
BaP 13.9 ± 0.4 6.44 ± 0.25 20.8 ± 4.5 13.0 ± 1.9 16.4 ± 0.6 8.13 ± 0.21 
DBA 1.23 ± 0.17 1.09 ± 0.06 1.64 ± 0.28 1.33 ± 0.29 1.41 ± 0.13 1.16 ± 0.23 
BgP 20.6 ± 0.6 19.8 ± 0.5 22.9 ± 2.8 20.3 ± 1.5 21.1 ± 1.1 17.7 ± 1.4 
PQ 0.28 ± 0.04 0.14 ± 0.02 0.29 ± 0.05 0.11 ± 0.02 0.31 ± 0.04 0.13 ± 0.03 
FLO 0.57 ± 0.03 0.49 ± 0.02 0.58 ± 0.06 0.40 ± 0.04 0.60 ± 0.03 0.43 ± 0.06 
AQ 3.22 ± 0.14 1.25 ± 0.22 3.47 ± 0.50 0.96 ± 0.15 3.78 ± 0.64 0.84 ± 0.18 
BAQ 0.75 ± 0.11 0.42 ± 0.06 0.75 ± 0.06 0.31 ± 0.04 0.81 ± 0.15 0.33 ± 0.05 
a Values represent means and standard deviations of four replicate extractions. Abbreviations are defined in Table B.1. 
  
  
114 
Table B.4 Removal of PAHs and oxy-PAHs during first-stage and 7-day second-stage treatment.a 
Compound 
Removal relative to untreated feed soil (%) 
7 day trial 1 7 day trial 2 7 day trial 3 
First stage Overallb First stage Overallb First stage Overallb 
NAP 10.7 ± 7.2 18.9 ± 7.1 8.5 ± 8.2 15.8 ± 9.1 14.0 ± 8.3 22.0 ± 7.1 
ACE 77.9 ± 3.4 89.2 ± 2.0 79.6 ± 3.4 94.0 ± 2.2 68.7 ± 4.3 86.2 ± 2.3 
FLU 69.5 ± 5.3 82.3 ± 3.2 65.1 ± 6.0 80.9 ± 3.6 66.2 ± 6.2 82.1 ± 3.1 
PHN 72.8 ± 5.4 87.9 ± 2.3 72.8 ± 5.1 88.4 ± 2.3 73.0 ± 5.0 89.5 ± 2.0 
ANT 69.1 ± 3.0 82.9 ± 1.6 67.7 ± 3.2 81.6 ± 2.7 68.6 ± 2.9 83.3 ± 1.6 
FLA 73.1 ± 2.0 95.5 ± 0.4 72.6 ± 2.5 93.9 ± 0.8 71.9 ± 1.9 96.0 ± 0.3 
PYR 71.6 ± 1.9 95.8 ± 0.3 71.5 ± 1.9 96.3 ± 0.4 71.0 ± 1.7 96.5 ± 0.2 
BaA 63.8 ± 2.8 93.0 ± 0.6 57.5 ± 3.3 78.3 ± 3.7 60.4 ± 2.9 92.9 ± 0.5 
CHR 51.2 ± 2.4 93.4 ± 1.4 56.4 ± 3.3 77.8 ± 2.1 61.1 ± 3.0 92.6 ± 0.4 
BbF 46.1 ± 3.7 62.7 ± 2.7 46.1 ± 4.2 54.4 ± 4.8 46.4 ± 4.2 62.0 ± 3.2 
BkF 44.9 ± 3.1 66.5 ± 2.0 46.6 ± 3.6 55.8 ± 3.9 47.1 ± 2.9 62.1 ± 2.4 
BaP 46.5 ± 3.5 65.0 ± 2.7 21.2 ± 9.0 38.2 ± 10.1 45.4 ± 3.9 64.8 ± 3.0 
DBA 32.0 ± 5.6 42.4 ± 6.0 25.0 ± 8.9 31.5 ± 15.8 38.6 ± 4.6 41.1 ± 16.0 
BgP 12.0 ± 13.3 17.9 ± 12.6 10.8 ± 14.1 20.7 ± 15.0 24.0 ± 11.3 27.0 ± 13.3 
PQ 74.8 ± 3.2 87.3 ± 1.5 79.7 ± 2.5 89.0 ± 1.7 76.0 ± 5.9 87.9 ± 2.0 
FLO 52.0 ± 10.5 61.8 ± 9.6 52.8 ± 11.6 62.9 ± 8.4 51.7 ± 10.9 65.6 ± 8.3 
AQ 86.0 ± 1.8 95.1 ± 0.6 85.9 ± 2.3 94.7 ± 1.1 85.4 ± 2.4 95.7 ± 0.9 
BAQ 60.5 ± 4.5 72.2 ± 5.3 62.2 ± 4.6 80.4 ± 1.1 64.9 ± 5.2 78.5 ± 3.4 
a Values represent means and standard deviations from four replicate extractions. Standard deviations are calculated through 
propagation of error. b Combined removal from first- and second-stage treatment. Abbreviations are defined in Table B.1. 
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Table B.5 Removal of PAHs and oxy-PAHs during first-stage and 12-day second-stage treatment.a 
 
Compound 
Removal relative to untreated feed soil (%) 
12 day trial 1 12 day trial 2 12 day trial 3 
First stage  Overallb First stage  Overallb First stage  Overallb 
NAP 17.7 ± 7.2 23.2 ± 6.3 13.0 ± 10.8 23.4 ± 9.1 11.3 ± 7.3 24.9 ± 6.6 
ACE 79.6 ± 3.2 89.1 ± 1.9 80.1 ± 3.8 94.3 ± 1.2 67.5 ± 4.6 87.2 ± 2.0 
FLU 72.0 ± 4.9 83.1 ± 3.0 68.4 ± 6.0 83.2 ± 3.1 64.4 ± 7.1 83.0 ± 3.0 
PHN 74.6 ± 4.8 88.1 ± 2.2 73.6 ± 5.4 89.7 ± 2.0 71.9 ± 5.2 89.6 ± 1.9 
ANT 71.3 ± 2.6 82.8 ± 1.5 69.2 ± 3.9 83.5 ± 2.0 64.8 ± 3.2 83.9 ± 1.4 
FLA 74.8 ± 1.7 95.6 ± 0.3 73.9 ± 3.1 96.5 ± 0.4 70.7 ± 2.1 96.5 ± 0.3 
PYR 73.7 ± 1.6 95.7 ± 0.3 72.1 ± 3.2 97.1 ± 0.2 69.8 ± 1.8 96.8 ± 0.2 
BaA 67.4 ± 3.8 94.5 ± 1.5 65.7 ± 15.6 92.9 ± 0.5 59.1 ± 2.7 94.2 ± 0.4 
CHR 55.8 ± 10.3 92.8 ± 1.8 58.9 ± 4.6 92.7 ± 0.6 59.8 ± 3.2 94.3 ± 0.3 
BbF 48.8 ± 3.8 76.6 ± 1.8 46.8 ± 6.8 62.3 ± 3.2 44.6 ± 3.9 68.3 ± 2.3 
BkF 48.7 ± 2.8 83.9 ± 1.0 47.8 ± 6.5 64.6 ± 2.2 44.0 ± 3.2 72.6 ± 1.5 
BaP 50.7 ± 3.2 77.2 ± 1.6 26.3 ± 16.7 53.8 ± 7.4 41.9 ± 4.1 71.2 ± 1.9 
DBA 41.9 ± 8.8 48.8 ± 4.4 22.8 ± 14.3 37.1 ± 14.1 33.5 ± 7.4 45.1 ± 11.6 
BgP 19.0 ± 12.1 22.4 ± 11.6 10.0 ± 17.1 20.4 ± 13.1 17.3 ± 12.9 30.5 ± 11.7 
PQ 74.6 ± 4.0 87.1 ± 1.9 74.4 ± 5.2 90.4 ± 1.6 72.1 ± 4.3 88.1 ± 3.1 
FLO 54.0 ± 10.2 61.0 ± 8.6 53.7 ± 10.9 67.7 ± 7.5 51.5 ± 10.7 65.3 ± 9.0 
AQ 86.3 ± 1.3 94.7 ± 1.0 85.3 ± 2.5 95.9 ± 0.7 83.9 ± 3.1 96.4 ± 0.8 
BAQ 62.9 ± 5.5 79.2 ± 3.0 63.0 ± 3.1 84.6 ± 2.0 59.9 ± 7.4 83.9 ± 2.5 
a Values represent means and standard deviations from four replicate extractions. Standard deviations are calculated through 
propagation of error. b Combined removal from first- and second-stage treatment. Abbreviations are defined in Table B.1. 
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